thiazoles has been researched along with warfarin in 519 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (1.16) | 18.7374 |
1990's | 9 (1.73) | 18.2507 |
2000's | 35 (6.74) | 29.6817 |
2010's | 406 (78.23) | 24.3611 |
2020's | 63 (12.14) | 2.80 |
Authors | Studies |
---|---|
Remmer, H; Snyder, R | 1 |
Berlin, I; Cournot, A; Sallord, JC; Singlas, E | 1 |
Prino, G; Santamaria, L | 1 |
Hume, M; Kuriakose, TX; Turner, RH; Zuch, L | 1 |
Freeman, RG; Knox, JM; Murtishaw, W | 1 |
Gibson, TE; Parfitt, JW | 1 |
Boyd, MR; Boyer, PL; Currens, MJ; Hughes, SH; McMahon, JB | 1 |
Beamand, JA; Lake, BG; Mistry, H; Price, RJ; Renwick, AB; Wield, PT | 1 |
Ito, K; Kasai, H; Miyashita, Y | 2 |
Bluhmki, E; Busch, U; Heinzel, G; Hoffmann, J; Su, CA; Türck, D | 1 |
Goldberg, MP; Handran, SD; Hyrc, K; Rothman, SM | 1 |
Häcker, G; Roloff, S; Wilhelm, S | 1 |
Morreale, AP; Plowman, BK | 1 |
Funae, Y; Funayama, M; Green, C; Inoue, K; Kamataki, T; Kimura, K; Kinoshita, M; Kodama, T; Nagashima, K; Nunoya, K; Yokoi, T | 1 |
Maliwal, BP; Thompson, RB; Zeng, HH | 1 |
Knaggs, AR | 1 |
Doss, SH; Louca, NA; Wardakhan, WW | 1 |
Jimenez, JA; Jones, G | 1 |
Krishna, DR; Rao, VR; Srimanth, K | 1 |
Deligeorgiev, TG; Katerinopoulos, HE; Liepouri, F; Savakis, C; Veneti, Z | 1 |
García-Báez E, EV; Höpfl, H; Martínez-Martínez, FJ; Padilla-Martínez, II | 1 |
Nauen, R; Rauch, N | 1 |
Gorman, AM; Quigney, DJ; Samali, A | 1 |
Greger, M; Landberg, T; Lindberg, S | 1 |
Crowell, KJ; Fattorusso, R; Forino, M; Jung, D; Pellecchia, M | 1 |
Baek, SH; Chai, KY; Chung, HT; Jang, SI; Kim, YJ; Kwak, GB; Kwak, KC; Kwon, TO; Lee, WY; Yun, YG | 1 |
Karguppikar, AM; Mulimani, BG; Nadaf, YF; Raikar, US; Renuka, CG; Soudagar, MK | 1 |
Friis, C; Gillberg, M; Skaanild, MT | 1 |
Erlanson, DA; Gordon, EM; Shiau, TP | 1 |
Dong, Y; Feng, SS | 1 |
Hadjipavlou-Litina, D; Kontogiorgis, CA; Luo, Y; Xu, Y | 1 |
Draeger, G; Hey-Hawkins, E; Jashari, A; Mikhova, B; Popovski, E | 1 |
Aryal, S; Chaudhari, AA; Dharmaraj, N; Kim, HY; Kim, WD; Park, SY; Prabu, P | 1 |
Alesiani, D; Bei, R; Canini, A; Cicconi, R; Mattei, M; Montesano, C | 1 |
Li, HL; Liu, RH; Shen, YH; Su, J; Wu, ZJ; Zhang, C; Zhang, WD | 1 |
Hoshide, S; Kanou, M; Mukoyoshi, M; Muroga, H; Nishimura, S; Taniguchi, K; Umeda, S | 1 |
Chen, S; Lui, K; Mori, T; Tamura, T; Zhou, D | 1 |
Cheng, G; Chung, SJ; Cui, F; Kim, DD; Kim, IW; Shim, CK; Shim, WS; Yang, R; Yang, SG | 1 |
Hiwatari, K; Hoffman, RM; Kataoka, M; Kimura, R; Ma, H; Masaoka, Y; Sakuma, S; Shoji, Y; Tachikawa, H; Tang, L; Yamashita, S; Yang, Z; Yano, T | 1 |
Gao, X; Hu, K; Jiang, X; Li, J; Lu, W; Shen, Y; Zhang, Q | 1 |
Cheng, G; Chung, SJ; Cui, FD; Han, X; Jin, QR; Kim, DD; Shim, CK; Shim, WS; Yang, R | 1 |
Hara, H; Hironaka, K; Inokuchi, Y; Shimazawa, M; Takeuchi, H; Tozuka, Y | 1 |
Anitha, P; Feng, SS; Gan, CW; Mei, L; Zhou, W | 1 |
Cavalli, R; Civra, A; Donalisio, M; Ferruti, P; Lembo, D; Ranucci, E; Trotta, F | 1 |
Jackson, AS; Rossignol, JF; Vets, E | 1 |
Baudoin, C; Féron, C; Koyama, S; Novotny, MV; Soini, HA; Wiesler, D | 1 |
Bakowsky, U; Kissel, T; Sitterberg, J; Trapani, A | 1 |
Kang, KH; Kim, MM; Kim, SK; Kong, CS; Seo, Y | 1 |
Ishibashi, T; Tsutsumi, N | 1 |
Fujisawa, T; Hara, H; Hironaka, K; Inokuchi, Y; Shimazawa, M; Takeuchi, H; Tozuka, Y; Tsuruma, K | 1 |
Trynda-Lemiesz, L; Wiglusz, K | 1 |
Chen, H; Fan, W; He, Q; Kuai, R; Qin, Y; Tang, J; Tang, W; Wu, Y; Yao, N; Yuan, W; Zhang, Z | 1 |
Ahn, H; Choi, KH; Kim, AJ; Kim, KB; Kim, KH; Lee, EB; Son, IJ | 1 |
Chen, H; He, Q; Liu, J; Qin, Y; Sun, X; Tang, J; Tang, L; Tang, W; Yin, Y; Zhang, Z | 1 |
Lopes, RD; Mahaffey, KW; Piccini, JP | 1 |
Bellvert, F; Bodo, B; Chaouch, S; Didierlaurent, L; Garmier, M; Kauffmann, S; Langlois-Meurinne, M; Marie, A; Massoud, K; Noctor, G; Saindrenan, P; Simon, C | 1 |
Cao, F; Cheng, J; Jin, X; Ping, Q; Sun, M; Xu, Y; You, W; Yuan, D | 1 |
Bolden, G; Chinta, DM; Dash, S; Graves, RA; Hazari, S; Kishore, V; Mandal, TK; Pamujula, S | 1 |
Feng, SS; Gan, CW | 1 |
Connolly, SJ; Jin, J; Kastrissios, H; Kunitada, S; Mendell, J; Patel, I; Rohatagi, S; Salazar, D; Weitz, JI | 1 |
Cormier, R; Labruère, R; Sicard, R; Turos, E; West, L | 1 |
Agarwal, S; Beck-Broichsitter, M; Gessler, T; Greiner, A; Kissel, T; Nguyen, J; Schmehl, T; Seeger, W; Thieme, M | 1 |
Ding, B; Ding, X; Fan, W; Gao, J; Gao, S; Hou, X; Wang, X; Wu, X; Zhang, M; Zhang, W; Zhu, Q | 1 |
Antman, EM; Bocanegra, T; Braunwald, E; Crugnale, SE; Giugliano, RP; Hanyok, J; McCabe, CH; Mercuri, M; Patel, I; Ruff, CT; Salazar, D; Shi, M | 1 |
Chen, SA; Chung, N; Chung, WS; Jeon, HK; Lai, WT; Lee, TH; Lien, LM; Tse, HF | 1 |
Fleita, DH; Mohareb, RM; Sakka, OK | 1 |
Gore, JC; Higashino, H; Hiwatari, K; Kataoka, M; Kimura, R; Kumagai, H; Masaoka, Y; Nakamura, K; Pham, W; Sakuma, S; Tachikawa, H; Yamashita, S; Yano, T | 1 |
Feng, SS; Kulkarni, SA | 1 |
Jethva, PN; Makwana, PK; Roy, I | 1 |
Gasco, MR; Gasco, P; Lettiero, B; Masserini, M; Miserocchi, G; Panariti, A; Rivolta, I; Sesana, S | 1 |
Chao, X; Chen, T; Fei, Z; Huo, J; Liu, W; Luo, P; Qu, Y; Xie, K; Zhang, L | 1 |
Michinaka, Y; Mitragotri, S | 1 |
Kong, D; Wan, Y; Wang, Z; Yang, C; Zhou, Z; Zhu, J | 1 |
Clavreul, A; Huynh, NT; Menei, P; Montero-Menei, C; Passirani, C; Roger, M; Schiller, P; Vessières, A | 1 |
Chiang Boey, FY; Huang, CL; Kumar, S; Loo, JS; Steele, TW; Venkatraman, SS; Widjaja, E | 1 |
Criscione, JM; Jun, L; Lavik, EB; Robinson, R; Tsai, JC; Viviano, SR; Williams, CA | 1 |
Hiwatari, K; Hoffman, RM; Pham, W; Sakuma, S; Yamashita, S | 1 |
Bui, T; Geldenhuys, W; Harrison, K; Mbimba, T; Sutariya, V | 1 |
Arshad, A; Bagley, MC; Lam, CK; Mohamad, S; Osman, H; Zahariluddin, AS | 1 |
Liu, R; Liu, W; Song, N; Tu, Q; Wang, J; Zhang, Y | 1 |
Chirico, G; Collini, M; D'Alfonso, L; Lettiero, B; Miserocchi, G; Panariti, A; Rivolta, I; Sironi, L | 1 |
Govedarica, B; Kristl, J; Pajk, S; Pečar, S; Plajnšek, KT; Srčič, S | 1 |
Booth, CJ; Cu, Y; Saltzman, WM | 1 |
Huang, A; Makhlof, A; Ping, Q; Takeuchi, H; Tozuka, Y | 1 |
Dehghan, G; Emami, S; Foroumadi, A; Khoobi, M; Ramazani, A; Shafiee, A | 1 |
Di Pasquale, G; Riva, L | 1 |
Chen, L; Chen, Y; Fang, X; Gao, X; Gu, J; Jiang, X; Jiang, Y; Law, K; Ren, Q; Ren, X; Sha, X; Wang, X; Xin, H | 1 |
Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, X; Liu, Z; Pang, Z; Song, Q; Xia, H; Yao, L; Zeng, N | 1 |
Chen, Z; Liang, H; Pan, Y; Wang, H; Yi, X; Zhang, Y; Zou, B | 1 |
Gao, H; Jiang, X; Lu, W; Pang, Z; Yin, Q; Yu, Y | 1 |
Chen, J; Feng, C; Jiang, X; Liu, Q; Shao, X; Shen, Y; Zhang, C; Zhang, Q | 1 |
Feng, SS; Kulkarni, SA; Muthu, MS; Xiong, J | 1 |
Chen, H; Gao, X; Guo, L; Jiang, X; Lai, R; Li, J; Qiu, M; Wu, H; Yan, X; Zhang, Q | 1 |
Chen, H; Huang, L; Jiang, L; Liu, R; Ma, Y; Mei, L; Zeng, X; Zheng, Y | 1 |
Inagi, T; Makino, K; Suzuki, K; Terada, H; Terashima, H; Tomoda, K | 1 |
Chen, J; Feng, C; Gao, X; Jiang, X; Liu, Q; Shen, Y; Wang, L; Zhang, Q | 1 |
Dai, W; He, B; He, Z; Wang, J; Zhang, Q; Zhang, X; Zhao, S | 1 |
Abd El-Wahab, AH; Ahmed, KA; Bedair, AH; Eid, FA; El-Agrody, AM; Khafagy, MM; Mohamed, HM | 1 |
Chen, H; Fan, W; Hai, L; He, Q; Li, X; Qin, Y; Tang, J; Wu, Y; Xie, F; Yao, N; Yuan, M; Zhang, Q | 1 |
Deng, L; Tang, C; Tu, L; Wei, M; Wu, C; Xu, T; Xu, Y; Zou, Q | 1 |
He, Z; Wang, J; Yuan, L; Zhang, Q; Zhang, X; Zhao, S | 1 |
Barooah, N; Bhasikuttan, AC; Mohanty, J; Pal, H | 1 |
Chen, X; Li, H; Niu, J; Ping, Q; Xiao, Y | 1 |
Kamijo, S; Kawasaki, T | 1 |
Appold, L; Fokong, S; Jorge, S; Kiessling, F; Koczera, P; Lammers, T; Resch-Genger, U; Storm, G; Theek, B; van Zandvoort, M; Wu, Z | 1 |
Bommer, WJ | 1 |
Halperin, JL; Varughese, CJ | 1 |
Edo, N; Honda, Y; Kamisato, C; Kita, A; Morishima, Y; Shibano, T; Tsuji, N | 1 |
Inoue, H; Kawai, Y; Koretsune, Y; Matsumoto, M; Ogawa, S; Uchiyama, S; Yamaguchi, T; Yamashita, T; Yasaka, M | 1 |
Arif, M; Iqbal, J; Mahmood, S; Muddassar, M; Raza, A; Raza, R; Saeed, A | 1 |
Lip, GY; Marín, F; Roldán, V | 1 |
Chen, C; Deng, J; Guo, T; Hu, Y; Jiang, X; Li, L; Mei, H; Pang, Z; Shen, S; Shi, W; Wang, H; Zhang, B | 1 |
Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, X; Liu, Z; Pang, Z; Song, Q; Tu, Y; Xia, H; Yao, L | 1 |
Guo, D; Hou, L; Mao, P; Mo, L; Xiao, X; Yang, X | 1 |
Jin, Y; Li, B; Ma, W; Xu, A; Xu, G; Yao, M; Ying, J | 1 |
Gomha, SM; Khalil, KD | 1 |
Mendell, J; Noveck, RJ; Shi, M | 1 |
Alver, O; Kurien Thomas, K; Rajasekharan, KN; Reshmy, R; Sajan, D; Selvanayagam, S; Sulekha, A | 1 |
Brenner, B; Hoffman, R | 1 |
Furugohri, T; Honda, Y; Kamisato, C; Morishima, Y; Shibano, T | 1 |
Gore, JC; Hiwatari, K; Kataoka, M; Kimura, R; Kumagai, H; Liu, EH; McBride, J; Nakamura, K; Pham, W; Sakuma, S; Tachikawa, H; Wilson, KJ | 1 |
Koziński, M; Kubica, A; Kubica, J; Navarese, EP; Obońska, K | 1 |
Du, W; Fan, Y; He, B; Wang, J; Wang, X; Yuan, L; Zhang, H; Zhang, Q; Zhang, X; Zheng, N | 1 |
Valle Bernad, R | 1 |
Martin, EN; Money, SR; Shamoun, FE | 1 |
Hirota, K; Kawamoto, T; Makino, K; Nakajima, T; Terada, H | 1 |
Aggarwal, R; Gupta, GK; Kaushik, D; Kaushik, P; Kumar, S | 1 |
Nile, SH; Park, SW; Patel, JK; Patel, RV | 1 |
Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, M; Jiang, X; Kang, T; Liu, Z; Miao, D; Pang, Z; Song, Q; Tu, Y; Yao, L | 1 |
Feng, SS; Muthu, MS; Raju, A | 1 |
Dai, W; Du, W; Fan, Y; He, B; Jia, Z; Wang, J; Wang, X; Yu, C; Yuan, L; Zhang, H; Zhang, Q; Zhang, X | 1 |
Chen, H; Guan, M; Liu, L; Wang, J; Zhang, Q; Zhang, T; Zhou, Z | 1 |
Liu, C; Liu, X; Lu, W; Wei, G; Xie, C; Zhang, W | 1 |
Gu, L; Zou, T | 1 |
Büller, H; Mercuri, M; Prins, M; Raskob, G; Schwocho, L; Segers, A; Shi, M; van Kranen, R | 1 |
Badimón, JJ; Briongos Figuero, S; García Santos-Gallego, C | 1 |
Chen, J; Jiang, X; Liu, Q; Qian, Y; Shao, X; Zha, Y; Zhang, C; Zhang, Q; Zhang, X; Zheng, X | 1 |
Spyropoulos, AC; Turpie, AG | 1 |
Chen, H; Dong, Y; Huang, H; Zhang, J; Zhang, W; Zhao, T; Zhu, J | 1 |
Honda, Y; Kamisato, C; Morishima, Y; Shibano, T | 1 |
Aneja, KR; Chandak, N; Jain, S; Kaushik, D; Kaushik, P; Kumar, P; Sharma, C; Sharma, PK; Varshney, P | 1 |
Tahara, K; Takeuchi, H; Ying, L | 1 |
Huang, L; Liu, T; Mei, L; Ouyang, C; Tao, W; Wang, Z; Xiong, Q; Zeng, X | 1 |
Lopes, RD; Newby, LK; Truffa, AA | 1 |
Agnelli, G; Becattini, C; Franco, L | 1 |
Bao, XH; Fink-Baldauf, IM; Fukazawa, T; Hao, H; Maeda, Y; Matsuoka, J; Nakajima, M; Naomoto, Y; Nelson, S; Okui, T; Papoian, R; Seibel, W; Shimo, T; Takaoka, M; Takigawa, N; Tomono, Y; Whitsett, JA; Yamatsuji, T | 1 |
Gao, H; Hu, Y; Jiang, X; Xiong, Y; Yang, J; Yu, L; Zhang, S | 1 |
Liang, WQ; Lv, YY; Sun, XY; Wu, S; Xiang, ZQ | 1 |
Gao, H; Jiang, X; Liu, Q; Pang, Z; Yang, Z; Zhang, S | 1 |
Antman, EM; Betcher, J; Braunwald, E; Ezekowitz, MD; Giugliano, RP; Grip, LT; Halperin, JL; Hanyok, JJ; Koretsune, Y; Mercuri, M; Murphy, SA; Patel, I; Patel, SP; Ruda, M; Ruff, CT; Ruzyllo, W; Shi, M; Špinar, J; Waldo, AL; Weitz, JI; Wiviott, SD | 1 |
Einecke, D | 1 |
Sprynger, M | 1 |
Dai, WB; He, B; Wang, XQ; Yu, C; Zhang, H; Zhang, Q | 1 |
Mitka, M | 1 |
Schulman, S | 1 |
Bredenbeck, J; Messmer, AT; van Wilderen, LJ | 1 |
Blanco, MD; Fernández, A; Olmo, R; Pérez, E; Teijón, JM | 1 |
Giugliano, RP; Gonzalez-Quesada, CJ | 1 |
Chen, H; Chen, J; Feng, X; Gao, X; Hu, Q; Huang, M; Jiang, D; Jiang, X; Kang, T; Pang, Z; Song, Q; Yao, L; Zhang, X | 1 |
Cao, S; Gao, H; Jiang, X; Pang, Z; Yang, Z; Zhang, S | 1 |
Giugliano, RP; Plitt, A | 3 |
Fan, M; Guo, W; Li, D; Men, W; Wei, X; Xu, Y; Yin, D; Zhu, JA | 1 |
Cavalieri, F; Ciaffardini, F; Crestini, C; Melone, F; Mosesso, P; Tortora, M | 1 |
Ballazhi, L; Dräger, G; Huwiler, A; Imeri, F; Jashari, A; Mikhova, B; Popovski, E; Shabani, A | 1 |
Yorozu, T | 1 |
Davidson, N; Galloway, SW; Lai, A; Thachil, J | 1 |
Li, Y; Liu, X; Sun, F; Teng, L; Wang, D; Zhao, J; Zhou, Y | 1 |
Duan, YW; En, D; Guo, Y; Li, CW; Li, J; Peng, MJ; Suzenet, F; Yang, XF; Yin, B | 1 |
Hürlimann, D; Noll, G; Noll, S | 1 |
Erga, SR; Frette, Ø; Hamre, B; Kristoffersen, AS | 1 |
Prabhakaran, S; Veltkamp, R | 1 |
Benjaminsen, J; Fenaroli, F; Griffiths, G; Hildahl, J; Kolstad, T; Meijer, AH; Nyström, B; Roos, N; Skjeldal, FM; Ulanova, L; van der Vaart, M; Westmoreland, D | 1 |
Antman, EM; Betcher, JM; Braunwald, E; Dave, J; Deenadayalu, N; Duggal, A; Giugliano, RP; Grip, LT; Lowe, C; Mercuri, M; Murphy, SA; Rost, NS; Ruff, CT; Shi, M; Silverman, S; Wiviott, SD | 1 |
Angeli, F; Lip, GY; Reboldi, G; Verdecchia, P | 1 |
Liberato, NL; Marchetti, M; Quaglini, S; Rognoni, C | 1 |
Bao, X; Chu, QC; Gao, M; Guan, X; Jiang, N; Liu, KX; Tian, Y; Xu, H; Zhang, CH | 1 |
Cai, XX; Fu, N; Lin, YF; Peng, Q; Shao, XR; Wei, XQ; Zhang, S; Zhang, T; Zhang, ZR | 1 |
Bongu, NR; Kocheril, AG; Turagam, MK; Velagapudi, P | 1 |
Antman, EM; Betcher, J; Braunwald, E; Cange, AL; Crompton, AE; Curt, V; Deenadayalu, N; Giugliano, RP; Grip, L; Mercuri, M; Murphy, SA; Ruff, CT | 1 |
Aleksic, M; Boyd, P; Cubberley, R; O'Connor, D; Parkinson, E; Skipp, P | 1 |
Bang, OY; Chung, CS; Kim, GM; Kim, JS; Kim, SJ; Lee, KH; Lee, MJ; Park, YK; Ryoo, S; Yoon, CH | 1 |
Giugliano, RP | 1 |
Jaggi, M; Joshi, V; Negi, LM; Ronodip, K; Talegaonkar, S | 1 |
Cormode, DP; Latourette, MT; Mallet, CL; Parys, M; Schwartz-Duval, AS; Shapiro, EM; Shuboni, DD; Swy, ER | 1 |
Das, S; Dhar, SK; Govindaraju, T; Kumar, M; Kundu, TK; Narayanaswamy, N; Pati, SK; Samanta, PK; Sharma, R | 1 |
Madhusudhana, S; Qasem, A; Strasser, KM | 1 |
Chandrasekaran, S; Enoch, IV; Sameena, Y | 1 |
Ezekowitz, MD; Kent, AP | 1 |
Al-Halhouli, AT; Bartels, J; Behrends, S; Büttgenbach, S; Dahl, K; Dietzel, A; Finke, JH; Krull, R; Lorenz, T; Müller-Goymann, CC; Peterat, G; Pretor, S; Reichl, S | 1 |
An, G; Fleisher, B; Shao, J; Unum, J | 1 |
Banothu, J; Bavantula, R; Crooks, PA; Gali, R; Gondru, R; Velivela, Y | 1 |
Ballow, C; Battegay, M; Chan, TS; Cooper, C; Girlich, B; Haschke, M; Kashuba, AD; Kort, J; Lang, B; Li, Y; O'Brien, D; Sabo, JP; Seibert, E; Ting, N; Tweedie, D; Zhang, W | 1 |
Astete, CE; Damann, KE; Muse, ES; Patel, NR; Sabliov, CM | 1 |
Baneham, S; Cox, D; Kirby, BP; Moollan, A; O'Donnell, A; Ozgul, M; Pabari, RM; Ramtoola, Z | 1 |
Chen, HZ; Dong, X; Fang, C; Gao, YG; Guan, YY; Liu, HJ; Liu, YR; Lu, Q; Luan, X; Wang, C; Yang, SC | 1 |
Amin, A; Deitelzweig, S | 1 |
Amin, A; Bruno, A; Lin, J; Lingohr-Smith, M; Trocio, J | 1 |
Arepally, GM; Ortel, TL | 1 |
Comparelli, R; Cordero, H; Cuesta, A; Di Franco, C; Esteban, MA; Mandracchia, D; Morcillo, P; Trapani, A | 1 |
Antman, EM; Braunwald, E; Cermak, O; Giugliano, RP; Grip, LT; Kania, G; Mercuri, MF; Murphy, SA; O'Donoghue, ML; Ruff, CT; Rutman, H; Shi, M | 1 |
Granger, CB; Pokorney, SD | 1 |
Gazioglu, I; Kucukislamoglu, M; Kurt, BZ; Sonmez, F | 1 |
Gore, JC; Hiwatari, K; Ikejima, T; Kitamura, T; Koike, S; Kumagai, H; McClure, R; Mohri, K; Pham, W; Sakuma, S; Shimosato, M; Tobita, E | 1 |
Loffredo, L; Perri, L; Violi, F | 1 |
Oberhofer, E | 1 |
Antman, EM; Braunwald, E; Deenadayalu, N; Giugliano, RP; Lee, J; Mega, JL; Mercuri, MF; Murphy, SA; Nordio, F; Ruff, CT; Sabatine, MS; Vandell, AG; Walker, JR | 1 |
Wu, AH | 1 |
Ballazhi, L; Ibrahimi, I; Imeri, F; Jashari, A; Mikhova, B; Mladenovska, K; Popovski, E | 1 |
Hogg, K; Weitz, JI; Yeh, CH | 1 |
Du, Z; Lang, M; Zhang, Y | 1 |
Huynh, K | 1 |
Chen, C; Chen, X; Fan, Z; Fang, X; Liang, H; Pang, X; Qi, Y; Sha, X; Yu, Z | 1 |
Fukazawa, T; Ishida, N; Kato, K; Maeda, Y; Matsumoto, K; Naomoto, Y; Shimo, T; Takigawa, N; Whitsett, JA; Yamatsuji, T | 1 |
Dişli, A; Gümüş, M; Koca, İ; Özgür, A; Tutar, Y | 1 |
Harenberg, J; Krejczy, M; Lip, GY; Obermann, K; Wehling, M | 1 |
Ito, M; Nakamura, M; Yamada, N | 2 |
Boakye, CH; Patel, K; Singh, M | 1 |
Al-Saadi, N; Ellenbogen, K; Ezekowitz, M; Goette, A; Jin, J; Lanz, H; Lip, GY; Mercuri, M; Merino, J; Zamoryakhin, D | 1 |
Wright, GE | 1 |
Antman, EM; Atar, D; Braunwald, E; Camm, AJ; Giugliano, RP; Heidbuchel, H; Murphy, SA; Ruff, CT; Steffel, J | 1 |
Conen, D | 1 |
MegallyAbdo, NY; Mohareb, RM | 1 |
Abe, K; Büller, H; Kimura, T; Lee, LH; Mercuri, M; Miyazaki, K; Nakamura, M; Oh, D; Segers, A; Wang, C; Wang, YQ; Yin, WH | 1 |
Dai, W; Deng, F; He, B; Wang, X; Yu, C; Zhang, H; Zhang, Q; Zheng, Y | 1 |
Ding, J; Feng, M; Guan, W; Wang, F; Wang, H | 1 |
Chen, J; Long, M; Su, C; Wang, L; Zhuang, X | 1 |
Hong, K; Lane, DA; Lau, YC; Lip, GY; Senoo, K; Xiong, Q | 1 |
Wang, L; Xiao, H | 1 |
Hijazi, Z; Oldgren, J | 1 |
McCormack, PL | 1 |
Antman, EM; Braunwald, E; Geller, BJ; Giugliano, RP; Hanyok, JJ; Jin, J; Mercuri, M; Murphy, SA; Ruff, CT | 1 |
Iemsam-Arng, J; Ketchart, O; Rattana-Amron, T; Tapaneeyakorn, S; Wutikhun, T | 1 |
Colonna, P; Rubboli, A | 1 |
Ameloot, M; Berden, M; D'Olieslaeger, L; Deville, S; Ethirajan, A; Penjweini, R | 1 |
Eikelboom, J; Weitz, JI | 1 |
Hierrezuelo, JM; Molina-Bolivar, JA; Ruiz, CC | 1 |
Goldhaber, SZ; Kwong, WJ; Preblick, R; White, RH | 1 |
Dzeshka, MS; Lip, GY | 1 |
McBane, RD; Schaefer, JK; Wysokinski, WE | 1 |
Antman, EM; Cohen, DJ; Giugliano, RP; Kwong, WJ; Li, H; Magnuson, EA; Ruff, CT; Vilain, K; Wang, K | 1 |
Didier, R; Escarcega, RO; Kiramijyan, S; Koifman, E; Lipinski, MJ; Torguson, R; Waksman, R | 1 |
Cheung, BM; Kumana, CR; Lauder, IJ; Siu, DC; Tse, HF | 1 |
Keloglu, N; Sohier, J; Trimaille, T; Verrier, B | 1 |
Chen, X; Chu, B; He, Y; Huang, Y; Long, C; Ou, C; Qian, Z; Qu, Y; Zhang, L | 1 |
Katti, DS; Mahaling, B | 1 |
Wei, MY; Wu, CB; Xu, YH; Zou, Q | 1 |
Antman, EM; Awasty, VR; Braunwald, E; Eisen, A; Giugliano, RP; Gogia, HS; Henderson, DA; Mercuri, MF; Nordio, F; Ruff, CT; Rutman, H | 1 |
Alamneh, EA; Bereznicki, LR; Chalmers, L | 1 |
Chu, Q; Deng, S; Gao, M; Guan, X; Huo, X; Liu, H; Liu, K; Ma, X; Tian, Y; Xu, H | 1 |
Cui, X; Li, Z; Liu, S; Wang, H; Wang, S; Xu, F; Yang, T; Zhao, T | 1 |
Abe, K; Chen, SA; Chung, N; Giugliano, RP; Kimura, T; Koretsune, Y; Mercuri, M; Miyazaki, K; Ruff, CT; Shimada, YJ; Yamashita, T; Yang, Y | 1 |
Koch, B; Kumar, M; Muthu, MS; Pandey, BL; Sharma, G; Singh, RP; Singh, S | 1 |
Antman, EM; Braunwald, E; Giugliano, RP; Mercuri, M; Murphy, SA; Nordio, F; Patel, I; Ruff, CT; Shi, M; Xu, H | 1 |
He, D; Li, J; Li, X; Peng, Z; Wang, G | 1 |
Antman, EM; Braunwald, E; Giugliano, RP; Kappelhof, JA; Mercuri, MF; Murphy, SA; Nordio, F; Ruff, CT; Shi, M; Wiviott, SD | 1 |
Bauersachs, R; Bleker, SM; Boda, Z; Brekelmans, MP; Büller, HR; Choi, Y; Cohen, AT; Gallus, A; Grosso, MA; Middeldorp, S; Oh, D; Raskob, G; Schwocho, L | 1 |
Coleman, CI; Egri, F; Mearns, ES; Nguyen, E; White, CM | 1 |
De Caterina, R; Ezekowitz, MD; Giugliano, RP; Nordio, F; Peterson, N; Plitt, A | 1 |
Hayes, CJ; Martin, BC; Shah, A; Shewale, A | 1 |
Ageno, W; Brekelmans, MP; Büller, HR; Cohen, AT; Grosso, MA; Lin, M; Meyer, G; Raskob, G; Segers, A; Verhamme, P; Weitz, JI; Wells, PS; Winters, SM | 1 |
Lee, SM; Li, Y; Miao, X; Wang, X; Zheng, Y | 1 |
Aoyagi, H; Asano, M; Hirao, K; Kawaguchi, N; Kurabayashi, M; Nakamura, T; Okishige, K; Sasano, T; Shimura, T; Suzuki, H; Yamashita, M; Yamauchi, Y | 1 |
Cannon, K; Chinigo, A; Concha, M; Fayad, ZA; Goldhaber, SZ; Grosso, MA; Hsu, C; Lanz, HJ; Mani, V; Mercuri, M; Nadar, V; Piazza, G; Pullman, J; Ritchie, B; Schul, M; Schussler, S | 1 |
Alves Júnior, JL; Fernandes, CJ; Gavilanes, F; Morinaga, LK; Prada, LF; Souza, R | 1 |
Behl, G; Boakye, CH; Chowdhury, N; Doddapaneni, R; Patel, K; Singh, M | 1 |
Dubińska-Magiera, M; Kotulska, M; Kulbacka, J; Kulbacki, M; Pucek, A; Rossowska, J; Wilk, KA | 1 |
Chowdhury, N; Doddapaneni, R; Patel, K; Singh, M | 1 |
Lesko, LJ | 1 |
Antman, EM; Braunwald, E; Giugliano, RP; Jin, J; Kato, ET; Kimura, T; Kiss, RG; Koretsune, Y; Lanz, H; Mercuri, M; Murphy, SA; Nordio, F; Ruff, CT; Yamashita, T | 1 |
Cigarroa, J; Henrikson, CA; Steinberg, JS; Tereshchenko, LG | 1 |
Fukazawa, T; Ibaragi, S; Kurio, N; Masui, M; Matsumoto, K; Nagatsuka, H; Naomoto, Y; Okui, T; Sasaki, A; Shimo, T; Takabatake, K | 1 |
Koch, B; Muthu, MS; Pandey, BL; Patne, SCU; Sharma, G; Singh, RP; Singh, S | 1 |
Jönsson, S; Karlsson, KE; Karlsson, MO; Miller, R; Nyberg, J; Simonsson, U; Yin, O | 1 |
Abramson, S; Chan, KE; Giugliano, RP; Jardine, M; Maddux, FW; Patel, MR; Perkovic, V; Piccini, JP; Zhao, S | 1 |
Mizoguchi, T; Yasaka, M | 1 |
Cutler, NR; Goldenberg, NA; Halperin, JL; Hiatt, WR; Kessler, CM; Kittelson, JM; Schulman, S; Spyropoulos, AC; Steg, PG; Turpie, AG | 1 |
Antman, EM; Braunwald, E; Giugliano, RP; Magnani, G; Mercuri, M; Metra, M; Mitrovic, V; Moccetti, T; Murphy, SA; Nordio, F; Ruff, CT; Shi, M | 1 |
Groen-Wijnberg, M; Kerbusch, V; Krauwinkel, W; Meijer, J; Tretter, R; van Dijk, J; van Gelderen, M; Zhang, W | 1 |
Antman, EM; Bohula, EA; Braunwald, E; Giugliano, RP; Kuder, JF; Murphy, SA; Ruff, CT | 1 |
Gul, S; Imran, S; Ismail, NH; Khan, KM; Perveen, S; Salar, U; Taha, M; Wadood, A | 1 |
Antman, EM; Braunwald, E; Crompton, AE; Giugliano, RP; Mercuri, MF; Murphy, SA; Nicolau, JC; Norden, AD; Rost, NS; Ruff, CT; Silverman, S; Singhal, AB; SomaRaju, B | 1 |
Ageno, W; Brekelmans, MP; Buller, H; Cohen, AT; Grosso, MA; Meyer, G; Raskob, G; Segers, A; Verhamme, P; Weitz, JI; Wells, PS; Zhang, G | 1 |
Alexander, C; Bansal, KK; Dailey, LA; Howdle, S; Irvine, D; Johnston, HJ; Kakde, D; Mantovani, G; Millar, G; Powell, LG; Stone, V | 1 |
Amasya, G; Badilli, U; Sengel-Turk, CT; Tarimci, N | 1 |
Bajorath, J; Furtmann, N; Hameed, A; Ibrar, A; Iqbal, J; Khan, I; Saeed, A; Tehseen, Y | 1 |
Chen, Y; Cheng, X; He, W; Li, J; Ni, L; Wei, M; Xiong, P | 1 |
Ikuta, N; Komaru, S; Murata, S; Sebata, S; Takizawa, SY; Zeng, F | 1 |
Ageno, W; Beenen, LF; Brekelmans, MP; Brenner, B; Buller, HR; Chen, CZ; Cohen, AT; Grosso, MA; Meyer, G; Raskob, G; Segers, A; Vanassche, T; Verhamme, P; Weitz, JI; Wells, PS; Zhang, G | 1 |
Eikelboom, J; Merli, G | 2 |
Al-Saady, N; Batushkin, V; de Groot, JR; Ezekowitz, MD; Fernandez, V; Goette, A; Grosso, MA; Jin, J; Kushnir, M; Lip, GY; Melino, M; Mercuri, MF; Merino, JL; Merkely, B; Pelekh, N; Spinar, J; Zamoryakhin, D; Zenin, S | 1 |
Antman, EM; Aylward, P; Braunwald, E; Choi, Y; Giugliano, RP; Mercuri, M; Murphy, SA; Ruff, CT; Steffel, J; White, H; Zamorano, JL | 1 |
Dellegrottaglie, S; Filippatos, G; Giugliano, RP; Lund, LH; Magnani, G; McMurray, J; Perrone-Filardi, P; Rosano, GM; Savarese, G; Trimarco, B | 1 |
Cross, ES; Davies, W; Guerrero, S; Humby, T; Messer, L | 1 |
Aguilar, MR; Hoogenboom, R; Maji, S; Palao-Suay, R; Parra-Ruiz, FJ; Rohner, NA; Román, JS; Thomas, SN | 1 |
Hernandez, I; Smith, KJ; Zhang, Y | 1 |
Horiuchi, D; Ishida, Y; Itoh, T; Kimura, M; Kinjo, T; Nishizaki, K; Okumura, K; Sasaki, K; Sasaki, S; Shoji, Y; Tomita, H; Tsushima, Y | 1 |
Dunn, A | 1 |
Doukky, R; Jaffer, AK; Moseley, A; Volgman, AS; Williams, KA | 1 |
Blann, AD; Boriani, G; Lip, GY | 1 |
Bhatt, DL; Fonarow, GC; Harding, T; Hernandez, AF; Khan, Y; Peterson, ED; Schwamm, LH; Suter, RE; Xian, Y | 1 |
Guo, L; Hong, Y; Li, S; Wang, P; Zhong, X | 1 |
Coyle, D | 1 |
Antman, EM; Braunwald, E; Fanola, CL; Giugliano, RP; Mercuri, MF; Nordio, F; Ruff, CT; Trevisan, M | 1 |
Antman, EM; Braunwald, E; Crompton, AE; Giugliano, RP; Huikuri, H; Lanz, H; Link, MS; Mercuri, MF; Murphy, SA; Oto, A; Ruff, CT; Scirica, BM | 1 |
Jia, Y; Liu, S; Liu, X; Pan, W; Tian, C; Wang, H; Wang, Y; Yan, J | 1 |
Baig, U; David, T; Poulakos, M; Walker, JN | 1 |
Oda, H; Sugiyama, T | 1 |
Büller, HR; Cohen, A; Di Nisio, M; Grosso, MA; Raskob, G; Winters, SM; Zhang, G | 1 |
Hu, X; Li, L; Liao, Y; Yang, F; Zhang, L | 1 |
Ageno, W; Agnelli, G; Boriani, G; Colonna, P; De Caterina, R; Ghirarduzzi, A; Patti, G; Rossini, R; Rubboli, A; Schinco, P | 1 |
Antman, E; Carnicelli, AP; De Caterina, R; Giugliano, RP; Halperin, JL; Mercuri, MF; Nordio, F; Renda, G; Ruff, CT; Trevisan, M | 1 |
EncisoSilva, J; Greenberg, B; Schlueter, M; Thomas, I | 1 |
Agrawal, AK; Dora, CP; Garg, T; Jain, S; Kushwah, V; Thanki, K | 1 |
Barco, S; Klok, FA; Konstantinides, SV | 1 |
Antman, EM; Braunwald, E; Carnicelli, AP; De Caterina, R; Giugliano, RP; Mercuri, MF; Nordio, F; Renda, G; Ruff, CT; Trevisan, M | 1 |
Connolly, SJ; Eikelboom, JW; Hirsh, J; Quinlan, DJ; Weitz, JI | 1 |
Cui, X; Feng, Y; Li, Z; Liu, Y; Shi, C; Wang, G; Zhang, H; Zhong, S | 1 |
Barbera, V; Bellasi, A; Campana, C; Cozzolino, M; De Pascalis, A; Di Iorio, B; Di Lullo, L; Galliani, M; Ronco, C; Russo, D; Russo, L; Santoboni, F; Vitaliano, E | 1 |
Collins, R; Gil, VM; Hanon, O; Hardt, R; Hoffmeister, M; Monteiro, P; Quinn, TJ; Ropers, D; Sergi, G; Verheugt, FWA; Wehling, M | 1 |
Burnett, AE; Dobesh, PP; Fanikos, J; Mahan, CE | 1 |
Chang, S; Chang, Y; Lu, S; Sun, Q; Zhang, Y | 1 |
Antman, EM; Giugliano, RP; Hamershock, RA; Lanz, HJ; Mercuri, MF; Murphy, SA; Roy, D; Ruff, CT; Senior, R; Steffel, J | 1 |
Ashaye, A; Deitelzweig, S; Farmer, C; Hamilton, M; Horblyuk, R; Li, X; Luo, X; Vo, L | 1 |
Imberti, D; Mastroiacovo, D | 1 |
Cohen, DJ; Giugliano, RP; Hsu, WH; Hui Tan, EC; Li, H; Magnuson, EA; Vilain, KA; Wang, K; Yang, MC | 1 |
Cheng, B; Li, J; Liu, D; Pan, H; Wu, Q | 1 |
Hu, SJ; Wu, T; Xu, WW | 1 |
Casson, RJ; Chan, W; Sanders, P; Selva, D; Sun, MT; Wong, CX; Wood, MK | 1 |
Brown, KS; Grosso, MA; Lin, M; Mercuri, MF; Vandell, AG; Walker, J; Zhang, G | 1 |
Jolobe, OM | 1 |
Byström, B; Norrving, B; Oldgren, J; Renlund, H; Själander, A; Sjögren, V; Svensson, PJ | 1 |
Jolobe, OMP | 1 |
Li, Y; Pan, H; Pan, W; Yang, X; Zhu, Z | 1 |
Alonso, A; Norby, FL | 1 |
Kamata, F; Kamata, M; Murano, J; Nagaba, H; Nagaba, Y; Nonoguchi, H; Okina, C; Shimada, H; Shimada, Y; Takeuchi, Y | 1 |
Fogerty, AE; Oertel, LB | 1 |
Petrasko, M; Petraskova, T; Raizada, A | 1 |
Abbas, Q; Channar, PA; Hassan, M; Larik, FA; Mahesar, PA; Raza, H; Saeed, A; Seo, SY | 1 |
Araújo, PHH; Cardoso, PB; Feuser, PE; Machado, TO; Sayer, C | 1 |
Antman, EM; Cohen, DJ; Giugliano, RP; Kwong, WJ; Li, H; Magnuson, EA; Ruff, CT; Wang, K | 1 |
Cheng, B; Li, J; Liu, D; Pan, W; Tan, G | 1 |
Ameen, BAH; Dissanayake, AA; Nair, MG | 1 |
Chen, S; Guo, H; He, H; Li, C; Liang, XJ; Ren, T; Tang, X; Wang, Q; Ye, X; Yin, T; Zhang, Y | 1 |
Weng, KG; Yuan, YL | 1 |
Doganlar, O; Doganlar, ZB; Erdogan, S; Serttas, R; Turkekul, K | 1 |
Bansal, VK; Choi, MJ; Herzog, CA; Jaar, BG; Kramer, H; Mehta, R; Rocco, MV; Sarnak, MJ | 1 |
Griffiths, CL; Hicks, S; Livengood, SJ; Vestal, ML | 1 |
Chu, XC; Gao, JH; Ning, B; Wang, LL; Zhao, CX | 1 |
Fukuda, R; Gotoh, N; Hashida, M; Hashida, Y; Murakami, T; Suda, K; Tsujikawa, A; Yoshimura, N | 1 |
Boulouis, G; Charidimou, A; Goldstein, JN; Gurol, ME; Morotti, A; Pasi, M | 1 |
Kanai, Y; Matsuda, H; Mitaki, S; Oguro, H; Onoda, K; Tahara, N; Takayoshi, H; Yamaguchi, S | 1 |
Lee, SM; Li, Y; Song, X; Wang, R; Wang, X; Yi, X; Zheng, Y | 1 |
Akaike, M; Amano, R; Fukuda, D; Hara, T; Ise, T; Kadota, M; Kusunose, K; Matsuura, T; Oomichi, Y; Sangawa, T; Sata, M; Soeki, T; Tobiume, T; Torii, Y; Ueno, R; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K; Yamazaki, H | 1 |
Fukuhara, S; Fukuma, S; Furukawa, TA; Goto, Y; Kimachi, K; Kimachi, M | 1 |
Beer, TM; Daughety, MM; DeLoughery, TG; Olson, SR; Shatzel, JJ | 1 |
Al-Saady, N; Banach, M; Ezekowitz, MD; Goette, A; Lip, GYH | 1 |
Je, HJ; Kim, ES; Lee, HG; Lee, JS | 1 |
Aguilar, MR; Arévalo, H; García-Fernández, L; Martín-Saldaña, S; Palao-Suay, R; Ramírez-Camacho, R; San Román, J; Trinidad, A | 1 |
Banerjee, R; Purkayastha, P | 1 |
Ageno, W; Brekelmans, MPA; Büller, HR; Chen, CZ; Cohen, AT; Grosso, MA; Lin, M; Medina, A; Mercuri, MF; Raskob, G; Segers, A; Vanassche, T; Verhamme, P; Weitz, JI; Wells, PS; Winters, SM | 1 |
Abe, K; Akao, M; Akishita, M; Fukuzawa, M; Lip, GYH; Okumura, K; Tanizawa, K; Yamashita, T | 1 |
Avorn, J; Choudhry, NK; Gagne, JJ; Glynn, RJ; Krumme, AA; Kulldorff, M; Ortiz, AS; Pawar, A; Schneeweiss, S | 1 |
Carlson, MA; Chen, S; Gombart, AF; Jiang, J; Wang, H; Xie, J | 1 |
Fujino, T; Hamai, A; Hara, F; Harada, M; Ikeda, T; Kabuki, T; Ohara, H; Wakakura, S | 1 |
Emoto, N; Hirata, KI; Nakayama, K; Okano, M; Okita, Y; Onishi, H; Shinke, T; Shinkura, Y; Tamada, N; Tanaka, H; Yanaka, KI | 1 |
Antman, EM; Braunwald, E; Cavallari, I; Deenadayalu, N; Giugliano, RP; Lanz, H; Mercuri, MF; Nordio, F; Ruff, CT; Rutman, H; Shi, M | 1 |
Houkin, K; Iwasaki, M; Kawabori, M; Mabuchi, S; Matsubara, K; Niiya, Y; Ozaki, H | 1 |
Cao, W; Chen, G; Wen, L; Xie, S; Xu, Y; Zhang, L | 1 |
Asahina, H; Furuta, M; Goudarzi, H; Ikezawa, Y; Kikuchi, E; Kikuchi, H; Kikuchi, J; Mizugaki, H; Nishimura, M; Sakakibara-Konishi, J; Shinagawa, N; Shoji, T; Takashima, Y; Tsujino, I | 1 |
Jeong, YY; Lee, BI; Moon, MJ; Park, HJ; Park, IK; Surendran, SP; Thomas, RG | 1 |
Aguilera-Garrido, A; Boulaiz, H; Galisteo-González, F; Marchal, JA; Molina-Bolívar, JA; Navarro, SA; Ramírez, A | 1 |
Abdallah, AEM; Mohamed, AA; Mohareb, RM | 1 |
Battistella, M; Cameron, K; Farrell, A; Feldberg, J; Ma, J; Patel, P; Sivarajahkumar, S | 1 |
Higashiya, S; Hina, K; Hirohata, S; Kamikawa, S; Kawamura, H; Kusachi, S; Murakami, M; Murakami, T; Yamaji, H | 1 |
Csanádi, Z; Szegedi, A | 1 |
Aguinaco, MR; Bustins, A; Campoy, D; Canals, T; Cerdá, M; Constans, M; Ene, G; Gabilondo, M; Jiménez, C; Johansson, E; Las Heras, G; López, M; Marzo, C; Mateo, J; Moya, Á; Oliver, A; Olivera, P; Perea, G; Plensa, E; Pons, V; Reverter, JC; Sánchez, E; Santamaría, A; Santos, N; Sorigue, M; Tàssies, D; Varela, A; Vicente, L | 1 |
Duan, D; Jiang, Y; Li, Y; Mu, H; Ni, L; Sun, K; Wang, A; Wu, Z; Yan, X; Zhang, L | 1 |
Badreldin, H | 1 |
Camm, J; Cappato, R; Diener, HC; Heidbuchel, H; Hohnloser, SH; Kautzner, J; Lanz, HJ; Mont, L; Morillo, CA; Smolnik, R; Yin, OQP | 1 |
Hu, Y; Jiang, G; Kan, C; Wang, J; Yu, C; Zhang, H | 1 |
Boswell, R; Pearson, GJ | 1 |
Antman, EM; Braunwald, E; Douketis, JD; Giugliano, RP; Grip, LT; Mercuri, MF; Murphy, SA; Ruff, CT; Weitz, JI | 1 |
Hernandez, I; Hospodar, AR; Smith, KJ; Zhang, Y | 1 |
Aisenberg, J; Antman, EM; Braunwald, E; Chatterjee-Murphy, P; Choi, Y; Friedman Flack, K; Giugliano, RP; Mercuri, MF; Nordio, F; Ruff, CT; Weitz, JI | 1 |
Jain, N; Reilly, RF | 1 |
Myers, B | 1 |
He, Z; Hill, MR; Jiang, X; Niedz, RP; Sumerlin, BS; Xin, X | 1 |
Ayati, A; Emami, S; Esmaeili, R; Firoozpour, L; Foroumadi, A; Majidzadeh-A, K; Moghimi, S; Oghabi Bakhshaiesh, T; Safavi, M | 1 |
Ageno, W; Ay, C; Blondon, M; Brekelmans, M; Büller, HR; Delluc, A; Eichinger, S; Hutten, BA; Klok, FA; Middeldorp, S; Scheres, L; Schreiber, K; Stach, K | 1 |
Banach, M; Ezekowitz, MD; Goette, A; Hjortshoj, SP; Kwong, WJ; Lip, GYH; Zamoryakhin, D | 1 |
Lane, DA; Proietti, M | 1 |
Antman, EM; Blanc, JJ; Braunwald, E; Cappato, R; Giugliano, RP; Lanz, H; Mercuri, MF; Nordio, F; Ruff, CT; Wiviott, SD; Zelniker, TA | 1 |
Arena, G; Baratta, A; Bianchi, S; Catarzi, S; Conti, A; Covelli, A; Dell'Amico, I; Mazzucchelli, M; Molesti, D; Orlandi, G; Pampana, A; Perrotta, ME; Tognarelli, A; Torri, T | 1 |
Adam, TJ; Alonso, A; Lutsey, PL; MacLehose, RF; Roetker, NS; Zakai, NA | 1 |
Akaboshi, S; Fujita, H; Inoue, M; Kada, A; Kaneko, H; Kawasaki, M; Koretsune, Y; Kumode, M; Maruhashi, K; Miyanomae, T; Murata, H; Nakamura, M; Ohmori, H; Okumura, A; Saito, AM; Sanayama, Y; Sano, N; Shinagawa, T; Sone, S; Sumimoto, R; Takechi, T; Takizawa, N; Taniguchi, H; Tanuma, N; Wakisaka, A | 1 |
Chigurupati, S; Ghufran, M; Khan, KM; Perveen, S; Riaz, M; Salar, U; Syed, S; Vijayabalan, S; Wadood, A | 1 |
Antman, EM; Botero, R; Braunwald, E; Corbalán, R; Garcia-Castillo, A; Giugliano, RP; Grip, LT; Hamershock, RA; Horna, M; López-Sendon, J; Nicolau, JC; Ruff, CT; Sotomora, G | 1 |
Dubner, SJ; Martinenghi, N | 1 |
Maurea, N; Riva, L | 1 |
Guo, H; Li, J; Li, M; Song, K; Tan, Y; Wu, X; Xin, M; Yu, H; Zheng, Z | 1 |
Asghar, S; Chen, Z; Jin, X; Ping, Q; Xiao, Y; Zhang, J; Zhang, M | 1 |
Antman, EM; Giugliano, RP; Ruff, CT; Zelniker, TA | 1 |
Lip, GYH | 1 |
Andersen, M; Braunschweig, F; Forslund, T; Hjemdahl, P; Komen, JJ; Mantel-Teeuwisse, AK; von Euler, M; Wettermark, B | 1 |
Jang, E; Joung, B; Kim, D; Kim, JY; Kim, TH; Lee, MH; Lip, GYH; Pak, HN; Uhm, JS; Yang, PS; Yu, HT | 1 |
Antman, EM; Babilonia, NA; Braunwald, E; Duggal, A; Fanola, CL; Giugliano, RP; Jin, J; Kamphuisen, PW; Mercuri, MF; Murphy, SA; Ruff, CT; Sritara, P | 1 |
Aoki, J; Kanamaru, T; Kimura, K; Matsumoto, N; Mishina, M; Nishiyama, Y; Nito, C; Okubo, S; Sakamoto, Y; Sekine, T; Shimoyama, T; Suda, S; Suzuki, K | 1 |
Chang, SH; Chu, PH; Kuo, CF; Tseng, HJ; Wang, CL; Wen, MS; Wu, VC | 1 |
Braunschweig, F; Forslund, T; Hjemdahl, P; Holmström, M; Johnsson, H; von Euler, M; Wallén, H | 1 |
Hu, A; Niu, J; Winkelmayer, WC | 1 |
Antman, EM; Braunwald, E; Giugliano, RP; Hamershock, RA; Lanz, HJ; Mercuri, MF; Murphy, SA; Nieminen, M; Peterson, N; Ruff, CT; Steffel, J | 1 |
Oldgren, J | 1 |
Cowperthwaite, M; Fanale, C; Nadasdy, Z; Ramakrishnan, A; Shpak, M | 1 |
Cipriano, LE; Hachinski, V; Lee, SAW; Ruiz Vargas, E; Sposato, LA | 1 |
Campodonico, P; Guiddo, G; Lerza, R; Malerba, M; Minuto, P; Motta, G; Riccardi, A; Spinola, MB | 1 |
Antman, EM; Braunwald, E; Chao, TF; Chen, SA; Giugliano, RP; Hamershock, RA; Mercuri, MF; Ruff, CT | 1 |
Büller, HR; Chiang, CE; Giugliano, RP; Lopes, RD; Patel, MR; Tan, DS; Wang, KL | 1 |
Ageno, W; Agnelli, G; Chan, NC; De Caterina, R; Diener, HC; Hylek, E; Lip, GYH; Raskob, GE; Siegal, DM; Verheugt, FWA; Weitz, JI | 1 |
Antman, EM; Boriani, G; Braunwald, E; Giugliano, RP; Kuder, JF; Lanz, HJ; Mercuri, MF; Ruff, CT; Rutman, H; Shi, M | 1 |
Chou, PY; Hsu, PC; Huang, TC; Kao, PH | 1 |
Cohen, AA; De Caterina, R; Goette, A; Heidbuchel, H; Jin, J; Le Heuzey, JY; Lip, GYH; Melino, M; Merino, JL; Winters, SM | 1 |
Cui, W; He, Z; Li, Z; Luo, C; Sun, B; Sun, J; Sun, M; Ye, Q; Zhang, S; Zhao, H | 1 |
Eguchi, T; Fukuchi, T; Kitamura, T; Kumagai, H; Matsuura, M; Mohri, K; Nakai, K; Nakase, H; Pham, W; Sakuma, S; Tobita, E; Tomono, T; Ukawa, M; Yamada, K; Yoshino, T; Yoshizaki, T | 1 |
Ali, MM; Batran, RZ; Elseginy, SA; Mahmoud, AE; Mohamed, TK | 1 |
Chen, S; Keit, E; Wang, H; Xie, J | 1 |
Abd El-Karim, SS; Abdelghany, TM; El Kerdawy, AM; Syam, YM | 1 |
Ahmad, A; Al-Khatib, SM; Blank, M; Coylewright, M; DiBattiste, P; Gersh, BJ; Granger, CB; Healey, JS; Hedrich, O; Hylek, EM; Kline-Rogers, E; Mendys, P; Mirro, MJ; Naccarelli, G; Patel, P; Peterson, ED; Pokorney, SD; Ruff, CT; Rutman, H; Stockbridge, N; Temple, R | 1 |
Alvala, M; Alvala, R; Ghouse, MS; Goud, NS; Pranay, J; Qureshi, IA; Talla, V; Vishnu, J | 1 |
Barrios, V; Cervantes, CE; Merino, JL | 1 |
Pickett, JD | 1 |
Avin, BRV; Khanum, SA; Prabhakar, BT; Prashanth, T; Ranganatha, VL; Sharath Chandra, JNN; Thirusangu, P | 1 |
Anker, SD; Doehner, W; von Haehling, S | 1 |
Mahmoud, MY; Ramasubramanian, A; Sims, LB; Steinbach-Rankins, JM; Stocke, S; Tyo, KM | 1 |
Chen, C; Davis, JR; Di, G; Liao, D; Shi, W; Tang, L; Wang, H; Wu, Z; Zhang, B | 1 |
Chan, YH; Chang, SH; Chao, TF; Kuo, CT; Lee, HF; Lip, GYH; See, LC; Tu, HT; Wu, LS; Yeh, YH | 1 |
Guo, H; Guo, L; Guo, P; Kebebe, D; Li, N; Liu, Z; Pi, J; Qi, D; Wu, Y; Zhang, B | 1 |
Katti, DS; Reddy, GB; Reddy, SS; Srinivasarao, DA | 1 |
Choi, EK; Lee, SR | 1 |
Chen, H; Deng, Y; Li, S; Tong, Y; Zou, L | 1 |
Lv, H; Xie, Z; Zhang, Z | 1 |
Antman, EM; Bergmark, BA; Braunwald, E; Chung, N; Giugliano, RP; Lanz, HJ; Park, S; Ruff, CT; Shi, M | 1 |
Patel, MH; Sawant, KK | 1 |
Ashraf, Z; Channar, PA; Iqbal, J; Irum, H; Larik, FA; Lecka, J; Mahmood, A; Saeed, A; Sévigny, J; Shabir, G; Zaib, S | 1 |
Cohen, AA; De Caterina, R; de Groot, JR; Ezekowitz, MD; Goette, A; Heidbuchel, H; Jin, J; Le Heuzey, JY; Lip, GYH; Melino, M; Merino, JL; Merkely, B; Themistoclakis, S; Winters, SM | 1 |
Bai, X; Dong, B; Huang, G; Liu, J; Liu, M; Lv, J; Song, H; Sun, J; Sun, L; Sun, X; Xu, L; Xu, W; Zhang, G; Zhang, L | 1 |
Bagde, A; Kutlehria, S; Patel, N; Singh, M | 1 |
Ahsan Halim, S; Al-Harrasi, A; Csuk, R; Ibrar, A; Khan, A; Khan, I; Mehsud, S; Saeed, A | 1 |
Antman, EM; Bergmark, BA; Braunwald, E; Giugliano, RP; Kamphuisen, PW; Kuder, JF; Lanz, HJ; Mercuri, MF; Nordio, F; Ruff, CT; Wiviott, SD | 1 |
Anderson, CF; Chakroun, RW; Cui, H; Mitrut, RE; Su, H | 1 |
Antman, EM; Corbalan, R; Duris, T; Giugliano, RP; Juul-Möller, S; Kerschnitzki, M; Nicolau, AM; Nicolau, JC; Nordio, F; Ruff, CT; Trevisan, M; Voitk, J; Zierhut, W | 1 |
Pastori, D; Pignatelli, P; Violi, F | 1 |
Duong, HD; Rhee, JI; Shin, Y | 1 |
Al-Saady, N; Cohen, A; Goette, A; Goudev, A; Hjortshøj, SP; Huber, K; Jin, J; Kozieł, M; Lip, GYH; Melino, M; Winters, SM | 1 |
Du, W; Huang, S; Wen, L; Xu, H; Zhu, C | 1 |
Chaiyakunapruk, N; Dilokthornsakul, P; Hollingworth, W; Jahan, NK; Kongpakwattana, K; Lai, NM; Nathisuwan, S; Ng, SS | 1 |
Ali, H; Hanley, DF; Marsh, EB; Nyquist, PA; Shin, SS; Ziai, WC | 1 |
Ahmad, Z; Al-Qawasmeh, RA; Al-Tel, TH; Hersi, F; Jaber, AM; Omar, HA; Zaher, DM | 1 |
Bachmann, P; Böhm, M; Custodis, F; Millenaar, D; Schirmer, SH | 1 |
Zidek, W | 1 |
De Caterina, R; Goette, A; Huber, K; Jin, J; Kozieł, M; Lip, GYH; Melino, M; Merino, JL | 1 |
Cai, Y; Gao, X; Shuai, Q; Sun, X; Xu, J; Xu, Z; Zhu, F | 1 |
Cui, X; Dou, Y; Gao, Y; He, S; Li, Z; Qiao, F; Xu, L; Zhong, S | 1 |
Barillari, G; Bortoluzzi, C; Dentali, F; Giorgi, M; Orabona, R; Pacetti, E; Sciatti, E; Zaffaroni, M | 1 |
De Caterina, R; Goette, A; Heidbuchel, H; Huber, K; Jin, J; Lip, GYH; Merino, JL | 1 |
Ho, KH; Leng, G; van Hove, M | 1 |
Acar, RD; Akgün, T; Camm, AJ; Emren, V; Kanat, S; Karacağlar, E; Kepez, A; Kul, Ş; Özel, E; Şimşek, E; Tülüce, K; Türk, UÖ; Yakar Tülüce, S | 1 |
Liu, X; Xu, ZX; Yu, P; Yuan, P; Zhu, WG | 1 |
Jenkins, A; Katada, J; Kohsaka, S; Li, B; Mardekian, J; Saito, K; Terayama, Y | 1 |
Bauersachs, J; Berliner, D; Flierl, U; Schäfer, A | 1 |
Bansal, V; Bhagat, S; Gupta, N; Jangid, AK; Kulhari, H; Pooja, D; Singh, M; Singh, S | 1 |
Cheng, X; Chu, ZW; Hu, R; Liu, H; Lv, XH; Xia, DG | 1 |
Fukushima, K; Hagiwara, N; Haruki, S; Jujo, K; Kikuchi, Y; Minami, Y; Murasaki, K; Ogawa, H; Sekiguchi, H; Tanaka, H; Yoshida, A | 1 |
Huang, M; Liu, X; Ma, J; Ye, C; Zeng, C; Zeng, J | 1 |
Doyama, H; Fujishiro, M; Fujita, T; Hasatani, K; Hatta, W; Hiasa, Y; Hikichi, T; Igarashi, K; Iguchi, M; Inoue, T; Kawaguchi, K; Kitamura, K; Kuribayashi, S; Mikami, T; Morita, Y; Nishida, T; Nishikawa, J; Oda, I; Sumiyama, K; Sumiyoshi, T; Tomida, H; Tsuji, Y; Uraoka, T; Yada, T; Yamamoto, K; Yanagitani, A; Yoshio, T | 1 |
Eichinger, S; Grosso, MA; Kyrle, PA; Lin, M; Shi, M | 1 |
Duong, HD; Rhee, JI; Sohn, OJ | 1 |
Lopes, DG; Schipp, B; Siepmann, T; Tamayo, A | 1 |
Choe, WS; Choi, EK; Han, KD; Jung, JH; Kwon, S; Lee, E; Lee, SR; Lip, GYH; Oh, S | 1 |
Kawano, Y; Tamura, A; Yamamoto, E | 1 |
Abbas, EMH; Abdel-Aziz, MM; Farghaly, TA; Harras, MF; Masaret, GS; Omar, MA | 1 |
Antman, EM; Braunwald, E; Cohen, DJ; Giugliano, RP; Kwong, WJ; Li, H; Magnuson, EA; Ruff, CT; Vilain, K | 1 |
Yavelov, IS | 1 |
Aprile, F; Breccia, M; Chistolini, A; Fiori, L; Gioia, S; Lucani, B; Merli, M; Riggio, O; Serrao, A | 1 |
Arya, R; Brown, A; Byrne, R; Coles, E; Czuprynska, J; Gee, E; Patel, JP; Patel, R; Rea, C; Roberts, LN; Saul, G; Speed, V; Vadher, B | 1 |
Clegg, A; Gale, CP; Hall, M; Kunadian, V; Rockwood, K; Searle, SD; Todd, O; Wilkinson, C; Wu, J | 1 |
Avorn, J; Gagne, JJ; Kesselheim, AS; Rome, BN | 1 |
Egred, M; Farag, M; Gorog, DA; Gue, YX; Spinthakis, N | 1 |
Bu, Y; Wang, L; Xu, T; Yang, L; Yu, Z; Zhang, J; Zhang, Y; Zhou, H; Zhu, X | 1 |
Antman, EM; Braunwald, E; Giugliano, RP; Lanz, HJ; Nelson, SE; Norden, AD; Park, JG; Rost, NS; Ruff, CT; Silverman, S; Singhal, AB | 1 |
Liang, X; Lin, Z; Liu, M; Xie, W | 1 |
Fu, Q; He, Z; Liu, Y; Wang, Y; Zhang, G; Zhang, Z | 1 |
Oh, HJ; Park, BJ; Ryu, KH; Yoon, BH | 1 |
Dufès, C; Laskar, P; Mullin, M; Sakpakdeejaroen, I; Somani, S | 1 |
Bradley, SM; Gosch, KL; Hess, PL; Jani, SM; Maddox, TM; Michael Ho, P; Varosy, PD; Virani, SS | 1 |
Cui, X; Dou, Y; Fang, Y; Gao, Y; He, S; Meng, Q; Zhong, S | 1 |
Drabik, L; Undas, A | 1 |
Grove, EL; Larsen, TB; Lip, GYH; Nielsen, PB; Ording, AG; Skjøth, F; Søgaard, M | 1 |
Ansari, MF; Cheng, Y; Hu, C; Hu, Y; Pan, G; Yadav Bheemanaboina, RR; Yu, C; Zhang, J; Zhou, C | 1 |
Jensen, M; Lip, GY; Nielsen, PB; Ording, AG; Søgaard, M | 1 |
Duong, HD; Rhee, JI | 1 |
Ciszkowicz, E; Creaven, B; Jenkins, H; Kamiński, D; Karcz, D; Lecka-Szlachta, K; Matwijczuk, A; Miłoś, A; Radomski, P; Ślusarczyk, L; Starzak, K | 1 |
Abdo, NYM; Ibrahim, RA; Mohareb, RM; Samir, EM | 1 |
Duggal, A; Grosso, MA; Kakkar, T; Kotsuma, M; Lanz, H; Shi, M; Yin, O | 1 |
Antman, EM; Bonaca, MP; Braunwald, E; Cunningham, JW; Giugliano, RP; Grosso, MA; Halperin, JL; Lanz, HJ; Murphy, SA; Ruff, CT; Weitz, JI; Wiviott, SD | 1 |
Chang, C; Hou In Chou, O; Iltaf Satti, D; Ka Chung Wai, A; Lee, S; Liu, T; Liu, X; Roever, L; Tai Loy Lee, T; Tak Wong, W; Tse, G; Zhang, Q; Zhou, J | 1 |
Antman, EM; Berger, D; Braunwald, E; Chen, C; Eisen, A; Gencer, B; Giugliano, RP; Grip, LT; Lanz, H; Murphy, SA; Nordio, F; Ruff, CT | 1 |
Akao, M; Fukuzawa, M; Hayashi, T; Imamura, Y; Kuroda, M; Lip, GYH; Nose, T; Ogimoto, A; Okumura, K; Tamiya, E; Taura, J; Yamashita, T | 1 |
Geng, RX; Hu, CF; Hu, CS; Li, S; Yang, XC; Zhang, PL; Zhou, CH | 1 |
Bhatia, M; Kapoor, A; Kumar, A; Kumar, P; Kumar, S | 1 |
Akao, M; Betsuyaku, T; Hayashi, T; Hirabayashi, K; Imamura, Y; Mikami, T; Okawa, K; Okumura, K; Tanizawa, K; Watanabe, S; Yamashita, T | 1 |
Angeli, A; Arifuddin, M; Chirra, H; Goud, NS; Newaskar, V; Shaik, AB; Sigalapalli, DK; Supuran, CT; Thacker, PS | 1 |
Abdel-Aziem, A; Elsharabasy, SA; Sayed, MT | 1 |
85 review(s) available for thiazoles and warfarin
Article | Year |
---|---|
Classes of hepatic microsomal mixed function oxidase inducers.
Topics: Animals; Barbiturates; Cell Nucleus; Coumarins; Cytochrome P-450 Enzyme System; Environmental Pollutants; Enzyme Induction; Flavonoids; Humans; Insecticides; Liver; Microsomes, Liver; Mixed Function Oxygenases; Oxidoreductases; Polycyclic Compounds; Protein Biosynthesis; Thiazoles; Time Factors; Xanthines | 1979 |
List of the photodynamic substances.
Topics: Acridines; Alkaloids; Anthraquinones; Anti-Bacterial Agents; Benzhydryl Compounds; Benzothiadiazines; Coumarins; Light; Naphthalenesulfonates; Nitroso Compounds; Oxazines; Oxidation-Reduction; Phenazines; Phenothiazines; Photochemistry; Polycyclic Compounds; Pyrones; Quinolines; Stilbenes; Sulfonamides; Thiazines; Thiazoles; Trityl Compounds; Vitamins; Xanthenes | 1972 |
The biosynthesis of shikimate metabolites.
Topics: 3-Deoxy-7-Phosphoheptulonate Synthase; 3-Phosphoshikimate 1-Carboxyvinyltransferase; Alkyl and Aryl Transferases; Animals; Anthranilate Synthase; Bacteria; Betalains; Catalysis; Chorismate Mutase; Coumarins; Flavonoids; Hydro-Lyases; Indoleacetic Acids; Indoles; Intramolecular Transferases; Lignans; Molecular Structure; Penicillium; Phenylalanine; Phenylpropionates; Phosphorus-Oxygen Lyases; Prephenate Dehydratase; Prephenate Dehydrogenase; Pristinamycin; Pyrrolnitrin; Quaternary Ammonium Compounds; Quinones; Shikimic Acid; Staurosporine; Tannins; Thiazoles; Thyroxine; Tryptophan; Tyrosine; Ubiquinone | 2001 |
Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Benzamides; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism; Warfarin | 2010 |
Lectin-immobilized fluorescent nanospheres for targeting to colorectal cancer from a physicochemical perspective.
Topics: Acetamides; Animals; Colonoscopy; Colorectal Neoplasms; Coumarins; Drug Delivery Systems; Fluorescent Dyes; Humans; Nanospheres; Peanut Agglutinin; Polystyrenes; Polyvinyls; Thiazoles | 2011 |
[Thromboembolic prophylaxis 2011: is warfarin on the wane?].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzamides; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Evidence-Based Medicine; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism; Treatment Outcome; Warfarin | 2011 |
Current and future alternatives to warfarin for the prevention of stroke in atrial fibrillation.
Topics: Anticoagulants; Antithrombin Proteins; Atrial Appendage; Atrial Fibrillation; Benzimidazoles; Chemoprevention; Dabigatran; Fibrinolytic Agents; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin | 2012 |
Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options.
Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombolytic Therapy; Ticlopidine; Warfarin | 2012 |
The promise of novel direct oral anticoagulants.
Topics: Anticoagulants; Antithrombins; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombin; Thromboembolism; Warfarin | 2012 |
[New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Electric Countershock; Factor Xa Inhibitors; Humans; Kidney Failure, Chronic; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin | 2012 |
The novel anticoagulants: the surgeons' prospective.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Surgical Procedures, Operative; Thiazoles; Thiophenes; Venous Thromboembolism; Warfarin | 2013 |
[Improvements in oral anticoagulant therapy for atrial fibrillation].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Embolism; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Treatment Outcome; Warfarin | 2013 |
Venous thromboembolism management: where do novel anticoagulants fit?
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Factor X; Heparin; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombin; Venous Thromboembolism; Vitamin K; Warfarin | 2013 |
Alternatives to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a look back at the state of the field in 2012.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin | 2013 |
New oral anticoagulants for the treatment of venous thromboembolism.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Humans; Middle Aged; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Thiophenes; Venous Thromboembolism; Warfarin | 2013 |
New oral anticoagulant agents - general features and outcomes in subsets of patients.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Hemorrhage; Humans; Morpholines; Patient Selection; Pyrazoles; Pyridines; Pyridones; Risk; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Treatment Outcome; Venous Thromboembolism; Warfarin | 2014 |
Edoxaban: Review of pharmacology and key phase I to III clinical trials.
Topics: Anticoagulants; Atrial Fibrillation; Clinical Trials as Topic; Factor Xa Inhibitors; Hemorrhage; Humans; Pyridines; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome; Venous Thrombosis; Warfarin | 2014 |
[Prevention of venous thromboembolism and anticoagulant therapy].
Topics: Anesthesia, Epidural; Anticoagulants; Biomarkers; Diagnostic Imaging; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Intraoperative Complications; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Pulmonary Embolism; Pyridines; Risk Factors; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2014 |
Novel anticoagulants vs warfarin for stroke prevention in atrial fibrillation.
Topics: Animals; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Discovery; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin | 2014 |
Target-specific oral anticoagulants: practice issues for the clinician.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Humans; Medication Adherence; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Venous Thromboembolism; Warfarin | 2014 |
Switching between oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; United States; Warfarin | 2014 |
Target-specific oral anticoagulants and the hospitalist.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Hospitalists; Humans; International Normalized Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thrombosis; Warfarin | 2015 |
Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Venous Thromboembolism; Warfarin | 2015 |
Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Thiazoles; Warfarin | 2015 |
Overview of the new oral anticoagulants: opportunities and challenges.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Sensitivity and Specificity; Stroke; Thiazoles; Thiophenes; Thromboembolism; Warfarin | 2015 |
Anticoagulation therapy. Optimal dosages and genotypes for edoxaban therapy.
Topics: Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Humans; Pyridines; Thiazoles; Warfarin | 2015 |
Current management of venous thromboembolism in Japan: Current epidemiology and advances in anticoagulant therapy.
Topics: Anticoagulants; Fondaparinux; Heparin; Humans; Japan; Polysaccharides; Pulmonary Embolism; Pyridines; Quality of Life; Risk Factors; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2015 |
Efficacy and Safety of Edoxaban in Nonvalvular Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials.
Topics: Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Humans; Pyridines; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome; Warfarin | 2015 |
Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials.
Topics: Anticoagulants; Atrial Fibrillation; Heart Failure; Hemorrhage; Humans; Pyridines; Randomized Controlled Trials as Topic; Risk Adjustment; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2015 |
[Large studies of NOAC shows good and safe stroke protection].
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Factor Xa Inhibitors; Humans; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2015 |
Edoxaban: a review in nonvalvular atrial fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Factor Xa Inhibitors; Hemorrhage; Humans; Pyridines; Risk Factors; Stroke; Thiazoles; Warfarin | 2015 |
Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridines; Pyridones; Research Design; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2016 |
Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Topics: Atrial Fibrillation; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Embolism; Factor Xa Inhibitors; Humans; Pyridines; Risk; Stroke; Thiazoles; Thromboembolism; Vitamin K; Warfarin | 2015 |
How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; beta-Alanine; Clinical Decision-Making; Dabigatran; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Stroke; Thiazoles; Warfarin | 2016 |
Comparison of Watchman device with new oral anti-coagulants in patients with atrial fibrillation: A network meta-analysis.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Clinical Trials as Topic; Dabigatran; Defibrillators, Implantable; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Thiazoles; Warfarin | 2016 |
Non-vitamin K Oral Anticoagulants Versus Warfarin for Patients with Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Male; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2016 |
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation Factors; Dabigatran; Dose-Response Relationship, Drug; Evidence-Based Medicine; Factor Xa Inhibitors; Humans; Medication Errors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2016 |
New anticoagulants for the treatment of venous thromboembolism.
Topics: Anticoagulants; Dabigatran; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Time Factors; Venous Thromboembolism; Warfarin | 2016 |
Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis.
Topics: Anticoagulants; Atrial Appendage; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Intracranial Hemorrhages; Network Meta-Analysis; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2016 |
Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.
Topics: Anticoagulants; Atrial Fibrillation; Creatinine; Dabigatran; Glomerular Filtration Rate; Hemorrhage; Humans; Kidney; Kidney Failure, Chronic; Pyrazoles; Pyridines; Pyridones; Renal Dialysis; Renal Insufficiency, Chronic; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2016 |
[Anticoagulation for patients with non-valvular atrial fibrillation].
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thrombolytic Therapy; Warfarin | 2016 |
Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience.
Topics: Administration, Oral; Anticoagulants; Antidotes; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2016 |
Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Cardiovascular Diseases; Cause of Death; Dabigatran; Embolism; Factor Xa Inhibitors; Heart Failure; Hemorrhage; Humans; Intracranial Hemorrhages; Mortality; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2016 |
Bleeding with direct oral anticoagulants vs warfarin: clinical experience.
Topics: Anticoagulants; Clinical Trials, Phase III as Topic; Dabigatran; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Warfarin | 2016 |
Comparative Efficacy of Clinical Events Prevention of Five Anticoagulants in Patients With Atrial Fibrillation (A Network Meta-Analysis).
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Mortality; Myocardial Infarction; Network Meta-Analysis; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2017 |
Edoxaban: A direct oral anticoagulant.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Drug Monitoring; Factor Xa Inhibitors; Hemorrhage; Humans; Pyridines; Stroke; Thiazoles; Venous Thromboembolism; Warfarin | 2017 |
Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.
Topics: Age Factors; Anticoagulants; Atrial Fibrillation; Comparative Effectiveness Research; Humans; Medication Therapy Management; Practice Guidelines as Topic; Pyridines; Thiazoles; Venous Thromboembolism; Warfarin | 2017 |
Anticoagulation Therapy and NOACs in Heart Failure.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Heart Failure; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism; Warfarin | 2017 |
Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Chromatography, High Pressure Liquid; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Intracranial Hemorrhages; Partial Thromboplastin Time; Prothrombin Time; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Tandem Mass Spectrometry; Thiazoles; Thrombin Time; Warfarin | 2017 |
Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan.
Topics: Administration, Oral; Anticoagulants; Clinical Trials as Topic; Factor Xa Inhibitors; Hemorrhage; Hospitalization; Humans; Japan; Neoplasms; Outpatients; Platelet Count; Pyrazoles; Pyridines; Pyridones; Recurrence; Rivaroxaban; Thiazoles; Venous Thromboembolism; Warfarin | 2017 |
Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Prospective Studies; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency, Chronic; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Warfarin | 2017 |
Appropriateness of Oral Anticoagulants for the Long-Term Treatment of Atrial Fibrillation in Older People: Results of an Evidence-Based Review and International Consensus Validation Process (OAC-FORTA 2016).
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Consensus; Dabigatran; Delphi Technique; Europe; Evidence-Based Practice; Female; Humans; Long-Term Care; Middle Aged; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Stroke; Thiazoles; Warfarin | 2017 |
Renal Function Considerations for Stroke Prevention in Atrial Fibrillation.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Embolism; Factor Xa Inhibitors; Hemorrhage; Humans; Pharmaceutical Research; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency; Risk Assessment; Rivaroxaban; Stroke; Therapeutic Equivalency; Thiazoles; Warfarin | 2017 |
The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis.
Topics: Anticoagulants; Aspirin; Bayes Theorem; Cardiovascular Diseases; Clopidogrel; Dabigatran; Dipyridamole; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Thiazoles; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies.
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Risk; Rivaroxaban; Thiazoles; Warfarin | 2017 |
Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Bayes Theorem; Clinical Trials as Topic; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Markov Chains; Middle Aged; Monte Carlo Method; Network Meta-Analysis; Odds Ratio; Pyridines; Randomized Controlled Trials as Topic; Risk; Thiazoles; Warfarin | 2017 |
Risk of Intraocular Bleeding With Novel Oral Anticoagulants Compared With Warfarin: A Systematic Review and Meta-analysis.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Eye Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Rivaroxaban; Thiazoles; Venous Thromboembolism; Warfarin | 2017 |
Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Drug Administration Schedule; Epidemiologic Methods; Factor Xa Inhibitors; Female; Humans; Male; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2017 |
Use of direct oral anticoagulants for stroke prevention in elderly patients with nonvalvular atrial fibrillation.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2017 |
Reversal agents for oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Warfarin | 2017 |
Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis.
Topics: Anticoagulants; Arthroplasty; Azetidines; Benzylamines; Dabigatran; Enoxaparin; Heparin; Heparin, Low-Molecular-Weight; Humans; Network Meta-Analysis; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Treatment Outcome; Venous Thromboembolism; Warfarin | 2017 |
Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
Topics: Anticoagulants; Antithrombins; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Hematoma; Humans; Mortality; Odds Ratio; Phenprocoumon; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Thiazoles; Vitamin K; Warfarin | 2018 |
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Embolism; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2017 |
Management of Anticoagulation in Patients With Prostate Cancer Receiving Enzalutamide.
Topics: Androgen Receptor Antagonists; Anticoagulants; Atrial Fibrillation; Benzamides; Dabigatran; Drug Interactions; Embolism; Heart Valve Prosthesis; Heparin, Low-Molecular-Weight; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Warfarin | 2017 |
A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Embolism; Glomerular Filtration Rate; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2019 |
A review of the use of direct oral anticoagulant use in orthotopic heart transplantation recipients.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Heart Transplantation; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Warfarin | 2018 |
Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease.
Topics: Administration, Oral; Anticoagulants; Antidotes; Antithrombins; Dabigatran; Factor Xa Inhibitors; Humans; International Normalized Ratio; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency, Chronic; Rivaroxaban; Thiazoles; Warfarin | 2019 |
The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trials.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Case-Control Studies; Clinical Trials, Phase III as Topic; Coronary Artery Disease; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Pyridines; Randomized Controlled Trials as Topic; Safety; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2019 |
The safety of NOACs in atrial fibrillation patient subgroups: A narrative review.
Topics: Administration, Oral; Age Factors; Anticoagulants; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2019 |
[Improved stroke prevention in atrial fibrillation: the Stockholm experience of the introduction of NOACs].
Topics: Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Humans; Ischemic Attack, Transient; Observational Studies as Topic; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Sweden; Thiazoles; Warfarin | 2018 |
Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Kidney Failure, Chronic; Pyrazoles; Pyridines; Pyridones; Renal Dialysis; Rivaroxaban; Thiazoles; Thromboembolism; Warfarin | 2018 |
Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.
Topics: Anticoagulants; Atrial Fibrillation; Dose-Response Relationship, Drug; Embolism; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2019 |
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Atrial Fibrillation; Benzamides; Biomarkers; Blood Coagulation; Clinical Trials as Topic; Dabigatran; Drug Administration Schedule; Factor Xa; Heart Diseases; Humans; Piperazines; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Risk; Rivaroxaban; Stroke; Thiazoles; Thrombin; Venous Thromboembolism; Vitamin K; Warfarin | 2019 |
Edoxaban for the prevention of stroke in patients with atrial fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Clinical Trials as Topic; Cost-Benefit Analysis; Factor Xa Inhibitors; Hemorrhage; Humans; Pyridines; Stroke; Thiazoles; Thromboembolism; Warfarin | 2019 |
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Neoplasms; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism; Warfarin | 2019 |
Comparative efficacy and safety of warfarin care bundles and novel oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Patient Care Bundles; Pyridines; Randomized Controlled Trials as Topic; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2020 |
Topics: Atrial Fibrillation; Blood Pressure; Humans; Hypertension; Pyridines; Thiazoles; Warfarin | 2020 |
Non-Vitamin K Antagonist Oral Anticoagulants in Secondary Stroke Prevention in Atrial Fibrillation Patients: An Updated Analysis by Adding Observational Studies.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Humans; Intracranial Hemorrhages; Observational Studies as Topic; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Secondary Prevention; Stroke; Thiazoles; Treatment Outcome; Vitamin K; Warfarin | 2020 |
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Vitamin K; Warfarin | 2020 |
The role of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A PRISMA-compliant article.
Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Asia; Asian People; Atrial Fibrillation; Cost of Illness; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Network Meta-Analysis; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Safety; Stroke; Thiazoles; Warfarin | 2020 |
[Direct Oral Anticoagulant Edoxaban in Patients with Non-Valvular Atrial Fibrillation: Results of Direct Comparison with Warfarin].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Factor Xa Inhibitors; Humans; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2020 |
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin for Patients With Left Ventricular Thrombus: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Antithrombins; Dabigatran; Embolism; Factor Xa Inhibitors; Heart Diseases; Heart Ventricles; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thrombosis; Warfarin | 2021 |
The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis.
Topics: Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Humans; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2021 |
The risk of gastrointestinal hemorrhage with non-vitamin K antagonist oral anticoagulants: A network meta-analysis.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Network Meta-Analysis; Observational Studies as Topic; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism; Warfarin | 2021 |
Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies.
Topics: Aldehydes; Ammonia; Caffeine; Chalcones; Chromones; Clorgyline; Coumarins; Hydrogen Peroxide; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Pyrazoles; Selegiline; Structure-Activity Relationship; Thiazoles; Thiourea | 2022 |
74 trial(s) available for thiazoles and warfarin
Article | Year |
---|---|
Effects of nitazoxanide on pharmacokinetics and pharmacodynamics of a single dose of warfarin.
Topics: Adolescent; Adult; Antiparasitic Agents; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Humans; Male; Middle Aged; Nitro Compounds; Thiazoles; Warfarin | 2009 |
Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation.
Topics: Administration, Oral; Aged; Alanine Transaminase; Anticoagulants; Aspartate Aminotransferases; Atrial Fibrillation; Bilirubin; Biomarkers; Blood Coagulation; Double-Blind Method; Europe, Eastern; Factor Xa; Factor Xa Inhibitors; Female; Fibrin Fibrinogen Degradation Products; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Pyridines; Stroke; Thiazoles; Time Factors; Treatment Outcome; United States; Warfarin | 2010 |
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infar
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Pyridines; Retrospective Studies; Stroke; Thiazoles; Thrombolytic Therapy; Treatment Outcome; Warfarin | 2010 |
Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Asian People; Atrial Fibrillation; Double-Blind Method; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Middle Aged; Pyridines; Thiazoles; Warfarin | 2011 |
Comparison of antithrombotic and haemorrhagic effects of edoxaban, an oral direct factor Xa inhibitor, with warfarin and enoxaparin in rats.
Topics: Administration, Oral; Animals; Anticoagulants; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Hemostatics; Male; Pyridines; Rats; Rats, Wistar; Thiazoles; Treatment Outcome; Venous Thrombosis; Warfarin | 2012 |
Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillation.
Topics: Aged; Anticoagulants; Asian People; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemorrhage; Humans; Incidence; International Normalized Ratio; Japan; Male; Middle Aged; Pyridines; Thiazoles; Warfarin | 2012 |
A randomized trial of the safety, pharmacokinetics and pharmacodynamics of edoxaban, an oral factor Xa inhibitor, following a switch from warfarin.
Topics: Administration, Oral; Adolescent; Adult; Anticoagulants; Blood Coagulation Tests; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Pyridines; Thiazoles; Warfarin | 2013 |
Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.
Topics: Administration, Oral; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Clinical Protocols; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Predictive Value of Tests; Pyridines; Research Design; Secondary Prevention; Thiazoles; Time Factors; Treatment Outcome; Venous Thromboembolism; Warfarin | 2013 |
Edoxaban versus warfarin in patients with atrial fibrillation.
Topics: Adult; Aged; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Double-Blind Method; Embolism; Female; Follow-Up Studies; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pyridines; Stroke; Thiazoles; Warfarin | 2013 |
[Hokusai-VTE: edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism].
Topics: Anticoagulants; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Hemorrhage; Heparin; Humans; Pyridines; Randomized Controlled Trials as Topic; Thiazoles; Venous Thromboembolism; Warfarin | 2013 |
Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2014 |
Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trial.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Drug Substitution; Factor Xa; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pyridines; Thiazoles; Treatment Outcome; Warfarin | 2014 |
Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: in vitro and in vivo correlation.
Topics: Adolescent; Adult; Aminoisobutyric Acids; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; Healthy Volunteers; Hepatitis C; Humans; In Vitro Techniques; Isoenzymes; Leucine; Male; Microsomes, Liver; Midazolam; Middle Aged; Oligopeptides; Proline; Protease Inhibitors; Quinolines; Thiazoles; Warfarin; Young Adult | 2015 |
Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Pyridines; Risk Factors; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2015 |
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Topics: Anticoagulants; Atrial Fibrillation; Cytochrome P-450 CYP2C9; Double-Blind Method; Factor Xa Inhibitors; Genetic Variation; Genotype; Hemorrhage; Humans; International Normalized Ratio; Pharmacogenetics; Pyridines; Risk Assessment; Stroke; Thiazoles; Vitamin K Epoxide Reductases; Warfarin | 2015 |
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study.
Topics: Adult; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Electric Countershock; Factor Xa Inhibitors; Female; Humans; Male; Prospective Studies; Pyridines; Research Design; Stroke; Thiazoles; Thromboembolism; Warfarin | 2015 |
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Female; Hemorrhage; Humans; Male; Middle Aged; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2015 |
Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Asia, Eastern; Asian People; Double-Blind Method; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Pulmonary Embolism; Pyridines; Recurrence; Therapeutic Equivalency; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Vitamin K; Warfarin; Young Adult | 2015 |
Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction
Topics: Aged; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Double-Blind Method; Embolism; Factor Xa; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Middle Aged; Myocardial Infarction; Pyridines; Retrospective Studies; Thiazoles; Thrombolytic Therapy; Treatment Outcome; Warfarin | 2015 |
Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMI 48 trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Monitoring; Embolism; Female; Hemorrhage; Humans; Male; Middle Aged; Patient Selection; Pyridines; Risk Assessment; Stroke; Survival Analysis; Thiazoles; Treatment Outcome; Warfarin | 2015 |
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardi
Topics: Aged; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Approval; Factor Xa; Factor Xa Inhibitors; Female; Humans; Male; Myocardial Infarction; Pyridines; Stroke; Thiazoles; Thrombolytic Therapy; United States; United States Food and Drug Administration; Warfarin | 2016 |
Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation - An ENGAGE AF-TIMI 48 Subanalysis.
Topics: Aged; Aged, 80 and over; Asia, Eastern; Atrial Fibrillation; Double-Blind Method; Embolism; Hemorrhage; Humans; Pyridines; Stroke; Thiazoles; Warfarin | 2016 |
Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Drug Administration Schedule; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyridines; Risk Assessment; Risk Factors; Stroke; Thiazoles; Time Factors; Treatment Outcome; Warfarin | 2016 |
Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Factor Xa Inhibitors; Female; Humans; Male; Pyridines; Thiazoles; Treatment Outcome; United States; Warfarin | 2016 |
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
Topics: Administration, Oral; Anticoagulants; Double-Blind Method; Factor Xa Inhibitors; Hemorrhage; Humans; Pyridines; Risk Factors; Thiazoles; Venous Thromboembolism; Vitamin K; Warfarin | 2016 |
Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Combined Modality Therapy; Double-Blind Method; Electric Countershock; Factor Xa Inhibitors; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Pyridines; Risk Factors; Stroke; Thiazoles; Time Factors; Treatment Outcome; Warfarin | 2016 |
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
Topics: Adult; Aged; Anticoagulants; Comparative Effectiveness Research; Double-Blind Method; Female; Follow-Up Studies; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pulmonary Embolism; Pyridines; Recurrence; Risk Assessment; Secondary Prevention; Thiazoles; Venous Thromboembolism; Ventricular Dysfunction, Right; Warfarin | 2016 |
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Anticoagulants; Blood Coagulation; Drug Therapy, Combination; Factor Xa Inhibitors; Feasibility Studies; Female; Heparin; Humans; International Normalized Ratio; Magnetic Resonance Angiography; Male; Middle Aged; Phlebography; Predictive Value of Tests; Pyridines; Thiazoles; Time Factors; Treatment Outcome; United States; Venous Thrombosis; Warfarin | 2016 |
Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
Topics: Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Embolism; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2016 |
Edoxaban Exposure-Response Analysis and Clinical Utility Index Assessment in Patients With Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism.
Topics: Aged; Double-Blind Method; Drug Dosage Calculations; Factor Xa Inhibitors; Female; Humans; Male; Pulmonary Embolism; Pyridines; Risk Assessment; Thiazoles; Venous Thrombosis; Warfarin | 2016 |
Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Factor Xa Inhibitors; Female; Heart Failure; Hemorrhage; Humans; Male; Middle Aged; Proportional Hazards Models; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2016 |
Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Creatinine; Double-Blind Method; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Humans; Kidney; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Pyridines; Risk; Thiazoles; Thrombophilia; Warfarin | 2016 |
Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Double-Blind Method; Female; Humans; Male; Middle Aged; Pyridines; Recurrence; Secondary Prevention; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2016 |
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial.
Topics: Adult; Aged; Double-Blind Method; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Pyridines; Thiazoles; Venous Thromboembolism; Warfarin | 2016 |
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
Topics: Adolescent; Adult; Aged; Anticoagulants; Double-Blind Method; Equivalence Trials as Topic; Europe; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Pulmonary Embolism; Pyridines; Recurrence; Survival Rate; Thiazoles; Venous Thromboembolism; Ventricular Dysfunction, Right; Warfarin; Young Adult | 2016 |
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Electric Countershock; Enoxaparin; Factor Xa Inhibitors; Hemorrhage; Humans; Middle Aged; Prospective Studies; Pyridines; Stroke; Thiazoles; Thromboembolism; Warfarin | 2016 |
Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.
Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Pyridines; Risk Factors; Single-Blind Method; Stroke; Thiazoles; Warfarin | 2016 |
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Pyridines; Risk Assessment; Risk Factors; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2017 |
Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
Topics: Aged; Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Pyridines; Risk Factors; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin | 2017 |
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
Topics: Aged; Anticoagulants; Blood Coagulation; Decision Support Techniques; Double-Blind Method; Factor Xa Inhibitors; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Predictive Value of Tests; Pyridines; Risk Assessment; Risk Factors; Thiazoles; Treatment Outcome; Venous Thromboembolism; Vitamin K; Warfarin | 2017 |
Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.
Topics: Anticoagulants; Atrial Fibrillation; Bioprosthesis; Blood Coagulation; Factor Xa Inhibitors; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Pyridines; Risk Factors; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin | 2017 |
External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism.
Topics: Aged; Anticoagulants; Disease Progression; Female; Hemorrhage; Humans; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Prognosis; Pyridines; Research Design; Risk; Surveys and Questionnaires; Thiazoles; Venous Thromboembolism; Warfarin | 2017 |
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Embolism; Female; Heart Valve Diseases; Hemorrhage; Humans; Male; Middle Aged; Pyridines; Stroke; Thiazoles; Warfarin | 2017 |
First experience with edoxaban and atrial fibrillation ablation - Insights from the ENGAGE AF-TIMI 48 trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Double-Blind Method; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Pyridines; Thiazoles; Thrombolytic Therapy; Warfarin | 2017 |
Genetics and clinical response to warfarin and edoxaban in patients with venous thromboembolism.
Topics: Adult; Aged; Anticoagulants; Blood Coagulation; Cytochrome P-450 CYP2C9; Double-Blind Method; Drug Monitoring; Factor Xa Inhibitors; Female; Genetic Predisposition to Disease; Hemorrhage; Humans; Male; Middle Aged; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Pyridines; Risk Assessment; Risk Factors; Thiazoles; Time Factors; Treatment Outcome; Venous Thromboembolism; Vitamin K Epoxide Reductases; Warfarin | 2017 |
Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 Trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Embolism; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Health Status; Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Pyridines; Quality of Life; Risk Factors; Stroke; Surveys and Questionnaires; Thiazoles; Time Factors; Treatment Outcome; Warfarin | 2017 |
The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Creatinine; Dose-Response Relationship, Drug; Electric Countershock; Factor Xa Inhibitors; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Pyridines; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin | 2017 |
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
Topics: Adult; Aged; Ambulatory Care; Anticoagulants; Double-Blind Method; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Pyridines; Thiazoles; United States; Venous Thromboembolism; Warfarin | 2017 |
Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study.
Topics: Administration, Oral; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Factor Xa Inhibitors; Female; Humans; Incidence; Japan; Male; Pyridines; Stroke; Survival Rate; Thiazoles; Treatment Outcome; Warfarin | 2017 |
Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pyridines; Retrospective Studies; Risk Factors; Stroke; Thiazoles; Thromboembolism; Warfarin; Withholding Treatment | 2018 |
Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
Topics: Anticoagulants; Atrial Fibrillation; Brain Ischemia; Catheter Ablation; Clinical Protocols; Drug Administration Schedule; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Pyridines; Research Design; Risk Factors; Stroke; Thiazoles; Time Factors; Treatment Outcome; Vitamin K; Warfarin | 2018 |
Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Cardiac Surgical Procedures; Double-Blind Method; Female; Hemorrhage; Humans; Male; Perioperative Care; Postoperative Complications; Pyridines; Stroke; Thiazoles; Treatment Outcome; United States; Warfarin | 2018 |
Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study.
Topics: Adult; Anticoagulants; Double-Blind Method; Female; Humans; Middle Aged; Pyridines; Thiazoles; Treatment Outcome; Uterine Hemorrhage; Venous Thromboembolism; Warfarin | 2018 |
Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cost Savings; Cost-Benefit Analysis; Drug Costs; Echocardiography, Transesophageal; Electric Countershock; Emergency Service, Hospital; Europe; Factor Xa Inhibitors; Female; Hemorrhage; Hospital Costs; Humans; Male; Middle Aged; Patient Readmission; Patient Satisfaction; Pyridines; Risk Factors; Thiazoles; Time Factors; Treatment Outcome; United States; Warfarin | 2018 |
Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Pyridines; Thiazoles; Thrombolytic Therapy; Treatment Outcome; Warfarin | 2019 |
Multicenter, Open-Label, Randomized Controlled Trial of Warfarin and Edoxaban Tosilate Hydrate for the Treatment of Deep Vein Thrombosis in Persons with Severe Motor Intellectual Disabilities.
Topics: Anticoagulants; Factor Xa Inhibitors; Hemorrhage; Humans; Intellectual Disability; Intelligence; Japan; Motor Activity; Motor Disorders; Multicenter Studies as Topic; Persons with Mental Disabilities; Pyridines; Randomized Controlled Trials as Topic; Thiazoles; Time Factors; Treatment Outcome; Venous Thrombosis; Warfarin | 2018 |
Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Embolism; Factor Xa Inhibitors; Female; Hospitalization; Humans; Intracranial Hemorrhages; Latin America; Male; Myocardial Infarction; Pyridines; Stroke; Thiazoles; Warfarin | 2018 |
Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cardiac Resynchronization Therapy Devices; Defibrillators, Implantable; Device Removal; Double-Blind Method; Drug Administration Schedule; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Pacemaker, Artificial; Prosthesis Implantation; Pyridines; Risk Assessment; Risk Factors; Stroke; Thiazoles; Time Factors; Treatment Outcome; Warfarin | 2019 |
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.
Topics: Aged; American Indian or Alaska Native; Anticoagulants; Asian People; Atrial Fibrillation; Black People; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Proportional Hazards Models; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin; White People | 2019 |
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Body Mass Index; Comorbidity; Embolism; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Obesity; Overweight; Proportional Hazards Models; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2019 |
Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial.
Topics: Anticoagulants; Atrial Fibrillation; Dose-Response Relationship, Drug; Electric Countershock; Factor Xa Inhibitors; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Pyridines; Remission, Spontaneous; Retrospective Studies; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin | 2019 |
Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Comorbidity; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Logistic Models; Male; Patient Safety; Prognosis; Proportional Hazards Models; Pyridines; Risk Assessment; Severity of Illness Index; Stroke; Survival Analysis; Thiazoles; Treatment Outcome; Warfarin | 2019 |
Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography, Transesophageal; Electric Countershock; Factor Xa Inhibitors; Female; Heart Atria; Heart Diseases; Humans; Male; Prospective Studies; Pyridines; Thiazoles; Thrombosis; Treatment Outcome; Warfarin | 2019 |
Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial.
Topics: Aged; Atrial Fibrillation; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Middle Aged; Pyridines; Risk Factors; Thiazoles; Warfarin | 2019 |
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Electric Countershock; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Pyridines; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin | 2020 |
Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial.
Topics: Aged; Atrial Fibrillation; Electric Countershock; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyridines; Thiazoles; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2020 |
Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF-TIMI 48 Trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Factor Xa Inhibitors; Female; Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Pyridines; Risk Assessment; Risk Factors; Thiazoles; Time Factors; Treatment Outcome; Warfarin | 2020 |
Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Double-Blind Method; Drug Administration Schedule; Factor Xa Inhibitors; Female; Follow-Up Studies; Frailty; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Pyridines; Thiazoles; Treatment Outcome; Warfarin | 2020 |
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Double-Blind Method; Factor Xa Inhibitors; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Pyridines; Thiazoles; Warfarin | 2021 |
Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min.
Topics: Anticoagulants; Atrial Fibrillation; Creatinine; Double-Blind Method; Humans; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2022 |
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48.
Topics: Anticoagulants; Atrial Fibrillation; Embolism; Factor Xa Inhibitors; Hemorrhage; Humans; Peripheral Arterial Disease; Pyridines; Stroke; Thiazoles; Warfarin | 2022 |
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Body Weight; Factor Xa Inhibitors; Humans; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2022 |
Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation: A Prespecified Subanalysis of the ELDERCARE-AF Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Embolism; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Pyridines; Stroke; Thiazoles; Warfarin | 2022 |
Laboratory Test Predictors for Major Bleeding in Elderly (≥80 Years) Patients With Nonvalvular Atrial Fibrillation Treated With Edoxaban 15 mg: Sub-Analysis of the ELDERCARE-AF Trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Creatinine; Double-Blind Method; Factor Xa Inhibitors; Hemorrhage; Humans; Pyridines; Stroke; Thiazoles; Warfarin | 2022 |
360 other study(ies) available for thiazoles and warfarin
Article | Year |
---|---|
Lack of interaction between nizatidine and warfarin during chronic administration.
Topics: Adult; Blood Coagulation Factors; Drug Interactions; Histamine H2 Antagonists; Humans; Nizatidine; Prothrombin; Thiazoles; Warfarin | 1988 |
125I fibrinogen and the prevention of venous thrombosis.
Topics: Adult; Amides; Anticoagulants; Fibrinogen; Hematoma; Hemorrhage; Heparin; Hip Joint; Humans; Iodine Radioisotopes; Joint Prosthesis; Leg; Phlebography; Physical Examination; Postoperative Complications; Radionuclide Imaging; Thiazines; Thiazoles; Thrombophlebitis; Ultrasonography; Warfarin | 1973 |
Tissue culture techniques in the study of cell photobiology and phototoxicity.
Topics: Animals; Antimalarials; Carcinoma; Cell Line; Coloring Agents; Coumarins; Culture Media; Culture Techniques; Fibroblasts; Haplorhini; Humans; Kidney; Laryngeal Neoplasms; Light; Methods; Penicillins; Phenothiazines; Photosensitivity Disorders; Porphyrins; Rabbits; Sulfanilamides; Tetracycline; Thiazoles; Tolbutamide | 1970 |
The action of six anthelmintics against Trichostrongylus axei in lambs.
Topics: Animals; Anthelmintics; Benzimidazoles; Carbamates; Coumarins; Imidazoles; Phenothiazines; Pyridines; Pyrimidines; Sheep; Sheep Diseases; Thiazoles; Time Factors; Trichostrongyloidiasis | 1972 |
Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.
Topics: Amino Acid Sequence; Antiviral Agents; Benzimidazoles; Coumarins; Drug Resistance, Microbial; HIV; HIV Reverse Transcriptase; Pyranocoumarins; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Thymine | 1993 |
Comparison of the toxicity of allyl alcohol, coumarin and menadione in precision-cut rat, guinea-pig, cynomolgus monkey and human liver slices.
Topics: 1-Propanol; Animals; Coloring Agents; Coumarins; Guinea Pigs; Humans; Liver; Macaca fascicularis; Male; Potassium; Propanols; Protein Biosynthesis; Rats; Tetrazolium Salts; Thiazoles; Toxicity Tests; Vitamin K | 1996 |
Micromolar and submicromolar Ca2+ spikes regulating distinct cellular functions in pancreatic acinar cells.
Topics: Acetylcholine; Animals; Benzothiazoles; Calcium; Coumarins; Exocytosis; Fluorescent Dyes; Fura-2; Image Processing, Computer-Assisted; Mice; Microscopy, Fluorescence; Pancreas; Photolysis; Thiazoles | 1997 |
Lack of interaction between meloxicam and warfarin in healthy volunteers.
Topics: Administration, Oral; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Drug Interactions; Humans; Male; Meloxicam; Protein Binding; Stereoisomerism; Thiazines; Thiazoles; Warfarin | 1997 |
Ionized intracellular calcium concentration predicts excitotoxic neuronal death: observations with low-affinity fluorescent calcium indicators.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzothiazoles; Calcium; Cell Death; Coumarins; Dextrans; Excitatory Amino Acid Agonists; Fluorescent Dyes; Forecasting; Fura-2; Intracellular Membranes; Ions; Mice; N-Methylaspartate; Neurons; Neurotoxins; Osmolar Concentration; Thiazoles | 1997 |
Inhibition of etoposide-induced apoptotic events by azide.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Azides; Coumarins; Etoposide; Flow Cytometry; Fluorescent Dyes; Humans; Jurkat Cells; Oligopeptides; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles; Ultraviolet Rays | 1997 |
Possible troglitazone-warfarin interaction.
Topics: Anticoagulants; Blood Coagulation; Chromans; Diabetes Mellitus; Drug Interactions; Humans; Hypoglycemic Agents; International Normalized Ratio; Male; Middle Aged; Thiazoles; Thiazolidinediones; Thromboembolism; Troglitazone; Warfarin | 1998 |
A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502).
Topics: Aryl Hydrocarbon Hydroxylases; Base Sequence; Cloning, Molecular; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Gene Deletion; Genomic Library; Humans; Hydroxylation; Microsomes, Liver; Mixed Function Oxygenases; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Substrate Specificity; Thiazoles; Thiazolidines | 1998 |
Kinetic control of multiple forms of Ca(2+) spikes by inositol trisphosphate in pancreatic acinar cells.
Topics: Acetylcholine; Animals; Benzothiazoles; Buffers; Calcium; Calcium Signaling; Coumarins; Dose-Response Relationship, Drug; Fluorescent Dyes; Inositol 1,4,5-Trisphosphate; Kinetics; Mice; Microscopy, Confocal; Models, Biological; Pancreas; Photolysis; Thiazoles | 1999 |
Zinc biosensing with multiphoton excitation using carbonic anhydrase and improved fluorophores.
Topics: Anisotropy; Benzothiazoles; Carbonic Anhydrases; Coumarins; Fluorescent Dyes; Humans; Oxazoles; Spectrometry, Fluorescence; Sulfonamides; Thiazoles; Zinc | 2000 |
The reaction of digitoxin and digoxin with cyanoacetic acid hydrazide: synthesis of coumarin, thiazole, thiophene and pyridine derivatives with potential biological activities.
Topics: Coumarins; Digitoxin; Digoxin; Hydrazines; Indicators and Reagents; Magnetic Resonance Spectroscopy; Pyridines; Thiazoles; Thiophenes | 2001 |
Azole-linked coumarin dyes as fluorescence probes of domain-forming polymers.
Topics: Benzimidazoles; Benzothiazoles; Coumarins; Fluorescent Dyes; Indicators and Reagents; Molecular Structure; Polymers; Polymethacrylic Acids; Spectrometry, Fluorescence; Thiazoles | 2001 |
Synthesis and evaluation of anticancer activity of some imidazothiazolyl, imidazobenzothiazolyl and dihydroimidazothiazolyl coumarins.
Topics: Antineoplastic Agents; Chemical Phenomena; Chemistry, Physical; Coumarins; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Spectrophotometry, Infrared; Thiazoles; Tumor Cells, Cultured | 2002 |
Near-membrane iminocoumarin-based low affinity fluorescent Ca(2+) indicators.
Topics: Animals; Benzimidazoles; Benzopyrans; Binding Sites; Calcium; Cell Membrane; Coumarins; Drosophila melanogaster; Embryo, Nonmammalian; Fluorescent Dyes; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Membrane Lipids; Microscopy, Fluorescence; Spectrum Analysis; Thiazoles | 2002 |
2-Amino-1,3-benzothiazole-ethyl coumarin-3-carboxylate (1/1).
Topics: Benzothiazoles; Coumarins; Crystallography, X-Ray; Hydrogen Bonding; Molecular Structure; Thiazoles | 2003 |
Identification of biochemical markers linked to neonicotinoid cross resistance in Bemisia tabaci (Hemiptera: Aleyrodidae).
Topics: Animals; Biological Assay; Biomarkers; Carbon Radioisotopes; Carboxylic Ester Hydrolases; Coumarins; Cytochrome P-450 Enzyme System; Glutathione Transferase; Hemiptera; Imidazoles; Insecticide Resistance; Insecticides; Lethal Dose 50; Neonicotinoids; Nitro Compounds; Oxazines; Plants; Pyridines; Radioligand Assay; Receptors, Nicotinic; Thiamethoxam; Thiazoles; Tritium | 2003 |
Heat shock protects PC12 cells against MPP+ toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Blotting, Western; Cell Death; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Fluorescent Dyes; Heat-Shock Proteins; Hot Temperature; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; MPTP Poisoning; Neoplasm Proteins; Oligopeptides; PC12 Cells; Rats; Shock; Tetrazolium Salts; Thiazoles | 2003 |
A new method to detect cadmium uptake in protoplasts.
Topics: Biological Transport, Active; Cadmium; Coumarins; Cytosol; Fluorescent Dyes; Ion Transport; Microscopy, Fluorescence; Protoplasts; Seedlings; Thiazoles; Triticum; Vacuoles | 2004 |
Discovery of a novel class of reversible non-peptide caspase inhibitors via a structure-based approach.
Topics: Caspase 3; Caspase 7; Caspase 8; Caspase Inhibitors; Caspases; Computer Simulation; Coumarins; Dioxanes; Magnetic Resonance Spectroscopy; Models, Molecular; Oligopeptides; Structure-Activity Relationship; Thiazoles | 2005 |
Scoparone from Artemisia capillaris inhibits the release of inflammatory mediators in RAW 264.7 cells upon stimulation cells by interferon-gamma Plus LPS.
Topics: Animals; Anti-Inflammatory Agents; Artemisia; Blotting, Western; Cell Line; Cell Survival; Coumarins; Cyclooxygenase 2; Cytokines; Dinoprostone; Inflammation Mediators; Interferon-gamma; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Plant Extracts; Prostaglandin-Endoperoxide Synthases; Stimulation, Chemical; Tetrazolium Salts; Thiazoles | 2005 |
Solvent effects on the absorption and fluorescence spectra of coumarins 6 and 7 molecules: determination of ground and excited state dipole moment.
Topics: Coumarins; Fluorescence; Imidazoles; Molecular Structure; Solvents; Spectrometry, Fluorescence; Thiazoles | 2006 |
Regulation of gender-dependent CYP2A expression in pigs: involvement of androgens and CAR.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cells, Cultured; Constitutive Androstane Receptor; Coumarins; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Liver; Male; Orchiectomy; Oximes; Phenobarbital; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; RNA, Messenger; Sex Factors; Steroid Hydroxylases; Swine; Swine, Miniature; Thiazoles; Transcription Factors | 2006 |
Selective reduction of peptide isothiazolidin-3-ones.
Topics: Coumarins; Fluorescent Dyes; Magnetic Resonance Spectroscopy; Organophosphonates; Oxidation-Reduction; Peptides; Spectrometry, Fluorescence; Spectrophotometry, Infrared; Sulfhydryl Compounds; Sulfur; Thiazoles | 2006 |
Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Calorimetry, Differential Scanning; Cell Survival; Chromatography, High Pressure Liquid; Coumarins; Drug Compounding; Fluorescent Dyes; Glioma; Humans; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pressure; Tetrazolium Salts; Thiazoles | 2007 |
Coumarin derivatives protection against ROS production in cellular models of Abeta toxicities.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line, Tumor; Coumarins; Free Radicals; Humans; Hydrogen Peroxide; Mice; Mice, Transgenic; Models, Chemical; Mutation; Oxidative Stress; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2007 |
An improved synthesis of 4-chlorocoumarin-3-sulfonyl chloride and its reactions with different bidentate nucleophiles to give pyrido[1',2':2,3]- and thiazino[3',2':2,3]-1,2,4-thiadiazino[6,5-c]benzopyran-6-one 7,7-dioxides.
Topics: Aminopyridines; Anti-HIV Agents; Antineoplastic Agents; Benzopyrans; Coumarins; Sulfones; Thiazoles | 2007 |
In vitro evaluation of poly(caporlactone) grafted dextran (PGD) nanoparticles with cancer cell.
Topics: Biocompatible Materials; Cell Line, Tumor; Cell Survival; Coumarins; Dextrans; Drug Delivery Systems; Fluorescent Dyes; Humans; Microscopy, Atomic Force; Microscopy, Confocal; Nanoparticles; Particle Size; Polyesters; Spectrophotometry; Stomach Neoplasms; Thiazoles | 2008 |
Cell cycle arrest and differentiation induction by 5,7-dimethoxycoumarin in melanoma cell lines.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Coumarins; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Melanoma; Melanoma, Experimental; Mice; Tetrazolium Salts; Thiazoles; Trypan Blue | 2008 |
Two new bis-coumarin glycosides from Daphne giraldii NITSCHE.
Topics: Antineoplastic Agents, Phytogenic; Carbohydrate Conformation; Cell Line, Tumor; Coumarins; Daphne; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Glycosides; Humans; Hydrolysis; Macrophages; Magnetic Resonance Spectroscopy; Nitric Oxide Synthase; Plant Bark; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tetrazolium Salts; Thiazoles | 2008 |
In vitro drug-drug interaction studies with febuxostat, a novel non-purine selective inhibitor of xanthine oxidase: plasma protein binding, identification of metabolic enzymes and cytochrome P450 inhibition.
Topics: Blood Proteins; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Febuxostat; Glucuronosyltransferase; Humans; Ibuprofen; In Vitro Techniques; Male; Microsomes, Liver; Protein Binding; Thiazoles; Warfarin; Xanthine Oxidase | 2008 |
MCF-7aro/ERE, a novel cell line for rapid screening of aromatase inhibitors, ERalpha ligands and ERRalpha ligands.
Topics: Anastrozole; Aromatase Inhibitors; Biological Assay; Cell Line, Tumor; Coumarins; ERRalpha Estrogen-Related Receptor; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Fulvestrant; Genes, Reporter; Genistein; Humans; Letrozole; Ligands; Luciferases; Nitriles; Receptors, Estrogen; Response Elements; Tamoxifen; Thiazoles; Transfection; Triazoles | 2008 |
Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chitosan; Coumarins; Lactic Acid; Lung; Lung Neoplasms; Male; Mice; Nanoparticles; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties; Thiazoles | 2009 |
In vitro/in vivo biorecognition of lectin-immobilized fluorescent nanospheres for human colorectal cancer cells.
Topics: Acetamides; Animals; Antigens, Tumor-Associated, Carbohydrate; Cell Line; Colorectal Neoplasms; Coumarins; Diagnostic Imaging; Fluorescent Dyes; Humans; Mice; Mice, Nude; Models, Animal; Nanospheres; Peanut Agglutinin; Polyvinyls; Thiazoles | 2009 |
Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations.
Topics: Animals; Brain; Cell Line; Cell Survival; Coumarins; Drug Delivery Systems; Endothelial Cells; Lactoferrin; Mice; Nanoparticles; Polyesters; Polyethylene Glycols; Thiazoles | 2009 |
Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chitosan; Coumarins; Drug Carriers; Humans; Hydrogen-Ion Concentration; Lactic Acid; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Microscopy, Confocal; Nanoparticles; Neoplasm Transplantation; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Static Electricity; Thiazoles; Xenograft Model Antitumor Assays | 2009 |
Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye.
Topics: Animals; Cell Line; Cell Survival; Chickens; Conjunctiva; Cornea; Coumarins; Eye; Fluorescent Dyes; Humans; Liposomes; Male; Mice; Microscopy, Atomic Force; Microscopy, Fluorescence; Ophthalmic Solutions; Ovum; Particle Size; Phosphatidylcholines; Retina; Thiazoles | 2009 |
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antioxidants; Bentonite; Cell Line; Coumarins; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Therapy; Humans; Lactic Acid; Male; Nanoparticles; Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Taxoids; Thiazoles; Vitamin E | 2009 |
Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles.
Topics: Acrylamides; Acyclovir; Animals; Antiviral Agents; beta-Cyclodextrins; Cell Membrane Permeability; Cell Survival; Chlorocebus aethiops; Coumarins; Drug Carriers; Herpesvirus 1, Human; Morpholines; Nanoparticles; Particle Size; Polymers; Thiazoles; Vero Cells | 2009 |
Comparison of urinary scents of two related mouse species, Mus spicilegus and Mus domesticus.
Topics: Animals; Coumarins; Gas Chromatography-Mass Spectrometry; Lactones; Male; Mice; Pheromones; Smell; Species Specificity; Thiazoles | 2009 |
The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs.
Topics: Caco-2 Cells; Chitosan; Coloring Agents; Coumarins; Cross-Linking Reagents; Cyclodextrins; Drug Carriers; Excipients; Fluorescence; Humans; Microscopy, Confocal; Nanoparticles; Particle Size; Polyphosphates; Solubility; Thiazoles | 2009 |
Anti-inflammatory effect of coumarins isolated from Corydalis heterocarpa in HT-29 human colon carcinoma cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Survival; Coloring Agents; Corydalis; Coumarins; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Furocoumarins; HT29 Cells; Humans; Inflammation Mediators; Lipopolysaccharides; Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Tetrazolium Salts; Thiazoles | 2009 |
Organic dye lasers with distributed Bragg reflector grating and distributed feedback resonator.
Topics: Coloring Agents; Coumarins; Equipment Design; Lasers; Light; Materials Testing; Optics and Photonics; Organometallic Compounds; Oscillometry; Polymers; Polystyrenes; Polyvinyls; Surface Properties; Thiazoles | 2009 |
Physicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eyedrop administration.
Topics: Animals; Coumarins; Drug Delivery Systems; Emulsions; Liposomes; Macaca fascicularis; Male; Mice; Microscopy, Fluorescence; Ophthalmic Solutions; Particle Size; Rabbits; Retina; Thiazoles | 2010 |
Interactions of human serum albumin with meloxicam: characterization of binding site.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bilirubin; Binding Sites; Circular Dichroism; Humans; Hydrogen-Ion Concentration; Ligands; Meloxicam; Molecular Structure; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence; Thiazines; Thiazoles; Warfarin; Water | 2010 |
In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes.
Topics: Animals; Area Under Curve; Astrocytes; Blood-Brain Barrier; Brain; Cholesterol; Coumarins; Drug Delivery Systems; Endothelial Cells; Glucose Transport Proteins, Facilitative; Liposomes; Mice; Rats; Rats, Sprague-Dawley; Thiazoles; Tissue Distribution | 2010 |
Risk factors of drug interaction between warfarin and nonsteroidal anti-inflammatory drugs in practical setting.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Drug Interactions; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Meloxicam; Middle Aged; Retrospective Studies; Risk Factors; Thiazines; Thiazoles; Warfarin | 2010 |
Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.
Topics: Animals; Blood-Brain Barrier; Brain; Coumarins; Dose-Response Relationship, Drug; Drug Carriers; Endothelial Cells; Lactoferrin; Liposomes; Mice; Molecular Structure; Rats; Thiazoles | 2010 |
The differential spatial distribution of secondary metabolites in Arabidopsis leaves reacting hypersensitively to Pseudomonas syringae pv. tomato is dependent on the oxidative burst.
Topics: Arabidopsis; Coumarins; Gene Expression Regulation, Plant; Glucosides; Indoles; Metabolome; Plant Diseases; Plant Leaves; Pseudomonas syringae; Reactive Oxygen Species; Respiratory Burst; Salicylic Acid; Signal Transduction; Thiazoles | 2010 |
A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery.
Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Coumarins; Drug Carriers; Humans; Lipids; Nanoparticles; Particle Size; Serum Albumin, Bovine; Thiazoles; Ursodeoxycholic Acid | 2010 |
Preparation and in-vitro/in-vivo evaluation of surface-modified poly (lactide-co-glycolide) fluorescent nanoparticles.
Topics: Animals; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Chitosan; Coumarins; Drug Carriers; Female; Flow Cytometry; Fluorescence; Lactic Acid; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectrometry, Fluorescence; Surface Properties; Technology, Pharmaceutical; Thiazoles; Tissue Distribution | 2010 |
Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Blood-Brain Barrier; Brain; Coumarins; Docetaxel; Drug Carriers; Drug Delivery Systems; Humans; Male; Materials Testing; Nanoparticles; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Succinates; Taxoids; Thiazoles; Tissue Distribution; Transferrin | 2010 |
Poly(vinyl benzoate) nanoparticles for molecular delivery: Studies on their preparation and in vitro properties.
Topics: Animals; Cattle; Cell Line; Cell Survival; Chemical Precipitation; Chemistry, Pharmaceutical; Coumarins; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Endothelial Cells; Escherichia coli K12; Fluoresceins; Fluorescent Dyes; Humans; Hydrolysis; Inhibitory Concentration 50; Keratinocytes; Kinetics; Microbial Sensitivity Tests; Nanoparticles; Nanotechnology; Particle Size; Poloxamer; Polyvinyls; Solubility; Staphylococcus aureus; Surface-Active Agents; Technology, Pharmaceutical; Thiazoles | 2010 |
Novel 'nano in nano' composites for sustained drug delivery: biodegradable nanoparticles encapsulated into nanofiber non-wovens.
Topics: Coloring Agents; Coumarins; Drug Delivery Systems; Electric Conductivity; Microscopy, Atomic Force; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanocomposites; Nanofibers; Nanoparticles; Nanotechnology; Particle Size; Polyglactin 910; Solubility; Spectrometry, Fluorescence; Surface Tension; Thiazoles | 2010 |
Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles.
Topics: Administration, Cutaneous; Chromatography, High Pressure Liquid; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Female; Humans; In Vitro Techniques; Lactic Acid; Microscopy, Confocal; Nanoparticles; Needles; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Skin; Skin Absorption; Thiazoles | 2010 |
Novel synthesis of hydrazide-hydrazone derivatives and their utilization in the synthesis of coumarin, pyridine, thiazole and thiophene derivatives with antitumor activity.
Topics: Antineoplastic Agents; Azides; Cell Division; Cell Line, Tumor; Coumarins; Drug Screening Assays, Antitumor; Humans; Hydrazones; Magnetic Resonance Spectroscopy; Pyridines; Thiazoles; Thiophenes | 2010 |
A potential of peanut agglutinin-immobilized fluorescent nanospheres as a safe candidate of diagnostic drugs for colonoscopy.
Topics: Animals; Caco-2 Cells; Colon; Colonoscopy; Colorectal Neoplasms; Coumarins; Early Detection of Cancer; Female; Fluorescent Dyes; Humans; Indicators and Reagents; Intestinal Mucosa; Mice; Nanospheres; Peanut Agglutinin; Thiazoles | 2011 |
Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier.
Topics: Animals; Antineoplastic Agents; Biological Transport; Blood-Brain Barrier; Cell Line; Cell Line, Tumor; Coumarins; Docetaxel; Dogs; Drug Carriers; Humans; Lactic Acid; Male; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Taxoids; Thiazoles | 2011 |
Coumarin 6 and 1,6-diphenyl-1,3,5-hexatriene (DPH) as fluorescent probes to monitor protein aggregation.
Topics: alpha-Synuclein; Benzothiazoles; Carbonic Anhydrases; Coumarins; Diphenylhexatriene; Fluorescent Dyes; Proteins; Quantum Theory; Spectrometry, Fluorescence; Thiazoles | 2011 |
Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles.
Topics: Animals; Calorimetry, Differential Scanning; Cell Membrane; Chlorocebus aethiops; COS Cells; Coumarins; Drug Carriers; Epithelial Cells; Fatty Acids; HEK293 Cells; Humans; Lipids; Materials Testing; Nanoparticles; Pulmonary Alveoli; Temperature; Thiazoles; Transport Vesicles; Triglycerides | 2011 |
Neuroprotective effect of osthole against oxygen and glucose deprivation in rat cortical neurons: involvement of mitogen-activated protein kinase pathway.
Topics: Animals; Animals, Newborn; Apoptosis; Cells, Cultured; Cerebral Cortex; Coumarins; Drug Interactions; Enzyme Inhibitors; Glucose; Hypoxia; L-Lactate Dehydrogenase; Mitogen-Activated Protein Kinases; Neurons; Neuroprotective Agents; Rats; Reperfusion; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors | 2011 |
Delivery of polymeric particles into skin using needle-free liquid jet injectors.
Topics: Coumarins; Drug Delivery Systems; Humans; In Vitro Techniques; Injections, Jet; Lactic Acid; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polystyrenes; Skin; Solubility; Surface Properties; Thiazoles | 2011 |
Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers.
Topics: Coumarins; Drug Carriers; Fluorescence; Folic Acid; HeLa Cells; Humans; Indomethacin; Magnetic Resonance Spectroscopy; Micelles; Molecular Weight; Nanostructures; Particle Size; Polyesters; Polyethylene Glycols; Propylene Glycols; Surface-Active Agents; Thiazoles | 2011 |
Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coculture Techniques; Coumarins; Drug Delivery Systems; Female; Ferrous Compounds; Glioblastoma; Humans; Injections, Intralesional; Lipids; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Nude; Nanocapsules; Particle Size; Plant Lectins; Polyethylene Glycols; Soybean Proteins; Static Electricity; Stearic Acids; Thiazoles; Treatment Outcome; Triglycerides; Xenograft Model Antitumor Assays | 2012 |
High-throughput screening of PLGA thin films utilizing hydrophobic fluorescent dyes for hydrophobic drug compounds.
Topics: Cardiovascular Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Coated Materials, Biocompatible; Coumarins; Delayed-Action Preparations; Drug Carriers; Fluoresceins; Fluorescent Dyes; High-Throughput Screening Assays; Hydrophobic and Hydrophilic Interactions; Kinetics; Lactic Acid; Magnetic Resonance Spectroscopy; Microscopy; Microscopy, Electron, Scanning; Molecular Structure; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rhodamines; Solubility; Spectrometry, Fluorescence; Spectrum Analysis, Raman; Surface Properties; Technology, Pharmaceutical; Thiazoles | 2011 |
Nanospheres delivering the EGFR TKI AG1478 promote optic nerve regeneration: the role of size for intraocular drug delivery.
Topics: Animals; Axons; Coumarins; Drug Delivery Systems; ErbB Receptors; Female; Lactic Acid; Microscopy, Fluorescence; Microspheres; Models, Chemical; Nanospheres; Nerve Regeneration; Neurons; Optic Nerve; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein-Tyrosine Kinases; Quinazolines; Rats; Rats, Sprague-Dawley; Thiazoles; Tyrphostins | 2011 |
Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Neoplasms; Cell Death; Cell Line, Tumor; Coumarins; Delayed-Action Preparations; Drug Delivery Systems; Glioma; Glutathione; Humans; Male; Mice; Mice, Inbred C57BL; Microtubules; Nanoparticles; Paclitaxel; Particle Size; Permeability; Rats; Thiazoles; Tubulin | 2011 |
Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives.
Topics: Anti-Infective Agents; Candida albicans; Coumarins; Crystallography, X-Ray; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Spectrophotometry, Infrared; Thiazoles | 2011 |
Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Coumarins; Desiccation; Drug Carriers; Emulsions; Fluorescent Dyes; Glutathione; Humans; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Nanoparticles; Neoplasms; Oxidation-Reduction; Paclitaxel; Particle Size; Polyesters; Polyethylene Glycols; Thiazoles | 2011 |
A biophysical model of intracellular distribution and perinuclear accumulation of particulate matter.
Topics: Cell Line; Cell Membrane Permeability; Coumarins; Cytoplasm; Cytoskeleton; Diffusion; Humans; Models, Biological; Nanoparticles; Particulate Matter; Pulmonary Alveoli; Temperature; Thiazoles | 2011 |
A novel fluorescent probe for more effective monitoring of nanosized drug delivery systems within the cells.
Topics: Cell Cycle; Cell Line; Cell Survival; Coumarins; Drug Carriers; Drug Compounding; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Nanoparticles; Particle Size; Surface Properties; Thiazoles | 2011 |
In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery.
Topics: Administration, Intravaginal; Animals; Avidin; Coumarins; Drug Carriers; Female; Mice; Mice, Inbred C57BL; Nanoparticles; Polyethylene Glycols; Polyglactin 910; Thiazoles; Vagina | 2011 |
N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin.
Topics: Administration, Oral; Animals; Blood; Bone Density Conservation Agents; Calcitonin; Calcium; Chitosan; Cholesterol; Coumarins; Drug Carriers; Hydrogen-Ion Concentration; Intestine, Small; Magnetic Resonance Spectroscopy; Male; Microscopy, Atomic Force; Mucins; Organophosphates; Particle Size; Phosphatidylcholines; Rats; Rats, Wistar; Static Electricity; Surface Properties; Thiazoles; Unilamellar Liposomes | 2011 |
Synthesis and free radical scavenging activity of coumarin derivatives containing a 2-methylbenzothiazoline motif.
Topics: Antioxidants; Benzothiazoles; Biphenyl Compounds; Coumarins; Free Radical Scavengers; Free Radicals; Picrates; Structure-Activity Relationship; Sulfonic Acids; Thiazoles | 2011 |
Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
Topics: Amino Acid Sequence; Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Coumarins; Dioxanes; Drug Delivery Systems; Humans; Integrins; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Sequence Data; Nanoparticles; Neoplasms; Paclitaxel; Particle Size; Peptides; Polyethylene Glycols; Polymers; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Subcellular Fractions; Thiazoles | 2011 |
Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.
Topics: Administration, Intranasal; Animals; Brain; Cell Death; Cell Line; Coumarins; Drug Delivery Systems; Humans; Male; Molecular Weight; Nanoparticles; Photoelectron Spectroscopy; Protamines; Rats; Rats, Sprague-Dawley; Thiazoles; Tissue Distribution | 2011 |
Synthesis and antioxidant activities of novel 4-Schiff base-7-benzyloxy-coumarin derivatives.
Topics: Benzothiazoles; Biphenyl Compounds; Coumarins; Free Radical Scavengers; Free Radicals; Picrates; Schiff Bases; Sulfonic Acids; Superoxides; Thiazoles | 2011 |
Self-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain delivery.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Caspase 3; Coumarins; Cryoelectron Microscopy; Drug Carriers; Lactic Acid; Lactoferrin; Liposomes; Male; Mice; Mice, Inbred BALB C; Particle Size; Peptides; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Surface Properties; Thiazoles; Tissue Distribution | 2012 |
Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations.
Topics: Administration, Intranasal; Animals; Anura; Brain; Cell Line, Tumor; Cell Survival; Chitin; Cilia; Coumarins; Drug Delivery Systems; Endocytosis; Humans; Imidazoles; Lactic Acid; Male; Nanoparticles; Particle Size; Plant Lectins; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Surface Properties; Thiazoles | 2012 |
Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells.
Topics: Absorption; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Coumarins; Docetaxel; Glioma; Humans; Liposomes; Microscopy, Atomic Force; Microscopy, Confocal; Microscopy, Electron, Transmission; Particle Size; Polyethylene Glycols; Taxoids; Thiazoles; Vitamin E | 2011 |
A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-β₂₅₋₃₅-treated rats following intranasal administration.
Topics: Administration, Intranasal; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Coumarins; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Glycine; Intracellular Signaling Peptides and Proteins; Lectins; Maze Learning; Peptide Fragments; Rats; Rats, Sprague-Dawley; Streptavidin; Thiazoles; Tissue Distribution | 2012 |
Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coumarins; Docetaxel; Nanocapsules; Particle Size; Polyesters; Polysorbates; Rats; Surface Properties; Taxoids; Thiazoles | 2011 |
Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo.
Topics: Administration, Cutaneous; Animals; Coumarins; Drug Delivery Systems; Indomethacin; Iontophoresis; Lactic Acid; Microscopy, Confocal; Nanoparticles; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Skin; Skin Absorption; Thiazoles | 2012 |
Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles.
Topics: Administration, Intranasal; Animals; Biological Transport; Brain; Coumarins; Nanoparticles; Nasal Mucosa; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Thiazoles; Wheat Germ Agglutinins | 2012 |
Monitoring the transport of polymeric micelles across MDCK cell monolayer and exploring related mechanisms.
Topics: Animals; Cell Line; Cell Membrane; Chelating Agents; Coumarins; Dogs; Egtazic Acid; Endocytosis; Epithelial Cells; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Kidney; Micelles; Microscopy, Confocal; Microscopy, Electron, Transmission; Polyethylene Glycols; Thiazoles | 2012 |
Synthesis, reactions and antimicrobial activities of 8-ethoxycoumarin derivatives.
Topics: Anti-Bacterial Agents; Coumarins; Cyclization; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrazones; Microbial Sensitivity Tests; Nitriles; Thiazoles; Thiocyanates; Transition Temperature | 2012 |
Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain; Brain Chemistry; Coumarins; Drug Delivery Systems; Drug Stability; Glucose; Liposomes; Mice; Polyethylene Glycols; Spectroscopy, Near-Infrared; Thiazoles; Tissue Distribution | 2012 |
Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Chemistry, Pharmaceutical; Coumarins; Hep G2 Cells; Humans; Lactoferrin; Liposomes; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Polyethylene Glycols; Random Allocation; Thiazoles; Xenograft Model Antitumor Assays | 2012 |
A novel and facile approach to imaging nanoparticles transport across Transwell filter grown cell monolayer in real-time and in situ under confocal laser scanning microscopy.
Topics: Animals; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Coumarins; Dogs; Endocytosis; Fluorescent Dyes; Melanoma, Experimental; Mice; Microscopy, Confocal; Nanoparticles; Thiazoles | 2012 |
Stimulus-responsive supramolecular pKa tuning of cucurbit[7]uril encapsulated coumarin 6 dye.
Topics: Bridged-Ring Compounds; Coumarins; Hydrogen-Ion Concentration; Imidazoles; Ions; Kinetics; Metals; Protons; Temperature; Thiazoles | 2012 |
Preparation of a cationic nanoemulsome for intratumoral drug delivery and its enhancing effect on cellular uptake in vitro.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cations; Caveolae; Cell Line, Tumor; Cells, Cultured; Cetrimonium; Cetrimonium Compounds; CHO Cells; Clathrin; Coumarins; Cricetinae; Drug Carriers; Drug Delivery Systems; Emulsions; Female; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Nanoparticles; Particle Size; Pinocytosis; Polymers; Solvents; Thiazoles | 2011 |
Inhibition of aggregation of amyloid β42 by arginine-containing small compounds.
Topics: Amyloid; Amyloid beta-Peptides; Arginine; Benzothiazoles; Coumarins; Dipeptides; Electrophoresis, Polyacrylamide Gel; Humans; Peptide Fragments; Polymerization; Protein Binding; Small Molecule Libraries; Solubility; Solutions; Thiazoles | 2012 |
Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles.
Topics: Acoustics; Animals; Cell Line, Tumor; Coumarins; Cyanoacrylates; Drug Delivery Systems; Enbucrilate; Fluorescent Dyes; Mice; Microbubbles; Microscopy, Fluorescence; Neoplasms; Rhodamines; Thiazoles; Vascular Endothelial Growth Factor Receptor-2 | 2012 |
Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Coumarins; Electrophorus; Horses; Molecular Docking Simulation; Schiff Bases; Thiazoles | 2012 |
Edoxaban in Japanese patients with nonvalvular atrial fibrillation: not the same dose for everybody.
Topics: Anticoagulants; Atrial Fibrillation; Female; Humans; Male; Pyridines; Thiazoles; Warfarin | 2012 |
A tissue factor targeted nanomedical system for thrombi-specific drug delivery.
Topics: Animals; Blood Coagulation; Brain; Cell Death; Cells, Cultured; Coumarins; Drug Delivery Systems; Endothelial Cells; Factor VII; Green Fluorescent Proteins; Injections, Intravenous; Nanomedicine; Nanoparticles; Particle Size; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence; Static Electricity; Thiazoles; Thromboplastin; Thrombosis; Tumor Necrosis Factor-alpha | 2012 |
Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery.
Topics: Animals; Brain; Carrier Proteins; Cell Survival; Cell-Penetrating Peptides; Coumarins; Dogs; Drug Carriers; Fluorescent Dyes; Madin Darby Canine Kidney Cells; Male; Mice; Mice, Inbred ICR; Mice, Nude; Nanoparticles; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Thiazoles | 2012 |
Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Topics: Acetone; Antineoplastic Agents; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Coumarins; Drug Carriers; Endocytosis; Fluorescent Dyes; Glioblastoma; Humans; Lactic Acid; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Teniposide; Thiazoles | 2012 |
A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants.
Topics: Caco-2 Cells; Cations; Coumarins; Emulsions; HT29 Cells; Humans; Lactic Acid; Microscopy, Fluorescence; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quaternary Ammonium Compounds; Structure-Activity Relationship; Surface-Active Agents; Thiazoles | 2012 |
A convenient ultrasound-promoted synthesis of some new thiazole derivatives bearing a coumarin nucleus and their cytotoxic activity.
Topics: Acetone; Acetophenones; Cell Line; Cell Survival; Coumarins; Dioxanes; Green Chemistry Technology; Humans; Hydrazones; Keratinocytes; Semicarbazides; Solvents; Sound; Thiazoles | 2012 |
Synthesis, growth and vibrational spectroscopic study of a novel coumarinoylthiazole.
Topics: Coumarins; Crystallization; Crystallography, X-Ray; Hydrogen Bonding; Molecular Conformation; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Thiazoles; Vibration | 2012 |
The effects of warfarin and edoxaban, an oral direct factor Xa inhibitor, on gammacarboxylated (Gla-osteocalcin) and undercarboxylated osteocalcin (uc-osteocalcin) in rats.
Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Carboxylic Acids; Enzyme-Linked Immunosorbent Assay; Factor Xa; Factor Xa Inhibitors; Male; Osteocalcin; Osteoporosis; Protein Processing, Post-Translational; Prothrombin Time; Pyridines; Rats; Rats, Wistar; Risk Factors; Thiazoles; Time Factors; Vitamin K; Warfarin | 2013 |
Multifunctional nanobeacon for imaging Thomsen-Friedenreich antigen-associated colorectal cancer.
Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; Blotting, Western; Case-Control Studies; Colon; Colorectal Neoplasms; Coumarins; Diagnostic Imaging; Fluorescent Dyes; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Transgenic; Nanospheres; Peanut Agglutinin; Polystyrenes; Real-Time Polymerase Chain Reaction; Rectum; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Surface Properties; Thiazoles; Tissue Distribution; Tumor Cells, Cultured | 2013 |
Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug delivery.
Topics: Administration, Oral; Animals; Coumarins; Drug Delivery Systems; Endocytosis; Humans; Intestinal Mucosa; Intestines; Lactones; Male; Nanostructures; Peptides; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Transferrin; Thiazoles | 2013 |
[Introduction].
Topics: Acenocoumarol; Anticoagulants; Benzamides; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism; Thrombosis; Warfarin | 2012 |
Distribution and deposition of respirable PLGA microspheres in lung alveoli.
Topics: Administration, Inhalation; Animals; Antibiotics, Antitubercular; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Coumarins; Fluorescence; Immunoenzyme Techniques; Lactic Acid; Lung; Macrophages, Alveolar; Male; Microspheres; Phagocytosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Rifampin; Thiazoles; Tissue Distribution; Trachea | 2013 |
Synthesis and pharmacological evaluation of some novel 2-(5-hydroxy-5-trifluoromethyl-4,5-dihydropyrazol-1-yl)-4-(coumarin-3-yl)thiazoles.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Coumarins; Dose-Response Relationship, Drug; Edema; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Microbial Sensitivity Tests; Molecular Structure; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazoles | 2013 |
Copper(II) triflate promoted multicomponent catalytic clubbing of piperazinyl-thiazoloquinolines and thiazolocoumarins as antimicrobials.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Aspergillus niger; Candida albicans; Catalysis; Coumarins; Drug Design; Gram-Negative Bacteria; Gram-Positive Bacteria; Mesylates; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Quinolines; Structure-Activity Relationship; Thiazoles | 2013 |
Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
Topics: Acetylcholinesterase; Administration, Intranasal; Amino Acid Sequence; Amyloid beta-Peptides; Animals; Brain; Carbocyanines; Cell Line; Choline O-Acetyltransferase; Coumarins; Drug Delivery Systems; Endocytosis; Humans; Ibotenic Acid; Lactoferrin; Male; Mice; Mice, Inbred ICR; Molecular Sequence Data; Nanoparticles; Neuroprotective Agents; Peptides; Polyesters; Polyethylene Glycols; Rats, Sprague-Dawley; Thiazoles; Tissue Distribution | 2013 |
Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Area Under Curve; Breast Neoplasms; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Coumarins; Docetaxel; Drug Carriers; Half-Life; Humans; Liposomes; Male; Microscopy, Confocal; Particle Size; Polyethylene Glycols; Rats, Sprague-Dawley; Receptor, ErbB-2; Spectroscopy, Fourier Transform Infrared; Taxoids; Thiazoles; Trastuzumab; Vitamin E | 2013 |
The transport pathways of polymer nanoparticles in MDCK epithelial cells.
Topics: Animals; Biological Transport; Coumarins; Dogs; Endocytosis; Epithelial Cells; Exocytosis; Flow Cytometry; Intracellular Space; L-Lactate Dehydrogenase; Light; Madin Darby Canine Kidney Cells; Microscopy, Confocal; Models, Biological; Nanoparticles; Organelles; Particle Size; Polymers; Protein Kinases; Scattering, Radiation; Thiazoles | 2013 |
Enhanced uptake and cytotoxity of folate-conjugated mitoxantrone-loaded micelles via receptor up-regulation by dexamethasone.
Topics: Antineoplastic Agents; Cell Survival; Coumarins; Dexamethasone; Endocytosis; Folate Receptor 1; Folic Acid; HeLa Cells; Humans; Micelles; Mitoxantrone; Phosphatidylethanolamines; Polyethylene Glycols; RNA, Messenger; Thiazoles; Up-Regulation | 2013 |
Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.
Topics: Animals; Biological Availability; Blood Glucose; Caco-2 Cells; Cell Survival; Cell-Penetrating Peptides; Coumarins; Humans; Ileum; Insulin; Intestinal Absorption; L-Lactate Dehydrogenase; Lactic Acid; Male; Nanoparticles; Oligopeptides; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Thiazoles | 2013 |
TPGS emulsified zein nanoparticles enhanced oral bioavailability of daidzin: in vitro characteristics and in vivo performance.
Topics: Administration, Oral; Animals; Biological Availability; Biological Transport, Active; Caco-2 Cells; Coumarins; Drug Delivery Systems; Emulsions; Humans; Intestinal Absorption; Isoflavones; Male; Mice; Nanoparticles; Phytoestrogens; Polyethylene Glycols; Solutions; Thiazoles; Vitamin E; Zein | 2013 |
Concanavalin A-conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal drug delivery to the cervical lymph nodes.
Topics: Administration, Intranasal; Animals; Cell Line, Tumor; Cervix Uteri; Concanavalin A; Coumarins; Drug Carriers; Drug Delivery Systems; Female; Humans; Lactates; Lymph Nodes; Male; Nanoparticles; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Thiazoles | 2013 |
Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Survival; Coumarins; Drug Delivery Systems; Humans; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Paclitaxel; Polyesters; Polyethylene Glycols; Thiazoles; Vitamin E; Xenograft Model Antitumor Assays | 2013 |
Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats.
Topics: Animals; Anticoagulants; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Heparin; Hirudins; Male; Pyridines; Rats; Rats, Wistar; Recombinant Proteins; Thiazoles; Thromboembolism; Warfarin | 2013 |
Dual evaluation of some novel 2-amino-substituted coumarinylthiazoles as anti-inflammatory-antimicrobial agents and their docking studies with COX-1/COX-2 active sites.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candida albicans; Carrageenan; Catalytic Domain; Coumarins; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Edema; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Molecular Docking Simulation; Molecular Structure; Rats; Rats, Wistar; Saccharomyces cerevisiae; Structure-Activity Relationship; Thiazoles | 2014 |
Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: effect of emulsion formulations and surface modification.
Topics: Administration, Ophthalmic; Animals; Animals, Outbred Strains; Chemistry, Pharmaceutical; Chitosan; Coumarins; Emulsions; Lipids; Male; Mice; Ophthalmic Solutions; Poloxamer; Retina; Surface Properties; Thiazoles | 2013 |
Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Calorimetry, Differential Scanning; Cell Survival; Chromatography, Gel; Coumarins; Docetaxel; Female; Humans; Inhibitory Concentration 50; Lactic Acid; Magnetic Resonance Spectroscopy; Mannitol; MCF-7 Cells; Molecular Weight; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Static Electricity; Taxoids; Thermogravimetry; Thiazoles; Vitamin E; Xenograft Model Antitumor Assays | 2013 |
Inhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Line, Tumor; Coumarins; Cytokines; Female; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Midkine; Molecular Weight; Neoplasms, Experimental; Nerve Growth Factors; Phosphatidylinositol 3-Kinases; RNA, Small Interfering; Signal Transduction; Thiazoles; Tumor Burden; Vascular Endothelial Growth Factor A | 2013 |
Glioma targeting and anti-glioma effect of interleukin 13 peptide and RGD peptide dual functionalized nanoparticles.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Coumarins; Drug Delivery Systems; Fluorescent Dyes; Glioma; Interleukin-13; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Oligopeptides; Particle Size; Thiazoles | 2014 |
[Effects of sub-micro emulsion composition on cellular disposition of incorporated lipophilic drug].
Topics: Anions; Cations; Coumarins; Emulsions; Endocytosis; HeLa Cells; Humans; Surface-Active Agents; Thiazoles | 2013 |
Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays.
Topics: Animals; Apoptosis; Biological Assay; Brain Neoplasms; Cell Death; Cell Proliferation; Coumarins; Drug Delivery Systems; Endocytosis; Glioma; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Spheroids, Cellular; Thiazoles; Tumor Microenvironment | 2014 |
[Edoxaban is safer than vitamin K antagonists].
Topics: Administration, Oral; Anticoagulants; Hemorrhage; Humans; Pulmonary Embolism; Pyridines; Randomized Controlled Trials as Topic; Secondary Prevention; Thiazoles; Venous Thrombosis; Vitamin K; Warfarin | 2013 |
[Transcellular process of coumarin 6 loaded PEG-PCL micelles on MDCK epithelial cells].
Topics: Animals; Biological Transport; Coumarins; Dogs; Drug Carriers; Drug Delivery Systems; Lactones; Madin Darby Canine Kidney Cells; Micelles; Particle Size; Polyethylene Glycols; Thiazoles | 2013 |
Another novel oral anticoagulant matches warfarin.
Topics: Anticoagulants; Atrial Fibrillation; Embolism; Hemorrhage; Humans; Pyridines; Randomized Controlled Trials as Topic; Risk; Stroke; Thiazoles; Warfarin | 2014 |
Mixed IR/Vis two-dimensional spectroscopy: chemical exchange beyond the vibrational lifetime and sub-ensemble selective photochemistry.
Topics: Coumarins; Molecular Structure; Photochemical Processes; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Thiazoles; Time Factors; Vibration | 2014 |
pH and glutathion-responsive hydrogel for localized delivery of paclitaxel.
Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Drug Carriers; Glutathione; HeLa Cells; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; MCF-7 Cells; Paclitaxel; Particle Size; Structure-Activity Relationship; Surface Properties; Thiazoles | 2014 |
Comparison of the phase III clinical trial designs of novel oral anticoagulants versus warfarin for the treatment of nonvalvular atrial fibrillation: implications for clinical practice.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Research Design; Rivaroxaban; Thiazoles; Thiophenes; Vitamin K; Warfarin | 2014 |
iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
Topics: Administration, Intravenous; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Collagen; Coumarins; Drug Combinations; Endocytosis; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Kaplan-Meier Estimate; Lactic Acid; Laminin; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Neovascularization, Pathologic; Oligopeptides; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proteoglycans; Rats; Rats, Sprague-Dawley; Spectroscopy, Near-Infrared; Thiazoles; Tissue Distribution; Treatment Outcome | 2014 |
In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Coumarins; Docetaxel; Drug Delivery Systems; Glioblastoma; Humans; Interleukin-13; Male; Mice, Inbred BALB C; Nanoparticles; Peptides; Taxoids; Thiazoles | 2014 |
A magnetic nanoparticle stabilized gas containing emulsion for multimodal imaging and triggered drug release.
Topics: Animals; Chemistry, Pharmaceutical; Contrast Media; Coumarins; Drug Carriers; Drug Delivery Systems; Emulsions; Gases; Liver; Magnetite Nanoparticles; Rats; Thiazoles; Tissue Distribution; Ultrasonics | 2014 |
Ultrasound driven assembly of lignin into microcapsules for storage and delivery of hydrophobic molecules.
Topics: Animals; Capsules; CHO Cells; Coumarins; Cricetulus; Hydrophobic and Hydrophilic Interactions; Lignin; Molecular Structure; Particle Size; Sonication; Surface Properties; Thiazoles | 2014 |
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
Topics: 4-Hydroxycoumarins; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Coumarins; Humans; Isoxazoles; MCF-7 Cells; Poly(ADP-ribose) Polymerases; Thiazoles; U937 Cells | 2014 |
Edoxaban or standard therapy with warfarin for stroke prevention in patients with atrial fibrillation?
Topics: Anticoagulants; Atrial Fibrillation; Clinical Trials as Topic; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Humans; Pyridines; Stroke; Thiazoles; Warfarin | 2014 |
Perioperative management of patients on new oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biological Availability; Clinical Trials as Topic; Dabigatran; Drug Monitoring; Elective Surgical Procedures; Emergencies; Half-Life; Hemorrhage; Humans; Medication Adherence; Morpholines; Preoperative Care; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Time Factors; Warfarin | 2014 |
Parenteral thermo-sensitive organogel for schizophrenia therapy, in vitro and in vivo evaluation.
Topics: Animals; Antipsychotic Agents; Coumarins; Drug Delivery Systems; Fatty Acids; Gels; Isoxazoles; Male; Mice, Nude; Paliperidone Palmitate; Phase Transition; Pyrimidines; Rats, Sprague-Dawley; Schizophrenia; Soybean Oil; Thiazoles; Transition Temperature; Viscosity | 2014 |
A hybrid coumarin-thiazole fluorescent sensor for selective detection of bisulfite anions in vivo and in real samples.
Topics: Anions; Biosensing Techniques; Color; Coumarins; Female; Fluorescent Dyes; Humans; MCF-7 Cells; Molecular Structure; Sensitivity and Specificity; Sulfites; Thiazoles | 2014 |
Direct oral anticoagulants in atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Embolism; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin | 2014 |
Testing fluorescence lifetime standards using two-photon excitation and time-domain instrumentation: rhodamine B, coumarin 6 and lucifer yellow.
Topics: Coumarins; Fluorescence; Fluorescent Dyes; Isoquinolines; Protons; Rhodamines; Spectrometry, Fluorescence; Thiazoles; Time Factors | 2014 |
Critique of Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation trial.
Topics: Adult; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Factor Xa Inhibitors; Humans; Pyridines; Randomized Controlled Trials as Topic; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2014 |
Nanoparticles as drug delivery system against tuberculosis in zebrafish embryos: direct visualization and treatment.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Coumarins; Drug Carriers; Embryo, Nonmammalian; Granuloma; Lactic Acid; Macrophages; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Nanoparticles; Optical Imaging; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rhodamines; Rifampin; Thiazoles; Tuberculosis; Zebrafish | 2014 |
Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Meta-Analysis as Topic; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Vitamin K; Warfarin | 2014 |
Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis.
Topics: Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Humans; Intracranial Hemorrhages; Italy; Markov Chains; Pyridines; Quality-Adjusted Life Years; Stroke; Thiazoles; Warfarin | 2015 |
A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Nanoparticles; Oleanolic Acid; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Thiazoles; Vitamin E | 2015 |
Nanocomplex based on biocompatible phospholipids and albumin for long-circulation applications.
Topics: Animals; Biocompatible Materials; Cattle; Cell Line; Coumarins; Drug Delivery Systems; Male; Mice; Nanoparticles; Particle Size; Phagocytosis; Phospholipids; Photoelectron Spectroscopy; Reproducibility of Results; Serum Albumin, Bovine; Static Electricity; Thiazoles | 2014 |
Stable isotope labeling method for the investigation of protein haptenation by electrophilic skin sensitizers.
Topics: Acrolein; Chromatography, Liquid; Coumarins; Dermatitis, Contact; Dinitrochlorobenzene; Haptens; Humans; Isotope Labeling; Protein Binding; Serum Albumin; Skin; Tandem Mass Spectrometry; Thiazoles | 2014 |
Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Morpholines; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Research Design; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin | 2014 |
Once-daily edoxaban: a safer option than well-managed warfarin for patients with atrial fibrillation?
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Drug Administration Schedule; Factor Xa Inhibitors; Humans; Pyridines; Randomized Controlled Trials as Topic; Stroke; Thiazoles; Warfarin | 2014 |
Hyaluronic acid decorated lipid nanocarrier for MDR modulation and CD-44 targeting in colon adenocarcinoma.
Topics: Adenocarcinoma; Camptothecin; Colonic Neoplasms; Coumarins; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Hyaluronan Receptors; Hyaluronic Acid; Irinotecan; Lipids; Nanoparticles; Thiazoles | 2015 |
Dual-modality, fluorescent, PLGA encapsulated bismuth nanoparticles for molecular and cellular fluorescence imaging and computed tomography.
Topics: Animals; Apoptosis; Bismuth; Cell Proliferation; Cell Survival; Chickens; Contrast Media; Coumarins; Lactic Acid; Lysosomes; Male; Metal Nanoparticles; Mice; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence; Temperature; Thiazoles; Tomography, X-Ray Computed; X-Ray Microtomography | 2014 |
A thiazole coumarin (TC) turn-on fluorescence probe for AT-base pair detection and multipurpose applications in different biological systems.
Topics: Base Pairing; Carbocyanines; Cell Cycle; Coumarins; DNA; Flow Cytometry; Fluorescence; Fluorescent Dyes; HEK293 Cells; HeLa Cells; Humans; Molecular Imaging; Thiazoles | 2014 |
Tuning the binding of coumarin 6 with DNA by molecular encapsulators: effect of β-cyclodextrin and C-hexylpyrogallol[4]arene.
Topics: Animals; beta-Cyclodextrins; Binding Sites; Cattle; Coumarins; DNA; Hydrogen Bonding; Macromolecular Substances; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Pyrogallol; Thiazoles | 2014 |
Novel anticoagulants eliminate the need for left atrial appendage exclusion devices.
Topics: Anticoagulants; Atrial Appendage; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Septal Occluder Device; Stroke; Thiazoles; Thiophenes; Unnecessary Procedures; Warfarin | 2014 |
Cellular uptake of coumarin-6 under microfluidic conditions into HCE-T cells from nanoscale formulations.
Topics: Biological Availability; Cell Line; Cell Line, Tumor; Cell Survival; Cornea; Coumarins; Crystallization; Drug Delivery Systems; Drug Design; Epithelial Cells; Eye; Fluorometry; Humans; Lipids; Liposomes; Micelles; Microfluidic Analytical Techniques; Microfluidics; Microscopy, Confocal; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Thiazoles | 2015 |
Ingredients in fruit juices interact with dasatinib through inhibition of BCRP: a new mechanism of beverage-drug interaction.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Beverages; Biological Transport; Cell Line; Coumarins; Dasatinib; Dogs; Flavonoids; Food-Drug Interactions; Fruit; Humans; Madin Darby Canine Kidney Cells; Membrane Transport Modulators; Neoplasm Proteins; Phytochemicals; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Recombinant Proteins; Sus scrofa; Thiazoles | 2015 |
One-pot multicomponent synthesis of indole incorporated thiazolylcoumarins and their antibacterial, anticancer and DNA cleavage studies.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; DNA Cleavage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indoles; Thiazoles | 2015 |
Surface association and uptake of poly(lactic-co-glycolic) acid nanoparticles by Aspergillus flavus.
Topics: Aspergillus flavus; Chemistry, Pharmaceutical; Coumarins; Drug Carriers; Fluorescent Dyes; Hyphae; Lactic Acid; Microscopy, Fluorescence; Nanoparticles; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rhodamines; Spores, Fungal; Surface Properties; Technology, Pharmaceutical; Thiazoles; Time Factors | 2014 |
Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide.
Topics: Administration, Intranasal; Administration, Intravenous; Analgesics; Animals; Arginine; Cell Line; Central Nervous System; Coumarins; Dogs; Drug Delivery Systems; Female; Lactic Acid; Loperamide; Male; Mice, Inbred C57BL; Nanoconjugates; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Thiazoles | 2015 |
Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Movement; Cell Survival; Collagen; Coumarins; Drug Combinations; Drug Delivery Systems; Endocytosis; Female; Human Umbilical Vein Endothelial Cells; Humans; Intracellular Signaling Peptides and Proteins; Laminin; Membrane Proteins; Mice, Inbred BALB C; Mice, Nude; Molecular Sequence Data; Nanomedicine; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Paclitaxel; Peptides; Proteoglycans; Rats, Sprague-Dawley; Subcutaneous Tissue; Thiazoles; Xenograft Model Antitumor Assays | 2015 |
Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.
Topics: Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Costs and Cost Analysis; Dabigatran; Health Expenditures; Hemorrhage; Humans; Models, Econometric; Myocardial Infarction; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; United States; Venous Thromboembolism; Warfarin | 2015 |
In vitro characterization of 6-Coumarin loaded solid lipid nanoparticles and their uptake by immunocompetent fish cells.
Topics: Animals; Calorimetry, Differential Scanning; Cell Line; Coumarins; Endocytosis; Flow Cytometry; Head Kidney; Immunocompetence; Lipids; Microscopy, Confocal; Microspheres; Nanoparticles; Sea Bream; Spectroscopy, Fourier Transform Infrared; Thiazoles | 2015 |
Should patients on vitamin K antagonists be treated differently?
Topics: Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Female; Humans; Male; Pyridines; Stroke; Thiazoles; Warfarin | 2015 |
Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives.
Topics: Acetylcholinesterase; Animals; Antioxidants; Butyrylcholinesterase; Cholinesterase Inhibitors; Coumarins; Electrophorus; Horses; Structure-Activity Relationship; Thiazoles; Urea | 2015 |
Toxicity studies of coumarin 6-encapsulated polystyrene nanospheres conjugated with peanut agglutinin and poly(N-vinylacetamide) as a colonoscopic imaging agent in rats.
Topics: Acetamides; Animals; Body Weight; Caco-2 Cells; CHO Cells; Colon; Colonoscopy; Colorectal Neoplasms; Coumarins; Cricetulus; Drinking; Eating; Fluorescent Dyes; Humans; Male; Nanospheres; Peanut Agglutinin; Polystyrenes; Polyvinyls; Rats; Rectum; Thiazoles | 2015 |
[New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Drug Substitution; Half-Life; Hemorrhage; Humans; Kidney Function Tests; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism; Warfarin | 2015 |
Pharmacogenomic testing and response to warfarin.
Topics: Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Humans; Pyridines; Thiazoles; Warfarin | 2015 |
Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases.
Topics: 4-Hydroxycoumarins; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Female; Humans; Inhibitory Concentration 50; Isoxazoles; Lung Neoplasms; Thiazoles; Time Factors | 2015 |
Synthesis of functionalized Pluronic-b-poly(ε-caprolactone) and the comparative study of their pendant groups on the cellular internalization behavior.
Topics: Animals; Cell Line; Coumarins; Diffusion; Drug Carriers; Glioma; Materials Testing; Micelles; Particle Size; Polyethylenes; Polypropylenes; Rats; Subcellular Fractions; Thiazoles | 2015 |
Adding vitamin E-TPGS to the formulation of Genexol-PM: specially mixed micelles improve drug-loading ability and cytotoxicity against multidrug-resistant tumors significantly.
Topics: Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Chemistry, Pharmaceutical; Coumarins; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Hydrophobic and Hydrophilic Interactions; Intracellular Space; Lactic Acid; Micelles; Paclitaxel; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Spheroids, Cellular; Thiazoles; Vitamin E | 2015 |
A novel PI3K inhibitor iMDK suppresses non-small cell lung Cancer cooperatively with A MEK inhibitor.
Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Coumarins; Diphenylamine; Drug Synergism; Female; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Neovascularization, Pathologic; Phosphoinositide-3 Kinase Inhibitors; Thiazoles; Xenograft Model Antitumor Assays | 2015 |
A Novel Approach to Inhibit Heat Shock Response as Anticancer Strategy by Coumarine Compounds Containing Thiazole Skeleton.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Heat-Shock Response; HSP90 Heat-Shock Proteins; Humans; Molecular Docking Simulation; Structure-Activity Relationship; Thiazoles | 2015 |
Cost-effectiveness of anticoagulation in patients with nonvalvular atrial fibrillation with edoxaban compared to warfarin in Germany.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Cost-Benefit Analysis; Dabigatran; Germany; Humans; Pyrazoles; Pyridines; Pyridones; Quality of Life; Quality-Adjusted Life Years; Rivaroxaban; Thiazoles; Warfarin | 2015 |
Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.
Topics: Animals; Antibiotics, Antineoplastic; Cell-Penetrating Peptides; Coumarins; Doxorubicin; Drug Carriers; Drug Liberation; Fluorescein-5-isothiocyanate; Fluorescence; Fluorescent Dyes; Gene Products, tat; In Vitro Techniques; Lipids; Male; Permeability; Polyethylene Glycols; Rats, Hairless; RNA, Small Interfering; Skin; Skin Absorption; Swine; Thiazoles | 2015 |
Warfarin pharmacogenetics in the era of new oral anticoagulants.
Topics: Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Humans; Pyridines; Thiazoles; Warfarin | 2015 |
[Simplified therapy regimen receives recommendation for approval].
Topics: Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Embolism; Humans; Pyridines; Recurrence; Stroke; Thiazoles; Venous Thromboembolism; Warfarin | 2015 |
Edoxaban and amiodarone: interactions on multiple levels.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Female; Humans; Male; Pyridines; Thiazoles; Warfarin | 2015 |
Uses of 3-(2-Bromoacetyl)-2H-chromen-2-one in the Synthesis of Heterocyclic Compounds Incorporating Coumarin: Synthesis, Characterization and Cytotoxicity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Screening Assays, Antitumor; Humans; Neoplasms; Pyrans; Structure-Activity Relationship; Thiazoles | 2015 |
The Effect of Hydrophilic and Hydrophobic Structure of Amphiphilic Polymeric Micelles on Their Transportation in Rats.
Topics: Animals; Biological Transport; Coumarins; Dogs; Drug Carriers; Epithelial Cells; Hydrophobic and Hydrophilic Interactions; Intestinal Mucosa; Madin Darby Canine Kidney Cells; Male; Micelles; Nanoparticles; Phosphatidylethanolamines; Polyesters; Polyethylene Glycols; Polymers; Rats; Rats, Sprague-Dawley; Thiazoles | 2016 |
Targeting effect of PEGylated liposomes modified with the Arg-Gly-Asp sequence on gastric cancer.
Topics: Cell Tracking; Coumarins; Fibronectins; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Indocyanine Green; Integrin alpha5beta1; Liposomes; Microscopy, Confocal; Oligopeptides; Phosphatidylethanolamines; Polyethylene Glycols; Stomach Neoplasms; Thiazoles | 2015 |
Effects of X-shaped reduction-sensitive amphiphilic block copolymer on drug delivery.
Topics: Apoptosis; Biocompatible Materials; Cell Line, Tumor; Coumarins; Docetaxel; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Micelles; Microscopy, Fluorescence; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Spectroscopy, Fourier Transform Infrared; Taxoids; Thiazoles | 2015 |
Modified NLC-loaded coumarin for pharmaceutical applications: the improvement of physical stability and controlled release profile.
Topics: Chemistry, Pharmaceutical; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Stability; Lipids; Nanostructures; Particle Size; Thiazoles; Workforce | 2016 |
[The ENGAGE AF-TIMI 48 study].
Topics: Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Humans; Pyridines; Randomized Controlled Trials as Topic; Thiazoles; Warfarin | 2015 |
Intracellular localization and dynamics of Hypericin loaded PLLA nanocarriers by image correlation spectroscopy.
Topics: Anthracenes; Biological Transport; Cell Line, Tumor; Coumarins; Drug Carriers; Fluorescent Dyes; Humans; Lactic Acid; Nanoparticles; Perylene; Polyesters; Polymers; Spectrum Analysis; Thiazoles | 2015 |
Analysis of the Photophysical Behavior and Rotational-Relaxation Dynamics of Coumarin 6 in Nonionic Micellar Environments: The Effect of Temperature.
Topics: Coloring Agents; Coumarins; Fluorescence Polarization; Fluorescent Dyes; Hydrophobic and Hydrophilic Interactions; Micelles; Molecular Conformation; Particle Size; Temperature; Thiazoles; Viscosity | 2015 |
Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study.
Topics: Adult; Anticoagulants; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Pyridines; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome; Venous Thromboembolism; Warfarin | 2015 |
Controlled association and delivery of nanoparticles from jet-sprayed hybrid microfibrillar matrices.
Topics: Adsorption; Coumarins; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Electrophoresis, Polyacrylamide Gel; Lactic Acid; Microfibrils; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Muramidase; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties; Thiazoles | 2016 |
PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line; Cell Line, Tumor; Cell Survival; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Fatty Alcohols; Female; Humans; Male; Maximum Tolerated Dose; Mice, Inbred BALB C; Micelles; Paclitaxel; Polyethylene Glycols; Rats, Sprague-Dawley; Thiazoles | 2016 |
Understanding the influence of surface properties of nanoparticles and penetration enhancers for improving bioavailability in eye tissues in vivo.
Topics: Animals; Benzalkonium Compounds; Biological Availability; Cell Line; Cell Survival; Coumarins; Decanoic Acids; Drug Delivery Systems; Edetic Acid; Eye; Gelatin; Glutaral; Glycolates; Mice; Microscopy, Electron, Scanning; Mucins; Nanoparticles; Permeability; Polymers; Rabbits; Surface Properties; Taurocholic Acid; Thiazoles | 2016 |
[In vitro targeting effect of lactoferrin modified PEGylated liposomes for hepatoma cells].
Topics: Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Coumarins; Drug Delivery Systems; Endocytosis; Hep G2 Cells; Humans; Lactoferrin; Liposomes; Liver Neoplasms; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Thiazoles | 2015 |
Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Coumarins; Drug Carriers; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Male; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Thiazoles; Vitamin E | 2016 |
Preparation of magnetic and pH-responsive chitosan microcapsules via sonochemical method.
Topics: Chitosan; Coumarins; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Hydrogen-Ion Concentration; Magnetics; Magnetite Nanoparticles; Oleic Acid; Particle Size; Sonication; Thiazoles | 2016 |
Vitamin E TPGS conjugated carbon nanotubes improved efficacy of docetaxel with safety for lung cancer treatment.
Topics: A549 Cells; Alkaline Phosphatase; Animals; Antineoplastic Agents; Apoptosis; Bronchoalveolar Lavage Fluid; Cell Cycle; Cell Survival; Coated Materials, Biocompatible; Coumarins; Docetaxel; Drug Liberation; Humans; L-Lactate Dehydrogenase; Lung; Lung Neoplasms; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanotubes, Carbon; Rats; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Taxoids; Thiazoles; Vitamin E | 2016 |
Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
Topics: alpha-Glucosidases; Coumarins; Dose-Response Relationship, Drug; Drug Design; Glycoside Hydrolase Inhibitors; Molecular Docking Simulation; Molecular Structure; Saccharomyces cerevisiae; Structure-Activity Relationship; Thiazoles | 2016 |
Cost-Effectiveness of High-Dose Edoxaban Compared with Adjusted-Dose Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation Patients.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Male; Markov Chains; Pyridines; Quality-Adjusted Life Years; Stroke; Thiazoles; Warfarin | 2016 |
Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cost-Benefit Analysis; Dabigatran; Humans; Insurance, Health; Middle Aged; Models, Theoretical; Pyrazoles; Pyridines; Pyridones; Quality-Adjusted Life Years; Risk; Rivaroxaban; Severity of Illness Index; Stroke; Thiazoles; Warfarin | 2016 |
Transport Mechanism of Coumarin 6 Nanocrystals with Two Particle Sizes in MDCKII Monolayer and Larval Zebrafish.
Topics: Animals; Biological Transport; Coumarins; Dogs; Madin Darby Canine Kidney Cells; Nanoparticles; Organelles; Particle Size; Thiazoles; Zebrafish | 2016 |
Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain; Brain Ischemia; Cryosurgery; Dabigatran; Embolism; Female; Hemorrhage; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Warfarin | 2017 |
Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents; Benzimidazoles; Benzoates; Coumarins; Docetaxel; Female; Heterografts; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Nude; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Surface Properties; Taxoids; Telmisartan; Thiazoles; Tumor Burden | 2016 |
The Effect of Millisecond Pulsed Electric Fields (msPEF) on Intracellular Drug Transport with Negatively Charged Large Nanocarriers Made of Solid Lipid Nanoparticles (SLN): In Vitro Study.
Topics: Animals; Biological Transport; Calorimetry, Differential Scanning; Cell Line; Cell Survival; Coumarins; Cytoskeleton; Drug Carriers; Drug Delivery Systems; Electroporation; Flow Cytometry; Humans; Lipids; Microscopy, Fluorescence; Molecular Structure; Nanoparticles; Particle Size; Thiazoles | 2016 |
Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Coumarins; Docetaxel; Drug Carriers; Enzyme Activation; Fluorescent Antibody Technique; Humans; JNK Mitogen-Activated Protein Kinases; Liposomes; Mice; Microtubules; Nanoparticles; Noscapine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Polymerization; Staining and Labeling; Taxoids; Thiazoles; Triple Negative Breast Neoplasms; Tubulin; Xenograft Model Antitumor Assays | 2016 |
Anticoagulants: What is new and what is the standard?
Topics: Administration, Oral; Anticoagulants; Dabigatran; Factor Xa Inhibitors; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Warfarin | 2016 |
Novel Midkine Inhibitor iMDK Inhibits Tumor Growth and Angiogenesis in Oral Squamous Cell Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Differentiation; Cell Line, Tumor; Coumarins; Cytokines; Female; Humans; Mice; Mice, Inbred BALB C; Midkine; Mouth Neoplasms; Neovascularization, Pathologic; Thiazoles | 2016 |
Effects of transferrin conjugated multi-walled carbon nanotubes in lung cancer delivery.
Topics: A549 Cells; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Cell Cycle; Coumarins; Docetaxel; Drug Delivery Systems; Drug Liberation; Endocytosis; Flow Cytometry; Humans; Intracellular Space; Lung; Lung Neoplasms; Microscopy, Atomic Force; Nanotubes, Carbon; Particle Size; Rats; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared; Staining and Labeling; Static Electricity; Taxoids; Thiazoles; Transferrin | 2016 |
Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Hemorrhage; Humans; Models, Statistical; Pyridines; Randomized Controlled Trials as Topic; Risk Factors; Thiazoles; Thromboembolism; Warfarin | 2016 |
Pharmacokinetic Interactions Between Mirabegron and Metformin, Warfarin, Digoxin or Combined Oral Contraceptives.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adult; Area Under Curve; Contraceptives, Oral, Combined; Digoxin; Double-Blind Method; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Metformin; Thiazoles; Urinary Bladder, Overactive; Warfarin | 2017 |
Syntheses of new 3-thiazolyl coumarin derivatives, in vitro α-glucosidase inhibitory activity, and molecular modeling studies.
Topics: alpha-Glucosidases; Chemistry Techniques, Synthetic; Coumarins; Glycoside Hydrolase Inhibitors; Molecular Docking Simulation; Protein Conformation; Thiazoles | 2016 |
Synthesis, characterization and evaluation of in vitro toxicity in hepatocytes of linear polyesters with varied aromatic and aliphatic co-monomers.
Topics: Cell Line, Tumor; Cell Survival; Comet Assay; Coumarins; DNA Damage; Fatty Alcohols; Fluorescent Dyes; Hepatocytes; Humans; Interleukin-8; Nanoparticles; Poloxamer; Polyesters; Succinates; Thiazoles | 2016 |
Novel Drug Delivery System for Dermal Uptake of Etofenamate: Semisolid SLN Dispersion.
Topics: Administration, Cutaneous; Animals; Coumarins; Drug Delivery Systems; Flufenamic Acid; In Vitro Techniques; Male; Nanoparticles; Rats; Rats, Sprague-Dawley; Skin Absorption; Thiazoles | 2017 |
Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Topics: Aldehyde Reductase; Animals; Cattle; Coumarins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Molecular Docking Simulation; Molecular Structure; Oxadiazoles; Structure-Activity Relationship; Thiazoles | 2016 |
Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin: An in vivo/in vitro evaluation.
Topics: alpha-Tocopherol; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Coumarins; Drug Carriers; Female; Humans; Liposomes; Luteolin; Mice; Particle Size; Polyethylene Glycols; Thiazoles; Xenograft Model Antitumor Assays | 2016 |
Impact of Substituents on Excited-State and Photosensitizing Properties in Cationic Iridium(III) Complexes with Ligands of Coumarin 6.
Topics: 2,2'-Dipyridyl; Cations; Coordination Complexes; Coumarins; Iridium; Light; Luminescent Measurements; Models, Molecular; Photosensitizing Agents; Thiazoles | 2016 |
A pharmacological mouse model suggests a novel risk pathway for postpartum psychosis.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Coumarins; Disease Models, Animal; Female; Gene Expression; Mice; Mice, Inbred C57BL; Piperazines; Psychotic Disorders; Puerperal Disorders; Steryl-Sulfatase; Sulfonamides; Thiazoles | 2016 |
Enhanced Bioactivity of α-Tocopheryl Succinate Based Block Copolymer Nanoparticles by Reduced Hydrophobicity.
Topics: alpha-Tocopherol; Antioxidants; Biocompatible Materials; Breast Neoplasms; Coumarins; Drug Delivery Systems; Female; Humans; Hydrophobic and Hydrophilic Interactions; Methacrylates; Nanoparticles; Polyethylene Glycols; Polymerization; Polymers; Thiazoles; Tumor Cells, Cultured | 2016 |
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Dabigatran; Hemorrhage; Humans; Markov Chains; Pyrazoles; Pyridines; Pyridones; Quality-Adjusted Life Years; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2017 |
Safety and efficacy of contemporary catheter ablation for atrial fibrillation patients with a history of cardioembolic stroke in the era of direct oral anticoagulants.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dabigatran; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pulmonary Veins; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2017 |
Edoxaban had similar efficacy to and better safety than warfarin in AF, regardless of previous stroke or TIA.
Topics: Humans; Pyridines; Stroke; Thiazoles; Warfarin | 2016 |
Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2017 |
Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives.
Topics: Administration, Oral; Atrial Fibrillation; Cost Savings; Cost-Benefit Analysis; Drug Costs; Europe; Factor Xa Inhibitors; Forecasting; Humans; Models, Economic; Practice Patterns, Physicians'; Pyridines; Stroke; Thiazoles; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2016 |
Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale.
Topics: Administration, Oral; Adult; Anticoagulants; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Emergency Treatment; Female; Humans; Male; Medication Therapy Management; Outcome and Process Assessment, Health Care; Pyrazoles; Pyridines; Pyridones; Quality Improvement; Registries; Rivaroxaban; Stroke; Thiazoles; United States; Warfarin | 2016 |
Increasing the methodological quality and relevance of cost effectiveness analysis.
Topics: Administration, Oral; Anticoagulants; Cost-Benefit Analysis; Decision Making; Humans; Probability; Pyridines; Thiazoles; Warfarin | 2017 |
Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Topics: Aconitic Acid; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Coumarins; Curcumin; Docetaxel; Drug Delivery Systems; Drug Liberation; Drug Stability; Drug Synergism; Endocytosis; Humans; Inhibitory Concentration 50; Lactic Acid; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Peptides; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Prostatic Neoplasms; Proton Magnetic Resonance Spectroscopy; Taxoids; Thiazoles | 2017 |
Edoxaban Versus Warfarin: Bone Fractures Due to Falling.
Topics: Accidental Falls; Atrial Fibrillation; Fractures, Bone; Humans; Pyridines; Thiazoles; Warfarin | 2017 |
Cholesterol-PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations.
Topics: Animals; Blood-Brain Barrier; Brain; Cell Survival; Cells, Cultured; Cholesterol; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Enbucrilate; Endothelial Cells; Mice; Nanoparticles; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Rabbits; Rats; Rats, Wistar; Thiazoles | 2017 |
α-Tocopherol as functional excipient for resveratrol and coenzyme Q10-loaded SNEDDS for improved bioavailability and prophylaxis of breast cancer.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Antioxidants; Area Under Curve; Biological Availability; Breast Neoplasms; Caco-2 Cells; Coumarins; Drug Delivery Systems; Emulsions; Excipients; Female; Humans; Nanoparticles; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Thiazoles; Ubiquinone | 2017 |
Folic acid functionalized reduction-responsive magnetic chitosan nanocapsules for targeted delivery and triggered release of drugs.
Topics: Chitosan; Coumarins; Drug Delivery Systems; Drug Liberation; Folic Acid; HeLa Cells; Humans; Magnetics; Nanocapsules; Thiazoles | 2017 |
Is it reasonable to use a lower DOACs dose in some patients with VTE? Yes.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Dose-Response Relationship, Drug; Evidence-Based Medicine; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Warfarin | 2017 |
Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial: Taiwanese Perspective.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Clinical Trials as Topic; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Monitoring; Factor Xa Inhibitors; Female; Humans; Male; Pyridines; Quality-Adjusted Life Years; Taiwan; Thiazoles; Warfarin | 2017 |
Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution.
Topics: Acetylcysteine; Animals; Chitosan; Cornea; Coumarins; Drug Carriers; Eye; Lipids; Nanoparticles; Nanostructures; Rabbits; Thiazoles | 2017 |
Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Craniocerebral Trauma; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridines; Pyridones; Stroke; Thiazoles; Warfarin | 2017 |
Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Proportional Hazards Models; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2017 |
A comparison between vitamin K antagonists and new oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Vitamin K; Warfarin | 2017 |
The reversion of anti-cancer drug antagonism of tamoxifen and docetaxel by the hyaluronic acid-decorated polymeric nanoparticles.
Topics: A549 Cells; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coumarins; Docetaxel; Female; Humans; Hyaluronic Acid; Male; MCF-7 Cells; Mice; Nanoparticles; Polymers; Tamoxifen; Taxoids; Thiazoles | 2017 |
Edoxaban was Effective for Treating Renal Vein Thrombosis in a Patient with Nephrotic Syndrome.
Topics: Adult; Factor Xa Inhibitors; Heparin; Humans; Male; Nephrotic Syndrome; Pulmonary Embolism; Pyridines; Renal Veins; Thiazoles; Treatment Outcome; Venous Thrombosis; Warfarin | 2017 |
New Oral Anticoagulants: What Prescribers Should Know; Differences and Similarities between Warfarin and "New Agents" (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) - Review of Indications, Contraindications and Safety of Use.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Diet; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Warfarin | 2016 |
Synthesis, molecular docking studies of coumarinyl-pyrazolinyl substituted thiazoles as non-competitive inhibitors of mushroom tyrosinase.
Topics: Agaricales; Coumarins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Molecular Docking Simulation; Molecular Structure; Monophenol Monooxygenase; Pyrazoles; Structure-Activity Relationship; Thiazoles | 2017 |
Thiol-ene miniemulsion polymerization of a biobased monomer for biomedical applications.
Topics: Animals; Coumarins; Emulsions; Fibroblasts; HeLa Cells; Humans; Mice; Nanoparticles; Polymerization; Polymers; Thiazoles | 2017 |
Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Topics: Acetylcysteine; Administration, Ophthalmic; Animals; Chitosan; Cornea; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Excipients; Lipids; Male; Nanostructures; Oligosaccharides; Ophthalmic Solutions; Particle Size; Permeability; Rabbits; Thiazoles | 2017 |
Lipid Peroxidation and Cyclooxygenase Enzyme Inhibitory Compounds from Prangos haussknechtii.
Topics: Anti-Inflammatory Agents; Antioxidants; Coumarins; Cyclooxygenase Inhibitors; Lipid Peroxidation; Molecular Structure; Plant Extracts; Tetrazoles; Tetrazolium Salts; Thiazoles | 2017 |
Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
Topics: A549 Cells; Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Caco-2 Cells; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; HT29 Cells; Humans; Intestinal Mucosa; Male; Maleates; Mice; Models, Animal; Nanoparticles; Paclitaxel; Permeability; Polyesters; Polyethylene Glycols; Polyethylenes; Rats; Rats, Sprague-Dawley; Thiazoles | 2017 |
Synthesis and evaluation of coumarin derivatives against human lung cancer cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Coumarins; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Magnetic Resonance Spectroscopy; Reference Values; Reproducibility of Results; Tetrazolium Salts; Thiazoles | 2017 |
Inhibition of Midkine Suppresses Prostate Cancer CD133
Topics: AC133 Antigen; Antineoplastic Agents; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Coumarins; Dose-Response Relationship, Drug; Gene Knockdown Techniques; Humans; Male; Midkine; Neoplastic Stem Cells; Nerve Growth Factors; Prostatic Neoplasms; RNA, Small Interfering; Thiazoles; Time Factors | 2017 |
Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Kidney Failure, Chronic; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Renal Dialysis; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2017 |
High-density lipoprotein mutant eye drops for the treatment of posterior eye diseases.
Topics: Angiogenesis Inhibitors; Animals; Apolipoprotein A-I; Cell-Penetrating Peptides; Choroidal Neovascularization; Coumarins; Drug Carriers; Indazoles; Lipoproteins, HDL; Liposomes; Male; Mice, Inbred C57BL; Mutation; Nanoparticles; Ophthalmic Solutions; Pyrimidines; Sulfonamides; Thiazoles | 2017 |
Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Japan; Magnetic Resonance Imaging; Male; Pyrazoles; Pyridines; Pyridones; Recurrence; Retrospective Studies; Risk Factors; Rivaroxaban; Secondary Prevention; Stroke; Thiazoles; Time Factors; Treatment Outcome; Warfarin | 2018 |
Zebrafish: A Visual Model To Evaluate the Biofate of Transferrin Receptor-Targeted 7Peptide-Decorated Coumarin 6 Micelles.
Topics: Animals; Coumarins; Drug Carriers; Drug Delivery Systems; Micelles; Polyesters; Polyethylene Glycols; Receptors, Transferrin; Thiazoles; Zebrafish | 2017 |
Edoxaban improves acute venous thromboembolism while preserving protein C and protein S levels.
Topics: Acute Disease; Aged; Anticoagulants; Antithrombin III; Female; Humans; Male; Middle Aged; Protein C; Protein S; Pulmonary Embolism; Pyridines; Thiazoles; Treatment Outcome; Venous Thromboembolism; Warfarin | 2018 |
Release Properties and Cellular Uptake in Caco-2 Cells of Size-Controlled Chitosan Nanoparticles.
Topics: Biological Transport; Caco-2 Cells; Cells; Chemistry, Pharmaceutical; Chitosan; Coumarins; Drug Carriers; Humans; Nanoparticles; Particle Size; Resveratrol; Stilbenes; Thiazoles | 2017 |
pH-sensitive polymeric nanoparticles with antioxidant and anti-inflammatory properties against cisplatin-induced hearing loss.
Topics: alpha-Tocopherol; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cisplatin; Coumarins; Dexamethasone; Hearing Loss; Hydrogen-Ion Concentration; Ibuprofen; Nanoparticles; Polymers; Rats, Wistar; Thiazoles | 2018 |
Piecemeal Rekindling of Coumarin 6 Fluorescence on Stepwise Unfolding of Protein by Surfactant.
Topics: Animals; Cattle; Coumarins; Fluorescence; Hydrophobic and Hydrophilic Interactions; Protein Unfolding; Serum Albumin, Bovine; Spectrometry, Fluorescence; Surface-Active Agents; Thiazoles | 2017 |
Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research study.
Topics: Anticoagulants; Antithrombins; Comparative Effectiveness Research; Dabigatran; Factor Xa Inhibitors; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Research Design; Rivaroxaban; Thiazoles; Venous Thrombosis; Warfarin | 2018 |
CO
Topics: Animals; Biocompatible Materials; Carbon Dioxide; Coumarins; Giant Cells; Nanofibers; Polyesters; Rats, Sprague-Dawley; Thiazoles; Tissue Engineering; Tissue Scaffolds | 2018 |
Comparison of Direct Oral Anticoagulants and Warfarin in the Treatment of Deep Venous Thrombosis in the Chronic Phase.
Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Chronic Disease; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Humans; Male; Pyrazoles; Pyridines; Pyridones; Recurrence; Thiazoles; Treatment Outcome; Ultrasonography; Venous Thrombosis; Warfarin | 2018 |
Reversible Parkinsonism and Multiple Cerebral Infarctions after Pulmonary Endarterectomy in a Patient with Antiphospholipid Syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Cerebral Infarction; Chronic Disease; Endarterectomy; Heparin; Humans; Hypertension, Pulmonary; Male; Parkinsonian Disorders; Postoperative Complications; Pyridines; Thiazoles; Treatment Outcome; Warfarin | 2018 |
Characteristics of Symptomatic Intracerebral Hemorrhage in Patient Receiving Direct Oral Anticoagulants: Comparison with Warfarin.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Cerebral Hemorrhage; Circadian Rhythm; Female; Humans; Male; Middle Aged; Prothrombin Time; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Thiazoles; Time Factors; Treatment Outcome; Warfarin | 2018 |
Understanding the translocation mechanism of PLGA nanoparticles across round window membrane into the inner ear: a guideline for inner ear drug delivery based on nanomedicine.
Topics: Animals; Coumarins; Drug Delivery Systems; Endocytosis; Exocytosis; Humans; Lactic Acid; Lysosomes; Microscopy, Confocal; Models, Biological; Nanomedicine; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Round Window, Ear; Thiazoles | 2018 |
Successful Application of Edoxaban in the Treatment of Venous Thromboembolism Recurrence in a Patient with Non-small Cell Lung Cancer after Tumor Shrinkage.
Topics: Aged; Anticoagulants; Carcinoma, Non-Small-Cell Lung; Heparin; Humans; Lung Neoplasms; Male; Pyridines; Thiazoles; Tumor Burden; Venous Thromboembolism; Warfarin | 2018 |
MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent.
Topics: Animals; Carbocyanines; Cell Line; Chitosan; Coloring Agents; Coumarins; Humans; Hyperthermia, Induced; Light; Mice, Inbred BALB C; Mice, Nude; Micelles; Nanoparticles; Neoplasms; Paclitaxel; Phototherapy; Spectroscopy, Near-Infrared; Theranostic Nanomedicine; Thiazoles; Tissue Distribution | 2018 |
Albumin-covered lipid nanocapsules exhibit enhanced uptake performance by breast-tumor cells.
Topics: Breast Neoplasms; Cell Proliferation; Cell Survival; Coumarins; Curcumin; Drug Liberation; Endocytosis; Female; Humans; Lipids; MCF-7 Cells; Nanocapsules; Serum Albumin; Thiazoles | 2018 |
Synthesis of Novel Thiophene, Thiazole and Coumarin Derivatives Based on Benzimidazole Nucleus and Their Cytotoxicity and Toxicity Evaluations.
Topics: Anilides; Animals; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Coumarins; Decapoda; Drug Screening Assays, Antitumor; Humans; Larva; Quinolines; Structure-Activity Relationship; Thiazoles; Thiophenes | 2018 |
Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarin.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Catheter Ablation; Factor Xa Inhibitors; Female; Heparin; Humans; Male; Middle Aged; Perioperative Period; Predictive Value of Tests; Pyridines; Thiazoles; Time Factors; Treatment Outcome; Warfarin; Whole Blood Coagulation Time | 2018 |
[The efficacy and safety of edoxaban in non-valvular atrial fibrillation].
Topics: Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Humans; Pyridines; Randomized Controlled Trials as Topic; Thiazoles; Thrombolytic Therapy; Warfarin | 2018 |
Tromboc@t Working Group recommendations for management in patients receiving direct oral anticoagulants.
Topics: Administration, Oral; Age Factors; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Embolism; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2018 |
Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo.
Topics: Animals; Cell Death; Cell Line, Tumor; Coumarins; Curcumin; Endocytosis; Female; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Injections, Intravenous; Mice, Inbred BALB C; Microscopy, Fluorescence; Nanoparticles; Polyesters; Polyethylene Glycols; Rats, Sprague-Dawley; Thiazoles; Tissue Distribution; Trastuzumab | 2018 |
Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study.
Topics: Adult; Aged; Anticoagulants; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Length of Stay; Male; Middle Aged; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Venous Thromboembolism; Warfarin | 2018 |
pH-Triggered Drug Release of Monodispersed P(St-co-DMAEMA) Nanoparticles: Effects of Swelling, Polymer Chain Flexibility and Drug-Polymer Interactions.
Topics: Coumarins; Drug Carriers; Drug Liberation; Emulsions; Hydrogen-Ion Concentration; Methacrylates; Nanoparticles; Polymers; Thiazoles | 2017 |
Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Cost-Benefit Analysis; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Hemorrhage; Humans; Markov Chains; Pyrazoles; Pyridines; Pyridones; Quality-Adjusted Life Years; Risk Adjustment; Rivaroxaban; Stroke; Therapeutic Equivalency; Thiazoles; Warfarin | 2018 |
Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction).
Topics: Aged; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Dose-Response Relationship, Drug; Drug Monitoring; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Pyridines; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Thiazoles; Time Factors; Treatment Outcome; Warfarin | 2018 |
Abnormal vaginal bleeding in the 'DOAC' era.
Topics: Female; Humans; Pyridines; Thiazoles; Uterine Hemorrhage; Venous Thromboembolism; Warfarin | 2018 |
Efficiency of Biodegradable and pH-Responsive Polysuccinimide Nanoparticles (PSI-NPs) as Smart Nanodelivery Systems in Grapefruit: In Vitro Cellular Investigation.
Topics: Agrochemicals; Aspartic Acid; Bacterial Load; Cell Nucleus; Cells, Cultured; Citrus paradisi; Coumarins; Cytoplasm; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kinetics; Nanoparticles; Particle Size; Peptides; Phloem; Plant Cells; Soil Microbiology; Static Electricity; Thiazoles | 2018 |
Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; MCF-7 Cells; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2018 |
Use of NOACs in the Peri-Operative Management of Patients with Atrial Fibrillation: To Stop, Bridge or Continue?
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Humans; Pyridines; Thiazoles; Warfarin | 2018 |
Role of Hypertension and Other Clinical Variables in Prognostication of Patients Presenting to the Emergency Department With Major Bleeding Events.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Blood Glucose; Blood Transfusion; Cardiovascular Diseases; Creatinine; Dabigatran; Emergency Service, Hospital; Epistaxis; Female; Gastrointestinal Hemorrhage; Hematuria; Hemoptysis; Hemorrhage; Humans; Hypertension; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Prognosis; Propensity Score; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Sex Factors; Thiazoles; Warfarin | 2018 |
All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Female; Humans; Male; Middle Aged; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Risk; Rivaroxaban; Survival Analysis; Thiazoles; Venous Thromboembolism; Warfarin | 2018 |
New Hybrid Scaffolds based on Hydrazinyl Thiazole Substituted Coumarin; As Novel Leads of Dual Potential; In Vitro α-Amylase Inhibitory and Antioxidant (DPPH and ABTS Radical Scavenging) Activities.
Topics: alpha-Amylases; Catalytic Domain; Coumarins; Enzyme Inhibitors; Free Radical Scavengers; Hydrazines; Ligands; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2019 |
Edoxaban in Latin America.
Topics: Atrial Fibrillation; Humans; Latin America; Pyridines; Thiazoles; Warfarin | 2018 |
[Edoxaban in patients with atrial fibrillation and cancer].
Topics: Anticoagulants; Atrial Fibrillation; Cancer Survivors; Cardiovascular Diseases; Embolism; Factor Xa Inhibitors; Hemorrhage; Humans; International Normalized Ratio; Neoplasms; Pyridines; Stroke; Thiazoles; Warfarin | 2018 |
Novel ultra-small micelles based on rebaudioside A: A potential nanoplatform for ocular drug delivery.
Topics: Administration, Ophthalmic; Animals; Cell Line; Cell Survival; Cornea; Coumarins; Diterpenes, Kaurane; Drug Delivery Systems; Humans; Mice; Micelles; Nanoparticles; Rabbits; Rats; Thiazoles | 2018 |
Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles.
Topics: Animals; Biological Transport; Caco-2 Cells; Coumarins; Drug Carriers; Emulsions; Enbucrilate; Fluorescent Dyes; Gastrointestinal Absorption; Glycine max; Humans; Jejunum; Male; Nanoparticles; Particle Size; Phospholipids; Polyethylene Glycols; Polymerization; Rats; Rats, Sprague-Dawley; Thiazoles | 2019 |
Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cohort Studies; Dabigatran; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2018 |
Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Embolism; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Pyridines; Stroke; Thiazoles; Warfarin | 2018 |
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Comorbidity; Embolism; Factor Xa Inhibitors; Female; Gastrointestinal Neoplasms; Hemorrhage; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Prostatic Neoplasms; Pyridines; Stroke; Thiazoles; Warfarin | 2018 |
Prior Direct Oral Anticoagulant Therapy is Related to Small Infarct Volume and No Major Artery Occlusion in Patients With Stroke and Non-Valvular Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cerebral Angiography; Dabigatran; Diffusion Magnetic Resonance Imaging; Female; Humans; Infarction, Middle Cerebral Artery; International Normalized Ratio; Logistic Models; Magnetic Resonance Angiography; Male; Multivariate Analysis; Prothrombin Time; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Stroke; Thiazoles; Warfarin | 2018 |
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hepatic Insufficiency; Humans; Male; Proportional Hazards Models; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Warfarin | 2018 |
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2018 |
Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cohort Studies; Dabigatran; Female; Humans; Incidence; Intracranial Hemorrhages; Male; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2018 |
Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Dabigatran; Disease Progression; Health Care Costs; Humans; Pyrazoles; Pyridines; Pyridones; Quality-Adjusted Life Years; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2018 |
Hemorrhagic risk and intracranial complications in patients with minor head injury (MHI) taking different oral anticoagulants.
Topics: Aged; Aged, 80 and over; Anticoagulants; Craniocerebral Trauma; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Pyrazoles; Pyridines; Pyridones; Risk; Rivaroxaban; Thiazoles; Vitamin K; Warfarin | 2019 |
Resolution of left ventricular thrombus by edoxaban after failed treatment with warfarin overdose: A case report.
Topics: Adult; Anticoagulants; Brain Ischemia; Heart Failure; Heart Ventricles; Humans; Male; Pyridines; Retreatment; Stroke; Thiazoles; Thrombosis; Warfarin | 2019 |
Formulating a single thioether-bridged oleate prodrug into a self-nanoemulsifying drug delivery system to facilitate oral absorption of docetaxel.
Topics: Administration, Oral; Animals; Coumarins; Docetaxel; Drug Carriers; Drug Liberation; Emulsions; Intestinal Mucosa; Intestines; Mice; Oleic Acid; Particle Size; Prodrugs; Rats; Rats, Sprague-Dawley; Solubility; Sulfides; Thiazoles | 2019 |
Tumor recognition of peanut agglutinin-immobilized fluorescent nanospheres in biopsied human tissues.
Topics: Animals; Colon; Colorectal Neoplasms; Coumarins; Female; Fluorescent Dyes; HT29 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanospheres; Peanut Agglutinin; Thiazoles | 2019 |
Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Caspase 7; Caspase 9; Catalytic Domain; Cell Line, Tumor; Coumarins; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Protein Binding; Protein Kinase Inhibitors; Pyrazoles; Quantitative Structure-Activity Relationship; Thiazoles; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Expansion of Two-dimension Electrospun Nanofiber Mats into Three-dimension Scaffolds.
Topics: Animals; Carbon Dioxide; Coumarins; Nanofibers; Polyesters; Porosity; Rats, Sprague-Dawley; Thiazoles; Tissue Engineering; Tissue Scaffolds | 2019 |
New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Coumarins; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Hydrazones; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Quantitative Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured | 2019 |
Edoxaban (Lixiana°).
Topics: Anticoagulants; Atrial Fibrillation; Chemical and Drug Induced Liver Injury; Factor Xa Inhibitors; Hemorrhage; Humans; International Normalized Ratio; Pulmonary Embolism; Pyridines; Stroke; Thiazoles; Venous Thrombosis; Warfarin | 2017 |
Stroke prevention in atrial fibrillation: Closing the gap.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Health Services Misuse; Hemorrhage; Humans; International Normalized Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Septal Occluder Device; Stroke; Thiazoles; Warfarin | 2019 |
Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coumarins; Drug Screening Assays, Antitumor; Heterocyclic Compounds; Humans; Imines; Membrane Potential, Mitochondrial; Molecular Docking Simulation; Thiazoles | 2019 |
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: Update and Periprocedural Management.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Critical Care Nursing; Dabigatran; Female; Humans; Male; Middle Aged; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2019 |
Synthesis of coumarin analogs appended with quinoline and thiazole moiety and their apoptogenic role against murine ascitic carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Computer Simulation; Coumarins; Lethal Dose 50; Mice; Quinolines; Structure-Activity Relationship; Thiazoles | 2019 |
The evolving obesity paradigm story: from heart failure to atrial fibrillation.
Topics: Atrial Fibrillation; Body Mass Index; Heart Failure; Humans; Obesity; Pyridines; Thiazoles; Warfarin | 2019 |
Surface-Modified Melphalan Nanoparticles for Intravitreal Chemotherapy of Retinoblastoma.
Topics: Antineoplastic Agents, Alkylating; Coumarins; Drug Delivery Systems; Flow Cytometry; Humans; Intravitreal Injections; Melphalan; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Retinal Neoplasms; Retinoblastoma; Thiazoles; Tumor Cells, Cultured | 2019 |
EGFP-EGF1-conjugated poly(lactic-co-glycolic acid) nanoparticles, a new diagnostic tool and drug carrier for atherosclerosis.
Topics: Animals; Aorta; Atherosclerosis; Coumarins; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Fluorescence; Green Fluorescent Proteins; Humans; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nanoparticles; Particle Size; Peptide Elongation Factor G; Polylactic Acid-Polyglycolic Acid Copolymer; Static Electricity; Thiazoles | 2019 |
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Asian People; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Hemorrhage; Humans; Male; Middle Aged; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Taiwan; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin | 2019 |
Preparation, optimization and cellular uptake study of tanshinone I nanoemulsion modified with lactoferrin for brain drug delivery.
Topics: Abietanes; Animals; Biological Availability; Biological Transport; Blood-Brain Barrier; Brain; Cell Line; Coumarins; Drug Carriers; Drug Delivery Systems; Emulsions; Lactoferrin; Mice; Nanoparticles; Particle Size; Permeability; Polyethylene Glycols; Solubility; Thiazoles; Tissue Distribution | 2019 |
Spatio-temporal control on the delivery of triamcinolone acetonide using polymeric nanoparticles reduces steroid induced cataract.
Topics: Administration, Ophthalmic; Animals; Biological Availability; Cadherins; Cataract; Coumarins; Diabetes Mellitus, Experimental; Drug Delivery Systems; Drug Liberation; Eye; Glucocorticoids; Male; Mice, Inbred C57BL; Poloxamer; Polyesters; Rats, Sprague-Dawley; Thiazoles; Triamcinolone Acetonide | 2019 |
DOACs in Patients With Atrial Fibrillation and Liver Disease: Time to Expand the Safety Zone?
Topics: Atrial Fibrillation; Humans; Liver Diseases; Pyridines; Thiazoles; Warfarin | 2019 |
Rapamycin loaded TPGS-Lecithins-Zein nanoparticles based on core-shell structure for oral drug administration.
Topics: Administration, Oral; Animals; Caco-2 Cells; Cell Survival; Coumarins; Drug Carriers; Drug Liberation; Humans; Intestinal Absorption; Lecithins; Male; Nanoparticles; Rats, Sprague-Dawley; Sirolimus; Thiazoles; Vitamin E; Zein | 2019 |
Self microemulsifying drug delivery system of lurasidone hydrochloride for enhanced oral bioavailability by lymphatic targeting: In vitro, Caco-2 cell line and in vivo evaluation.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Coumarins; Drug Delivery Systems; Emulsions; Female; Humans; Lipids; Lurasidone Hydrochloride; Permeability; Rats; Rats, Sprague-Dawley; Solubility; Surface-Active Agents; Suspensions; Thiazoles | 2019 |
Design, synthesis and biological evaluation of trinary benzocoumarin-thiazoles-azomethines derivatives as effective and selective inhibitors of alkaline phosphatase.
Topics: Alkaline Phosphatase; Animals; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops; COS Cells; Coumarins; Drug Design; Enzyme Inhibitors; GPI-Linked Proteins; Humans; Hydrazones; Molecular Docking Simulation; Molecular Structure; Protein Binding; Structure-Activity Relationship; Thiazoles | 2019 |
Ce6-C6-TPZ co-loaded albumin nanoparticles for synergistic combined PDT-chemotherapy of cancer.
Topics: Animals; Cattle; Cell Line, Tumor; Cell Survival; Chlorophyllides; Coumarins; Humans; Light; Liver; Mice; Microscopy, Confocal; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Serum Albumin, Bovine; Thiazoles; Tirapazamine; Transplantation, Homologous | 2019 |
Whole-Eye Perfusion Model for Screening of the Ocular Formulations via Confocal Laser Scanning Microscopy.
Topics: Administration, Ophthalmic; Animals; Coumarins; Drug Compounding; Drug Delivery Systems; Female; Micelles; Microscopy, Confocal; Perfusion; Rabbits; Swine; Thiazoles | 2019 |
Exploring biological efficacy of coumarin clubbed thiazolo[3,2-b][1,2,4]triazoles as efficient inhibitors of urease: A biochemical and in silico approach.
Topics: Binding Sites; Catalytic Domain; Coumarins; Enzyme Inhibitors; Models, Molecular; Molecular Structure; Protein Binding; Structure-Activity Relationship; Thiazoles; Triazoles; Urease | 2020 |
Interface-Enrichment-Induced Instability and Drug-Loading-Enhanced Stability in Inhalable Delivery of Supramolecular Filaments.
Topics: Administration, Inhalation; Aerosols; Antineoplastic Agents, Phytogenic; Coumarins; Drug Delivery Systems; Drug Stability; Humans; Lung Diseases; Lung Neoplasms; Macromolecular Substances; Nanostructures; Paclitaxel; Particle Size; Peptides; Small Molecule Libraries; Surface Properties; Thiazoles | 2019 |
Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Comorbidity; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Thiazoles; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2020 |
Anticoagulants in Atrial Fibrillation and Liver Disease.
Topics: Anticoagulants; Atrial Fibrillation; Humans; Liver Diseases; Pyridines; Thiazoles; Warfarin | 2019 |
Development of novel optical pH sensors based on coumarin 6 and nile blue A encapsulated in resin particles and specific support materials.
Topics: Actinobacteria; Color; Coumarins; Fermentation; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Membranes, Artificial; Oxazines; Sensitivity and Specificity; Spectrometry, Fluorescence; Thiazoles; Triazines; Urinalysis | 2020 |
Effects of the molecular weight and molar ratio of poly(2-ethyl-2-oxazoline)-based lipid on the pH sensitivity, stability, and antitumor efficacy of liposomes.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Coumarins; Drug Delivery Systems; Drug Liberation; Endosomes; Formates; Humans; Hydrogen-Ion Concentration; Lipids; Liposomes; Male; Mice; Molecular Weight; Polyamines; Polyethylene Glycols; Rats; Rats, Wistar; Thiazoles | 2020 |
Comparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists.
Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Blood Coagulation Factors; Coagulants; Dabigatran; Disease Progression; Factor Xa Inhibitors; Female; Glasgow Outcome Scale; Humans; Intracranial Hemorrhage, Traumatic; Length of Stay; Male; Middle Aged; Mortality; Neurosurgical Procedures; Plasma; Platelet Transfusion; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Vitamin K; Warfarin | 2020 |
Design and synthesis of new energy restriction mimetic agents: Potent anti-tumor activities of hybrid motifs of aminothiazoles and coumarins.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Proliferation; Cisplatin; Colorectal Neoplasms; Coumarins; Drug Design; Drug Screening Assays, Antitumor; Energy Metabolism; G1 Phase; Glucose; HCT116 Cells; HT29 Cells; Humans; Inhibitory Concentration 50; Reactive Oxygen Species; Thiazoles | 2020 |
Effects of edoxaban and warfarin on vascular remodeling: Atherosclerotic plaque progression and collateral artery growth.
Topics: Animals; Anticoagulants; Atherosclerosis; Collateral Circulation; Disease Models, Animal; Factor Xa Inhibitors; Fibrosis; Hindlimb; Ischemia; Mice, Inbred C57BL; Mice, Knockout, ApoE; Muscle, Skeletal; Neovascularization, Physiologic; Plaque, Atherosclerotic; Pyridines; Thiazoles; Vascular Remodeling; Warfarin | 2020 |
Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial.
Topics: Aged; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Clinical Decision-Making; Duration of Therapy; Echocardiography, Transesophageal; Electric Countershock; Enoxaparin; Female; Heart Diseases; Humans; International Normalized Ratio; Male; Middle Aged; Pyridines; Randomized Controlled Trials as Topic; Stroke; Thiazoles; Thrombosis; Warfarin | 2020 |
Tumor-targeting peptide functionalized PEG-PLA micelles for efficient drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Coumarins; Drug Delivery Systems; Drug Liberation; Female; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred ICR; Micelles; Paclitaxel; Peptides; Polyethylene Glycols; Spheroids, Cellular; Thiazoles; Tumor Burden | 2020 |
Sonochemical fabrication of magnetic reduction-responsive alginate-based microcapsules for drug delivery.
Topics: A549 Cells; Alginates; Capsules; Coumarins; Drug Carriers; Drug Liberation; HeLa Cells; Humans; Magnetite Nanoparticles; Oleic Acid; Thiazoles | 2020 |
Management of antithrombotic therapy in gray areas of venous thromboembolism: a Delphi consensus panel.
Topics: Administration, Oral; Delphi Technique; Factor Xa Inhibitors; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Humans; Male; Pyridines; Thiazoles; Venous Thromboembolism; Warfarin | 2020 |
Trends in anticoagulant prescribing: a review of local policies in English primary care.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Drug Utilization; England; Female; Humans; Male; Practice Patterns, Physicians'; Primary Health Care; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; State Medicine; Stroke; Thiazoles; Warfarin | 2020 |
Current clinician perspective on non-vitamin K antagonist oral anticoagulant use in challenging clinical cases.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cardiologists; Clinical Trials, Phase III as Topic; Consensus; Dabigatran; Disease Management; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiazoles; Vitamin K; Warfarin | 2020 |
Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data.
Topics: Administration, Oral; Administrative Claims, Healthcare; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Electronic Health Records; Female; Hemorrhage; Humans; Japan; Male; Middle Aged; Patient Safety; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Time Factors; Treatment Outcome; Vitamin K; Warfarin | 2020 |
Site-specific delivery of a natural chemotherapeutic agent to human lung cancer cells using biotinylated 2D rGO nanocarriers.
Topics: A549 Cells; Antineoplastic Agents; Biotinylation; Cell Survival; Coumarins; Drug Carriers; Endocytosis; Gallic Acid; Graphite; Humans; Lung Neoplasms; Microscopy, Fluorescence; Nanostructures; Sonication; Thiazoles | 2020 |
Novel coumarin-thiazolyl ester derivatives as potential DNA gyrase Inhibitors: Design, synthesis, and antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Coumarins; Drug Design; Esters; Humans; Molecular Docking Simulation; Thiazoles; Topoisomerase II Inhibitors | 2020 |
Quantitative Volumetric Comparison of Direct Oral Anticoagulant and Vitamin K Antagonist Treatment for Pulmonary Thrombus Reduction During the Acute Phase in Symptomatic Patients.
Topics: Aged; alpha-2-Antiplasmin; Anticoagulants; Antithrombin III; Contrast Media; Factor Xa Inhibitors; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Heparin; Humans; International Normalized Ratio; Length of Stay; Male; Middle Aged; Peptide Hydrolases; Prothrombin Time; Pulmonary Artery; Pulmonary Embolism; Pyridines; Retrospective Studies; Thiazoles; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2020 |
Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Endoscopic Mucosal Resection; Female; Humans; Japan; Male; Middle Aged; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stomach; Stomach Neoplasms; Thiazoles; Thromboembolism; Warfarin | 2021 |
Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial.
Topics: Anticoagulants; Factor Xa Inhibitors; Humans; Male; Pyridines; Thiazoles; Venous Thromboembolism; Warfarin | 2020 |
Development of a Ratiometric Fluorescent Glucose Sensor Using an Oxygen-Sensing Membrane Immobilized with Glucose Oxidase for the Detection of Glucose in Tears.
Topics: Biosensing Techniques; Coumarins; Fluorescent Dyes; Glucose; Glucose Oxidase; Tears; Thiazoles | 2020 |
Cost-effectiveness of edoxaban vs low-molecular-weight heparin and warfarin for cancer-associated thrombosis in Brazil.
Topics: Anticoagulants; Brazil; Cost-Benefit Analysis; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Pyridines; Quality-Adjusted Life Years; Thiazoles; Thrombosis; Warfarin | 2020 |
Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: A nationwide population-based study.
Topics: Aged, 80 and over; Atrial Fibrillation; Brain Ischemia; Databases, Factual; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridines; Pyridones; Republic of Korea; Stroke; Thiazoles; Vitamin K; Warfarin | 2020 |
Comparisons of Edoxaban Versus Warfarin on Levels of Plasma Prothrombin Fragment in Patients With Nonvalvular Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Female; Humans; Male; Peptide Fragments; Prospective Studies; Prothrombin; Pyridines; Stroke; Thiazoles; Warfarin | 2020 |
Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: Synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity.
Topics: Adenosine Triphosphatases; Anti-Bacterial Agents; Bordetella pertussis; Cell Line; Coumarins; DNA Gyrase; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Mycoplasma pneumoniae; Structure-Activity Relationship; Thiazoles; Topoisomerase II Inhibitors | 2020 |
Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
Topics: Acenocoumarol; Adult; Anticoagulants; Budd-Chiari Syndrome; Duration of Therapy; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Mesenteric Ischemia; Middle Aged; Portal Vein; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Secondary Prevention; Thiazoles; Venous Thrombosis; Warfarin | 2021 |
Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic.
Topics: Administration, Oral; Anticoagulants; Counseling; COVID-19; Drug Monitoring; Drug Substitution; Hospitals, University; Humans; Informed Consent; London; Pandemics; Patient Acceptance of Health Care; Patient Education as Topic; Pyridines; Quarantine; Rivaroxaban; SARS-CoV-2; Telemedicine; Tertiary Care Centers; Thiazoles; Thrombophilia; Warfarin | 2021 |
Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Databases, Factual; Deductibles and Coinsurance; Drug Costs; Factor Xa Inhibitors; Female; Humans; Male; Medicare Part C; Medication Adherence; Middle Aged; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Sample Size; Stroke; Thiazoles; United States; Warfarin | 2021 |
Defective transition metal hydroxide-based nanoagents with hypoxia relief for photothermal-enhanced photodynamic therapy.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Proliferation; Cell Survival; Coumarins; Drug Screening Assays, Antitumor; Female; Hep G2 Cells; Humans; Hydroxides; Liver Neoplasms, Experimental; Mice; Mice, Inbred ICR; Nanoparticles; Particle Size; Photochemotherapy; Photosensitizing Agents; Silicon Dioxide; Surface Properties; Thiazoles; Transition Elements; Tumor Cells, Cultured | 2021 |
FRET imaging revealed that nanocrystals enhanced drug oral absorption by dissolution rather than endocytosis: A case study of coumarin 6.
Topics: Administration, Oral; Animals; Biological Availability; Coumarins; Endocytosis; Fluorescence Resonance Energy Transfer; Nanoparticles; Pharmaceutical Preparations; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Solubility; Thiazoles; Tissue Distribution | 2021 |
Regression of Melanoma Following Intravenous Injection of Plumbagin Entrapped in Transferrin-Conjugated, Lipid-Polymer Hybrid Nanoparticles.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Liberation; Endocytosis; Female; Humans; Injections, Intravenous; Lipids; Melanoma, Experimental; Mice, Inbred BALB C; Nanoparticles; Naphthoquinones; Polymers; Skin Neoplasms; Thiazoles; Transferrin | 2021 |
Use of oral anticoagulants in patients with valvular atrial fibrillation: findings from the NCDR PINNACLE Registry.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Male; Practice Patterns, Physicians'; Pyrazoles; Pyridines; Pyridones; Registries; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2021 |
Sonochemical preparation of folate-decorated reductive-responsive carboxymethylcellulose-based nanocapsules for targeted drug delivery.
Topics: Carboxymethylcellulose Sodium; Cell Line, Tumor; Cell Survival; Coumarins; Drug Carriers; Drug Liberation; Folic Acid; Humans; Nanocapsules; Thiazoles; Ultrasonic Waves | 2021 |
Unsolved issues of The Efficacy and Safety of Edoxaban.
Topics: Atrial Fibrillation; Humans; Pyridines; Thiazoles; Warfarin | 2021 |
Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Confidence Intervals; Dabigatran; Denmark; Factor Xa Inhibitors; Female; Gastrointestinal Neoplasms; Hemorrhage; Humans; Male; Proportional Hazards Models; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2021 |
Novel chalcone-conjugated, multi-flexible end-group coumarin thiazole hybrids as potential antibacterial repressors against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Chalcones; Coumarins; Dose-Response Relationship, Drug; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2021 |
Comparative effectiveness and safety of edoxaban versus warfarin in patients with atrial fibrillation: A nationwide cohort study.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Pyridines; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin | 2022 |
Ratiometric Fluorescent Biosensors for Glucose and Lactate Using an Oxygen-Sensing Membrane.
Topics: Biosensing Techniques; Catalysis; Coumarins; Fluorescence; Fluorescent Dyes; Glucose; Glucose Oxidase; Humans; Lactic Acid; Limit of Detection; Oxygen; Platinum; Porphyrins; Spectrometry, Fluorescence; Thiazoles | 2021 |
Novel Coumarin-Thiadiazole Hybrids and Their Cu(II) and Zn(II) Complexes as Potential Antimicrobial Agents and Acetylcholinesterase Inhibitors.
Topics: Acetylcholinesterase; Anti-Bacterial Agents; Anti-Infective Agents; Cholinesterase Inhibitors; Copper; Coumarins; Crystallography, X-Ray; Escherichia coli; Ligands; Magnetic Resonance Spectroscopy; Metals; Microbial Sensitivity Tests; Neurodegenerative Diseases; Pseudomonas aeruginosa; Schiff Bases; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Staphylococcus aureus; Staphylococcus epidermidis; Thiadiazoles; Thiazoles; Zinc | 2021 |
Anti-proliferative, c-Met Inhibitions, and PAINS Evaluations of New Thiophene, Thiazole, Coumarin, Pyran, and Pyridine Derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Cyclohexanes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Protein Kinase Inhibitors; Pyrans; Pyridines; Structure-Activity Relationship; Thiazoles; Thiophenes | 2022 |
Hip fractures risks in edoxaban versus warfarin users: A propensity score-matched population-based cohort study with competing risk analyses.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Female; Hip Fractures; Humans; Male; Middle Aged; Propensity Score; Pyridines; Retrospective Studies; Risk Assessment; Stroke; Thiazoles; Warfarin | 2022 |
Coumarin thiazoles as unique structural skeleton of potential antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Coumarins; Mammals; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Skeleton; Thiazoles | 2022 |
Synthesis and biological evaluation of coumarin-thiazole hybrids as selective carbonic anhydrase IX and XII inhibitors.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Coumarins; Humans; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2022 |
Synthesis and antimicrobial activity of new series of thiazoles, pyridines and pyrazoles based on coumarin moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Coumarins; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Pyridines; Thiazoles | 2023 |